1.1 	A bill for an act
1.2 	relating to cannabis; transferring enforcement of edible cannabinoid products to 
1.3 	the Office of Cannabis Management; clarifying workplace testing for cannabis; 
1.4 	making technical changes related to the taxation of cannabis and related products; 
1.5 	replacing medical cannabis licenses with endorsements; establishing a petition 
1.6 	process to designate cannabinoids as nonintoxicating or approved for use in 
1.7 	lower-potency hemp edibles; authorizing lower-potency hemp edibles to contain 
1.8 	certain artificially derived cannabinoids created in making delta-9 
1.9 	tetrahydrocannabinol; allowing testing of certain hemp products to be performed 
1.10 	by labs meeting accreditation standards regardless of licensing status; authorizing 
1.11 	patients enrolled in the registry program to obtain cannabis flower from registered 
1.12 	designated caregivers; authorizing registered designated caregivers to cultivate 
1.13 	cannabis plants on behalf of patients enrolled in the registry program; authorizing 
1.14 	the Office of Cannabis Management to recall certain cannabis and related products; 
1.15 	transferring the duties of the medical cannabis program to the Office of Cannabis 
1.16 	Management on July 1, 2025; authorizing the appointment of deputy directors; 
1.17 	clarifying the process for transfer of certain licenses; providing for license 
1.18 	preapproval; removing the requirement that local governments perform certain 
1.19 	inspections; removing the requirement that license applications be scored based 
1.20 	on identified criteria and requiring that license applications be assessed based on 
1.21 	certain minimum criteria; requiring employees of cannabis businesses to meet 
1.22 	certain background check requirements; establishing social equity licenses; limiting 
1.23 	the number of certain licenses that can be made available in an application period; 
1.24 	providing for the conversion of a registration to sell certain hemp-derived products 
1.25 	into a hemp business license; providing for a cannabis research license 
1.26 	classification; authorizing the Office of Cannabis Management to adjust limits on 
1.27 	cultivation area; permitting certain businesses to transport cannabis and related 
1.28 	products between facilities operated by the business; replacing the prohibition on 
1.29 	certain sales of lower-potency hemp products with a prohibition on selling to an 
1.30 	obviously intoxicated person; providing for enforcement of unlicensed businesses 
1.31 	engaging in activities that require a license; making technical and conforming 
1.32 	changes;amending Minnesota Statutes 2022, sections 18K.03, by adding a 
1.33 	subdivision; 152.22, subdivisions 11, 14, by adding a subdivision; 152.25, 
1.34 	subdivision 2; 152.27, subdivisions 1, 2, 3, 4, 6, by adding a subdivision; 152.28, 
1.35 	subdivision 2; 152.29, subdivision 3; Minnesota Statutes 2023 Supplement, sections 
1.36 	3.9224; 151.72, subdivisions 1, 2, 4, 5a, 5b, 6, 7; 152.28, subdivision 1; 152.30; 
1.37 	256B.0625, subdivision 13d; 290.0132, subdivision 29; 290.0134, subdivision 19; 
1.38 	295.81, subdivisions 1, 4; 297A.67, subdivision 2; 297A.70, subdivision 2; 342.01, 
2.1 	subdivisions 3, 4, 12, 14, 16, 17, 19, 20, 48, 57, 64, 65, 66, by adding subdivisions; 
2.2 	342.02, subdivisions 2, 5, 6; 342.07, subdivision 3; 342.09, subdivisions 1, 3; 
2.3 	342.10; 342.11; 342.12; 342.13; 342.14; 342.15, subdivisions 1, 2, by adding a 
2.4 	subdivision; 342.16; 342.17; 342.18, subdivisions 2, 3, by adding subdivisions; 
2.5 	342.19, subdivisions 1, 3, 4, 5; 342.22; 342.24, subdivisions 1, 2; 342.28, 
2.6 	subdivision 2, by adding a subdivision; 342.29, subdivisions 1, 4; 342.30, 
2.7 	subdivision 4; 342.31, subdivision 4; 342.32, subdivision 4; 342.35, subdivision 
2.8 	1; 342.37, subdivision 1; 342.40, subdivision 7; 342.41, subdivisions 1, 3; 342.44, 
2.9 	subdivision 1; 342.46, subdivision 6; 342.51; 342.515; 342.52, subdivisions 1, 2, 
2.10 	3, 4, 5, 9, 11; 342.53; 342.54; 342.55, subdivisions 1, 2; 342.56, subdivisions 1, 
2.11 	2; 342.57, subdivisions 1, 2, 3, 4, 5, 6, 7; 342.58; 342.60; 342.61, subdivisions 4, 
2.12 	5; 342.62, by adding a subdivision; 342.63, subdivisions 2, 3, 4, 6; Laws 2023, 
2.13 	chapter 63, article 1, sections 2; 51; 52; 53; 54; 55; 56; 57; 58; 59; 61; article 6, 
2.14 	sections 10; 73; proposing coding for new law in Minnesota Statutes, chapter 342; 
2.15 	repealing Minnesota Statutes 2022, sections 152.22, subdivision 3; 152.36; 
2.16 	Minnesota Statutes 2023 Supplement, sections 342.01, subdivisions 28, 52, 53, 
2.17 	54, 55; 342.27, subdivision 13; 342.29, subdivision 9; 342.47; 342.48; 342.49; 
2.18 	342.50; 342.52, subdivision 8; Laws 2023, chapter 63, article 7, sections 4; 6.
2.19 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

2.20 	Section 1. Minnesota Statutes 2023 Supplement, section 3.9224, is amended to read:
2.21 	3.9224 MEDICAL CANNABIS; COMPACTS TO BE NEGOTIATED.
2.22 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
2.23 	meanings given.
2.24 	(b) "Medical cannabis law" or "medical cannabis program" means the regulatory 
2.25 	framework for cultivation, production, distribution, and sale of cannabis to qualifying 
2.26 	patients for therapeutic use in the treatment of a qualifying condition.
2.27 	(c) "Medical Cannabis flower" means cannabis flower approved for sale under the 
2.28 	medical cannabis law of a Minnesota Tribal government or under a compact entered into 
2.29 	under this section.
2.30 	(d) "Medical cannabis product" means a cannabis product approved for sale under the 
2.31 	medical cannabis law of a Minnesota Tribal government or under a compact entered into 
2.32 	under this section.
2.33 	(e) "Medical cannabis business" means a medical cannabis cultivator, processor, or 
2.34 	retailer business with a medical cannabis retail endorsement.
2.35 	(f) "Medical cannabis industry" means every item, product, person, process, action, 
2.36 	business, or other thing or activity related to medical cannabis flower or medical cannabis 
2.37 	products and subject to regulation under the law of a Minnesota Tribal government or under 
2.38 	a compact entered into under this section.
2.39 	(g) "Cannabis product" means any of the following:
3.1 	(1) cannabis concentrate;
3.2 	(2) a product infused with cannabinoids, whether artificially derived, or extracted or 
3.3 	derived from cannabis plants or cannabis flower, including but not limited to 
3.4 	tetrahydrocannabinol; or
3.5 	(3) any other product that contains cannabis concentrate.
3.6 	(h) "Minnesota Tribal governments" means the following federally recognized Indian 
3.7 	Tribes located in Minnesota:
3.8 	(1) Bois Forte Band;
3.9 	(2) Fond Du Lac Band;
3.10 	(3) Grand Portage Band;
3.11 	(4) Leech Lake Band;
3.12 	(5) Mille Lacs Band;
3.13 	(6) White Earth Band;
3.14 	(7) Red Lake Nation;
3.15 	(8) Lower Sioux Indian Community;
3.16 	(9) Prairie Island Indian Community;
3.17 	(10) Shakopee Mdewakanton Sioux Community; and
3.18 	(11) Upper Sioux Indian Community.
3.19 	(i) "Tribal medical cannabis business" means a medical cannabis business licensed by 
3.20 	a Minnesota Tribal government, including the business categories identified in paragraph 
3.21 	(e), as well as any others that may be provided under the law of a Minnesota Tribal 
3.22 	government.
3.23 	(j) "Tribally regulated land" means:
3.24 	(1) all land held in trust by the United States for the benefit of a Minnesota Tribal 
3.25 	government ("trust land");
3.26 	(2) all land held by a Minnesota Tribal government in restricted fee status; and
3.27 	(3) all land within the exterior boundaries of the reservation of a Minnesota Tribal 
3.28 	government that is subject to the civil regulatory jurisdiction of the Tribal government. For 
3.29 	the purposes of this section, land that is subject to the civil regulatory jurisdiction of the 
3.30 	Tribal government includes:
4.1 	(i) trust land, or fee land held, including leased land, by the Tribe, entities organized 
4.2 	under Tribal law, or individual Indians; and
4.3 	(ii) land held, including leased land, by non-Indian entities or individuals who consent 
4.4 	to the civil regulation of the Tribal government or are otherwise subject to such regulation 
4.5 	under federal law.
4.6 		Subd. 2.Acknowledgment and purpose; negotiations authorized. (a) The state of 
4.7 	Minnesota acknowledges the sovereign right of Minnesota Tribal governments to regulate 
4.8 	the medical cannabis industry and address other matters of cannabis regulation related to 
4.9 	the internal affairs of Minnesota Tribal governments or otherwise within their jurisdiction, 
4.10 	without regard to whether such Tribal government has entered a compact authorized by this 
4.11 	section. The purpose of this section is to provide for the negotiation of compacts to 
4.12 	proactively address jurisdictional issues related to the regulation of the medical cannabis 
4.13 	industry. The legislature finds that these agreements will facilitate and promote a cooperative 
4.14 	and mutually beneficial relationship between the state and the Tribes regarding the 
4.15 	legalization of cannabis. Such cooperative agreements will enhance public health and safety, 
4.16 	ensure a lawful and well-regulated medical cannabis market, encourage economic 
4.17 	development, and provide fiscal benefits to both Indian Tribes and the state.
4.18 	(b) The governor or the governor's designee shall negotiate in good faith, and has the 
4.19 	authority to execute and bind the state to, a compact with any Minnesota Tribal government 
4.20 	wishing to enter into such a compact regulating medical cannabis flower and medical 
4.21 	cannabis products.
4.22 		Subd. 3.Terms of compact; rights of parties. (a) A compact agreed to under this 
4.23 	section may address any issues related to the medical cannabis industry, including medical
4.24 	cannabis flower, medical cannabis products, extracts, concentrates, and artificially derived 
4.25 	cannabinoids that affect the interest of both the state and Minnesota Tribal government or 
4.26 	otherwise have an impact on Tribal-state relations. Indian Tribes are not required to enter 
4.27 	into compacts pursuant to this section in order to regulate the medical cannabis industry, 
4.28 	or engage in medical cannabis businesses or activities on Tribally regulated land or participate 
4.29 	as a licensee in the state's legal medical cannabis market.
4.30 	(b) The state shall not, as a condition for entering into a compact under this section:
4.31 	(1) require any Minnesota Tribal government to waive any right, privilege, or immunity 
4.32 	based on their status as independent sovereigns;
5.1 	(2) require that any revenue generated by a medical cannabis business licensed by a 
5.2 	Minnesota Tribal government be subject to any state cannabis gross receipt taxes or state 
5.3 	and local sales or use taxes on sales of cannabis;
5.4 	(3) require any taxes collected by Minnesota Tribal governments to be shared in any 
5.5 	manner with the state or any subdivisions thereof;
5.6 	(4) require a Minnesota Tribal government to consent to state licensing of a medical 
5.7 	cannabis business on the Tribally regulated land of the Minnesota Tribal government;
5.8 	(5) require any Minnesota Tribal government or any medical cannabis business licensed 
5.9 	by a Minnesota Tribal government pursuant to a compact agreed to under this section to 
5.10 	comply with specific state law or regulations on Tribally regulated land; or
5.11 	(6) impose, or attempt to impose, and shall not require or attempt to require any Indian 
5.12 	Tribe to impose, any taxes, fees, assessments, and other charges related to the production, 
5.13 	processing, sale, purchase, distribution, or possession of medical cannabis flower and medical 
5.14 	cannabis products on Minnesota Tribal governments, or their members, on a reservation or 
5.15 	Tribally regulated land.
5.16 	(c) Compacts agreed to under this section may allow an exemption from any otherwise 
5.17 	applicable tax for: (i) sales to a Minnesota Tribal government, a Tribal medical cannabis 
5.18 	business, or Tribal members, of medical cannabis flower and cannabis products grown, 
5.19 	produced, or processed as provided for in said compacts; or (ii) for activities of Tribal 
5.20 	medical cannabis businesses.
5.21 		Subd. 4.Civil and criminal immunities. (a) Without limiting any immunity or exemption 
5.22 	that may apply under federal law, the following acts, when performed by a Tribal medical 
5.23 	cannabis business or an employee in the course of their employment for a Tribal medical 
5.24 	cannabis business, pursuant to a compact entered into under this section, do not constitute 
5.25 	a criminal or civil offense under state law:
5.26 	(1) the cultivation of medical cannabis flower, and the extraction, processing, or 
5.27 	manufacture of medical cannabis and artificially derived cannabinoid products, extracts, or 
5.28 	concentrates;
5.29 	(2) the possession, purchase, and receipt of medical cannabis seed, cannabis flower, and 
5.30 	medical cannabis products that are properly packaged and labeled as authorized under a 
5.31 	compact entered into pursuant to this section, and the sale, delivery, transport, or distribution 
5.32 	of such products to a licensed cannabis business; and
6.1 	(3) the delivery, distribution, and sale of medical cannabis seed, cannabis flower, and 
6.2 	medical cannabis products as authorized under a compact entered into pursuant to this 
6.3 	section and that takes place on, or originates from, the premises of a Tribal medical cannabis 
6.4 	business on Tribally regulated land, to any person eligible to participate in a medical cannabis 
6.5 	program.
6.6 	(b) The following acts, when performed by a patron of a Tribal medical cannabis business 
6.7 	do not constitute a criminal or civil offense under state law: the purchase, possession, or 
6.8 	receipt of medical cannabis seed, cannabis flower, and medical cannabis products as 
6.9 	authorized under a compact entered into pursuant to this section.
6.10 	(c) Without limiting any immunity or exemption that may apply under federal law, 
6.11 	actions by a Tribal medical cannabis business, a Tribal member, employee, or agent of a 
6.12 	Minnesota Tribal government or Tribal medical cannabis business on Tribally regulated 
6.13 	land pursuant to Tribal laws governing cannabis, or a compact entered into under this section, 
6.14 	do not constitute a criminal or civil offense under state law.
6.15 	(d) The following acts, when performed by a state-licensed medical cannabis business, 
6.16 	or an employee of such business, and which would be permitted under the terms of the 
6.17 	applicable medical cannabis business license if undertaken with another state-licensed 
6.18 	medical cannabis business, are permitted under the state license conditions when undertaken 
6.19 	with a Tribal medical cannabis business and do not constitute a criminal or civil offense 
6.20 	under state law: the possession, purchase, wholesale and retail sale, delivery, transport, 
6.21 	distribution, and receipt of medical cannabis, seed, cannabis flower, and medical cannabis 
6.22 	products that are properly packaged and labeled as authorized under a compact entered into 
6.23 	pursuant to this section.
6.24 	(e) Without limiting any immunity or exemption that may apply under federal law, the 
6.25 	following acts, when performed by a Minnesota Tribal government, a Tribal medical cannabis 
6.26 	business licensed by such Tribal government, or an employee of such Tribal government 
6.27 	or Tribal medical cannabis business, regardless of whether the Minnesota Tribal government 
6.28 	issuing such license has compacted with the state under this section, do not constitute a 
6.29 	criminal or civil offense under state law: purchase, sale, receipt, or delivery (including 
6.30 	delivery that involves transit through the state, outside a reservation), of medical cannabis 
6.31 	flower, cannabis seed, and medical cannabis products from or to another Minnesota Tribal 
6.32 	government or cannabis business licensed by such government.
6.33 	(f) Notwithstanding any other provision of law, a state-licensed cannabis testing facility 
6.34 	may provide cannabis testing services to a Tribal medical cannabis business, and the 
7.1 	possession or transport of cannabis flower or cannabis products for such purpose by a Tribal 
7.2 	cannabis business shall not constitute a criminal or civil offense under state law.
7.3 		Subd. 5.Publication. The governor shall post any compact entered into under this section 
7.4 	on a publicly accessible website.

7.5 	EFFECTIVE DATE. This section is effective the day following final enactment.

7.6 	Sec. 2. Minnesota Statutes 2022, section 18K.03, is amended by adding a subdivision to 
7.7 	read:
7.8 		Subd. 3.Sale to cannabis and hemp businesses. (a) An industrial hemp grower licensed 
7.9 	under this chapter may sell hemp plant parts and propagules to a cannabis business or hemp 
7.10 	business licensed under chapter 342.
7.11 	(b) An industrial hemp processor licensed under this chapter may sell hemp concentrate 
7.12 	to a cannabis business or hemp business licensed under chapter 342.

7.13 	Sec. 3. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 1, is amended 
7.14 	to read:
7.15 		Subdivision 1.Definitions. For the purposes of this section, the following terms have 
7.16 	the meanings given.
7.17 	(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant 
7.18 	or hemp plant parts with a chemical makeup that is changed after extraction to create a 
7.19 	different cannabinoid or other chemical compound by applying a catalyst other than heat 
7.20 	or light. Artificially derived cannabinoid includes but is not limited to any 
7.21 	tetrahydrocannabinol created from cannabidiol.
7.22 	(b) "Batch" means a specific quantity of a specific product containing cannabinoids 
7.23 	derived from hemp, including an edible cannabinoid product, that is manufactured at the 
7.24 	same time and using the same methods, equipment, and ingredients that is uniform and 
7.25 	intended to meet specifications for identity, strength, purity, and composition, and that is 
7.26 	manufactured, packaged, and labeled according to a single batch production record executed 
7.27 	and documented.
7.28 	(c) "Certified hemp" means hemp plants that have been tested and found to meet the 
7.29 	requirements of chapter 18K and the rules adopted thereunder.
7.30 	(d) "Commissioner" means the commissioner of health.
8.1 	(e) (d) "Distributor" means a person who sells, arranges a sale, or delivers a product 
8.2 	containing cannabinoids derived from hemp, including an edible cannabinoid product, that 
8.3 	the person did not manufacture to a retail establishment for sale to consumers. Distributor 
8.4 	does not include a common carrier used only to complete delivery to a retailer.
8.5 	(f) (e) "Edible cannabinoid product" means any product that is intended to be eaten or 
8.6 	consumed as a beverage by humans, contains a cannabinoid in combination with food 
8.7 	ingredients, and is not a drug.
8.8 	(g) (f) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 
8.9 	3.
8.10 	(h) (g) "Label" has the meaning given in section 151.01, subdivision 18.
8.11 	(i) (h) "Labeling" means all labels and other written, printed, or graphic matter that are:
8.12 	(1) affixed to the immediate container in which a product regulated under this section 
8.13 	is sold;
8.14 	(2) provided, in any manner, with the immediate container, including but not limited to 
8.15 	outer containers, wrappers, package inserts, brochures, or pamphlets; or
8.16 	(3) provided on that portion of a manufacturer's website that is linked by a scannable 
8.17 	barcode or matrix barcode.
8.18 	(j) (i) "Matrix barcode" means a code that stores data in a two-dimensional array of 
8.19 	geometrically shaped dark and light cells capable of being read by the camera on a 
8.20 	smartphone or other mobile device.
8.21 	(k) (j) "Nonintoxicating cannabinoid" means substances extracted from certified hemp 
8.22 	plants that do not produce intoxicating effects when consumed by any route of administration.
8.23 	(k) "Office" means the director of the Office of Cannabis Management.
8.24 	(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and 
8.25 	pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp 
8.26 	plants, or hemp plant parts and is instead created or produced by chemical or biochemical 
8.27 	synthesis.
8.28 	(m) "Tincture" means a solution of hemp extract, derived either directly from a hemp 
8.29 	plant or from a manufactured hemp extract, dissolved in glycerin, food-grade oils, or other 
8.30 	food-grade solvents and is intended to be consumed through oral administration or intended 
8.31 	to be consumed in combination with food products, including beverages.

8.32 	EFFECTIVE DATE. This section is effective July 1, 2024.

9.1 	Sec. 4. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 2, is amended 
9.2 	to read:
9.3 		Subd. 2.Scope. (a) This section applies to the sale of any product that contains 
9.4 	cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended 
9.5 	for human or animal consumption by any route of administration.
9.6 	(b) This section does not apply to any product dispensed by a registered medical cannabis 
9.7 	manufacturer pursuant to sections 152.22 to 152.37.
9.8 	(c) The commissioner office must have no authority over food products, as defined in 
9.9 	section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from 
9.10 	hemp.

9.11 	EFFECTIVE DATE. This section is effective July 1, 2024.

9.12 	Sec. 5. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 4, is amended 
9.13 	to read:
9.14 		Subd. 4.Testing requirements. (a) A manufacturer of a product regulated under this 
9.15 	section must submit representative samples of each batch of the product to an independent, 
9.16 	accredited laboratory in order to certify that the product complies with the standards adopted 
9.17 	by the board on or before July 1, 2023, or the standards adopted by the commissioner office. 
9.18 	Testing must be consistent with generally accepted industry standards for herbal and botanical 
9.19 	substances, and, at a minimum, the testing must confirm that the product:
9.20 	(1) contains the amount or percentage of cannabinoids that is stated on the label of the 
9.21 	product;
9.22 	(2) does not contain more than trace amounts of any mold, residual solvents or other 
9.23 	catalysts, pesticides, fertilizers, or heavy metals; and
9.24 	(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.
9.25 	(b) A manufacturer of a product regulated under this section must disclose all known 
9.26 	information regarding pesticides, fertilizers, solvents, or other foreign materials applied to 
9.27 	industrial hemp or added to industrial hemp during any production or processing stages of 
9.28 	any batch from which a representative sample has been sent for testing, including any 
9.29 	catalysts used to create artificially derived cannabinoids. The disclosure must be made to 
9.30 	the laboratory performing testing or sampling and, upon request, to the commissioner office. 
9.31 	The disclosure must include all information known to the licensee manufacturer regardless 
10.1 	of whether the application or addition was made intentionally or accidentally, or by the 
10.2 	manufacturer or any other person.
10.3 	(c) Upon the request of the commissioner office, the manufacturer of the product must 
10.4 	provide the commissioner office with the results of the testing required in this section.
10.5 	(d) The commissioner office may determine that any testing laboratory that does not 
10.6 	operate formal management systems under the International Organization for Standardization 
10.7 	is not an accredited laboratory and require that a representative sample of a batch of the 
10.8 	product be retested by a testing laboratory that meets this requirement.
10.9 	(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or 
10.10 	possession of a certificate of analysis for such hemp, does not meet the testing requirements 
10.11 	of this section.

10.12 	EFFECTIVE DATE. This section is effective July 1, 2024.

10.13 	Sec. 6. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5a, is amended 
10.14 	to read:
10.15 		Subd. 5a.Additional requirements for edible cannabinoid products. (a) In addition 
10.16 	to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid 
10.17 	must meet the requirements of this subdivision.
10.18 	(b) An edible cannabinoid product must not:
10.19 	(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, 
10.20 	animal, or fruit that appeals to children;
10.21 	(2) be modeled after a brand of products primarily consumed by or marketed to children;
10.22 	(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a 
10.23 	commercially available candy or snack food item;
10.24 	(4) be substantively similar to a meat food product; poultry food product as defined in 
10.25 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
10.26 	7;
10.27 	(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved 
10.28 	by the United States Food and Drug Administration for use in food;
10.29 	(6) be packaged in a way that resembles the trademarked, characteristic, or 
10.30 	product-specialized packaging of any commercially available food product; or
11.1 	(7) be packaged in a container that includes a statement, artwork, or design that could 
11.2 	reasonably mislead any person to believe that the package contains anything other than an 
11.3 	edible cannabinoid product.
11.4 	(c) An edible cannabinoid product must be prepackaged in packaging or a container that 
11.5 	is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is 
11.6 	child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The 
11.7 	requirement that packaging be child-resistant does not apply to an edible cannabinoid product 
11.8 	that is intended to be consumed as a beverage.
11.9 	(d) If an edible cannabinoid product, other than a product that is intended to be consumed 
11.10 	as a beverage, is intended for more than a single use or contains multiple servings, each 
11.11 	serving must be indicated by scoring, wrapping, or other indicators designating the individual 
11.12 	serving size that appear on the edible cannabinoid product. If it is not possible to indicate 
11.13 	a single serving by scoring or use of another indicator that appears on the product, the edible 
11.14 	cannabinoid product may not be packaged in a manner that includes more than a single 
11.15 	serving in each container, except that a calibrated dropper, measuring spoon, or similar 
11.16 	device for measuring a single serving, when sold with the product, may be used for any 
11.17 	tincture, or other edible cannabinoid products that are intended to be combined with food 
11.18 	products, to include beverages, prior to consumption.
11.19 	(e) A label containing at least the following information must be affixed to the packaging 
11.20 	or container of all edible cannabinoid products sold to consumers:
11.21 	(1) the serving size;
11.22 	(2) the cannabinoid profile per serving and in total;
11.23 	(3) a list of ingredients, including identification of any major food allergens declared 
11.24 	by name; and
11.25 	(4) the following statement: "Keep this product out of reach of children."
11.26 	(f) An edible cannabinoid product must not contain more than five milligrams of any 
11.27 	tetrahydrocannabinol in a single serving. An edible cannabinoid product, other than a product 
11.28 	that is intended to be consumed as a beverage, may not contain more than a total of 50 
11.29 	milligrams of any tetrahydrocannabinol per package. An edible cannabinoid product that 
11.30 	is intended to be consumed as a beverage may not contain more than two servings per 
11.31 	container.
11.32 	(g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9 
11.33 	tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an 
12.1 	artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing 
12.2 	any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and 
12.3 	HHC, unless the commissioner office authorizes use of the artificially derived cannabinoid 
12.4 	in edible cannabinoid products. Edible cannabinoid products are prohibited from containing 
12.5 	synthetic cannabinoids.
12.6 	(h) Every person selling edible cannabinoid products to consumers, other than products 
12.7 	that are intended to be consumed as a beverage, must ensure that all edible cannabinoid 
12.8 	products are displayed behind a checkout counter where the public is not permitted or in a 
12.9 	locked case.

12.10 	EFFECTIVE DATE. This section is effective July 1, 2024.

12.11 	Sec. 7. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5b, is amended 
12.12 	to read:
12.13 		Subd. 5b.Registration; prohibitions. (a) On or before October 1, 2023, every person 
12.14 	selling edible cannabinoid products to consumers must register with the commissioner in 
12.15 	a form and manner established by the commissioner. After October 1, 2023, the sale of 
12.16 	edible cannabinoid products by a person that is not registered is prohibited.
12.17 	(a) Every person selling an edible cannabinoid product to a consumer must be registered 
12.18 	with the office. All existing registrations with the Department of Health, Office of Medical 
12.19 	Cannabis, as of June 30, 2024, will automatically transfer to the office on July 1, 2024. All 
12.20 	other persons required to register must register in a form and manner established by the 
12.21 	office. The sale of edible cannabinoid products by a person who is not registered with the 
12.22 	office is prohibited.
12.23 	(b) The registration form must contain an attestation of compliance and each registrant 
12.24 	must affirm that it is operating and will continue to operate in compliance with the 
12.25 	requirements of this section and all other applicable state and local laws and ordinances.
12.26 	(c) The commissioner shall office must not charge a fee for registration under this 
12.27 	subdivision.

12.28 	Sec. 8. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 6, is amended 
12.29 	to read:
12.30 		Subd. 6.Noncompliant products; enforcement. (a) A product regulated under this 
12.31 	section, including an edible cannabinoid product, shall be considered a noncompliant product 
12.32 	if the product is offered for sale in this state or if the product is manufactured, imported, 
13.1 	distributed, or stored with the intent to be offered for sale in this state in violation of any 
13.2 	provision of this section, including but not limited to if:
13.3 	(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;
13.4 	(2) it has been produced, prepared, packed, or held under unsanitary conditions where 
13.5 	it may have been rendered injurious to health, or where it may have been contaminated with 
13.6 	filth;
13.7 	(3) its container is composed, in whole or in part, of any poisonous or deleterious 
13.8 	substance that may render the contents injurious to health;
13.9 	(4) it contains any food additives, color additives, or excipients that have been found by 
13.10 	the FDA to be unsafe for human or animal consumption;
13.11 	(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different 
13.12 	than the amount or percentage stated on the label;
13.13 	(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is 
13.14 	an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits 
13.15 	established in subdivision 5a, paragraph (f); or
13.16 	(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, 
13.17 	or heavy metals.
13.18 	(b) A product regulated under this section shall be considered a noncompliant product 
13.19 	if the product's labeling is false or misleading in any manner or in violation of the 
13.20 	requirements of this section.
13.21 	(c) The commissioner office may assume that any product regulated under this section 
13.22 	that is present in the state, other than a product lawfully possessed for personal use, has 
13.23 	been manufactured, imported, distributed, or stored with the intent to be offered for sale in 
13.24 	this state if a product of the same type and brand was sold in the state on or after July 1, 
13.25 	2023, or if the product is in the possession of a person who has sold any product in violation 
13.26 	of this section.
13.27 	(d) The commissioner office may enforce this section, including enforcement against a 
13.28 	manufacturer or distributor of a product regulated under this section, under sections 144.989 
13.29 	to 144.993 section 342.19.
13.30 	(e) The commissioner may enter into an interagency agreement with The office of 
13.31 	Cannabis Management and may enter into an interagency agreement with the commissioner 
14.1 	of agriculture to perform inspections and take other enforcement actions on behalf of the 
14.2 	commissioner office.

14.3 	EFFECTIVE DATE. This section is effective July 1, 2024.

14.4 	Sec. 9. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 7, is amended 
14.5 	to read:
14.6 		Subd. 7.Violations; criminal penalties. (a) Notwithstanding section 144.99, subdivision 
14.7 	11, A person who does any of the following regarding a product regulated under this section 
14.8 	is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 
14.9 	364 days or to payment of a fine of not more than $3,000, or both:
14.10 	(1) knowingly alters or otherwise falsifies testing results;
14.11 	(2) intentionally alters or falsifies any information required to be included on the label 
14.12 	of an edible cannabinoid product; or
14.13 	(3) intentionally makes a false material statement to the commissioner office.
14.14 	(b) Notwithstanding section 144.99, subdivision 11, A person who does any of the 
14.15 	following on the premises of a registered retailer or another business that sells retail goods 
14.16 	to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for 
14.17 	not more than 364 days or to payment of a fine of not more than $3,000, or both:
14.18 	(1) sells an edible cannabinoid product knowing that the product does not comply with 
14.19 	the limits on the amount or types of cannabinoids that a product may contain;
14.20 	(2) sells an edible cannabinoid product knowing that the product does not comply with 
14.21 	the applicable testing, packaging, or labeling requirements; or
14.22 	(3) sells an edible cannabinoid product to a person under the age of 21, except that it is 
14.23 	an affirmative defense to a charge under this clause if the defendant proves by a 
14.24 	preponderance of the evidence that the defendant reasonably and in good faith relied on 
14.25 	proof of age as described in subdivision 5c.

14.26 	EFFECTIVE DATE. This section is effective July 1, 2024.

14.27 	Sec. 10. Minnesota Statutes 2022, section 152.22, subdivision 11, is amended to read:
14.28 		Subd. 11.Registered designated caregiver. "Registered designated caregiver" means 
14.29 	a person who:
14.30 	(1) is at least 18 years old;
15.1 	(2) does not have a conviction for a disqualifying felony offense;
15.2 	(3) (2) has been approved by the commissioner office to assist a patient who requires 
15.3 	assistance in administering medical cannabis or obtaining medical cannabis from a 
15.4 	distribution facility; and
15.5 	(4) (3) is authorized by the commissioner office to assist the patient with the use of 
15.6 	medical cannabis.

15.7 	EFFECTIVE DATE. This section is effective July 1, 2024.

15.8 	Sec. 11. Minnesota Statutes 2022, section 152.22, subdivision 14, is amended to read:
15.9 		Subd. 14.Qualifying medical condition. "Qualifying medical condition" means a 
15.10 	diagnosis of any of the following conditions:
15.11 	(1) Alzheimer's disease;
15.12 	(2) autism spectrum disorder that meets the requirements of the fifth edition of the 
15.13 	Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric 
15.14 	Association;
15.15 	(1) (3) cancer, if the underlying condition or treatment produces one or more of the 
15.16 	following:
15.17 	(i) severe or chronic pain;
15.18 	(ii) nausea or severe vomiting; or
15.19 	(iii) cachexia or severe wasting;
15.20 	(4) chronic motor or vocal tic disorder;
15.21 	(5) chronic pain;
15.22 	(2) (6) glaucoma;
15.23 	(3) (7) human immunodeficiency virus or acquired immune deficiency syndrome;
15.24 	(8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
15.25 	(9) obstructive sleep apnea;
15.26 	(10) post-traumatic stress disorder;
15.27 	(4) (11) Tourette's syndrome;
15.28 	(5) (12) amyotrophic lateral sclerosis;
15.29 	(6) (13) seizures, including those characteristic of epilepsy;
16.1 	(7) (14) severe and persistent muscle spasms, including those characteristic of multiple 
16.2 	sclerosis;
16.3 	(8) (15) inflammatory bowel disease, including Crohn's disease;
16.4 	(16) irritable bowel syndrome;
16.5 	(17) obsessive-compulsive disorder;
16.6 	(18) sickle cell disease;
16.7 	(9) (19) terminal illness, with a probable life expectancy of under one year, if the illness 
16.8 	or its treatment produces one or more of the following:
16.9 	(i) severe or chronic pain;
16.10 	(ii) nausea or severe vomiting; or
16.11 	(iii) cachexia or severe wasting; or
16.12 	(10) (20) any other medical condition or its treatment approved by the commissioner
16.13 	office.

16.14 	EFFECTIVE DATE. This section is effective July 1, 2024.

16.15 	Sec. 12. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
16.16 	read:
16.17 		Subd. 19.Veteran. "Veteran" means an individual who satisfies the requirements in 
16.18 	section 197.447 and is receiving care from the United States Department of Veterans Affairs.

16.19 	EFFECTIVE DATE. This section is effective July 1, 2024.

16.20 	Sec. 13. Minnesota Statutes 2022, section 152.25, subdivision 2, is amended to read:
16.21 		Subd. 2.Range of compounds and dosages; report. The commissioner office shall 
16.22 	review and publicly report the existing medical and scientific literature regarding the range 
16.23 	of recommended dosages for each qualifying condition and the range of chemical 
16.24 	compositions of any plant of the genus cannabis that will likely be medically beneficial for 
16.25 	each of the qualifying medical conditions. The commissioner office shall make this 
16.26 	information available to patients with qualifying medical conditions beginning December 
16.27 	1, 2014, and update the information annually every three years. The commissioner office
16.28 	may consult with the independent laboratory under contract with the manufacturer or other 
16.29 	experts in reporting the range of recommended dosages for each qualifying medical condition, 
16.30 	the range of chemical compositions that will likely be medically beneficial, and any risks 
17.1 	of noncannabis drug interactions. The commissioner office shall consult with each 
17.2 	manufacturer on an annual basis on medical cannabis offered by the manufacturer. The list 
17.3 	of medical cannabis offered by a manufacturer shall be published on the Department of 
17.4 	Health Office of Cannabis Management website.

17.5 	EFFECTIVE DATE. This section is effective July 1, 2024.

17.6 	Sec. 14. Minnesota Statutes 2022, section 152.27, subdivision 1, is amended to read:
17.7 		Subdivision 1.Patient registry program; establishment. (a) The commissioner office
17.8 	shall establish a patient registry program to evaluate data on patient demographics, effective 
17.9 	treatment options, clinical outcomes, and quality-of-life outcomes for the purpose of reporting 
17.10 	on the benefits, risks, and outcomes regarding patients with a qualifying medical condition 
17.11 	engaged in the therapeutic use of medical cannabis.
17.12 	(b) The establishment of the registry program shall not be construed or interpreted to 
17.13 	condone or promote the illicit recreational use of marijuana.

17.14 	EFFECTIVE DATE. This section is effective July 1, 2024.

17.15 	Sec. 15. Minnesota Statutes 2022, section 152.27, subdivision 2, is amended to read:
17.16 		Subd. 2.Commissioner Office duties. (a) The commissioner office shall:
17.17 	(1) give notice of the program to health care practitioners in the state who are eligible 
17.18 	to serve as health care practitioners and explain the purposes and requirements of the 
17.19 	program;
17.20 	(2) allow each health care practitioner who meets or agrees to meet the program's 
17.21 	requirements and who requests to participate, to be included in the registry program to 
17.22 	collect data for the patient registry;
17.23 	(3) provide explanatory information and assistance to each health care practitioner in 
17.24 	understanding the nature of therapeutic use of medical cannabis within program requirements;
17.25 	(4) create and provide a certification to be used by a health care practitioner for the 
17.26 	practitioner to certify whether a patient has been diagnosed with a qualifying medical 
17.27 	condition and include in the certification an option for the practitioner to certify whether 
17.28 	the patient, in the health care practitioner's medical opinion, is developmentally or physically 
17.29 	disabled and, as a result of that disability, the patient requires assistance in administering 
17.30 	medical cannabis or obtaining medical cannabis from a distribution facility;
18.1 	(5) supervise the participation of the health care practitioner in conducting patient 
18.2 	treatment and health records reporting in a manner that ensures stringent security and 
18.3 	record-keeping requirements and that prevents the unauthorized release of private data on 
18.4 	individuals as defined by section 13.02;
18.5 	(6) develop safety criteria for patients with a qualifying medical condition as a 
18.6 	requirement of the patient's participation in the program, to prevent the patient from 
18.7 	undertaking any task under the influence of medical cannabis that would constitute negligence 
18.8 	or professional malpractice on the part of the patient; and
18.9 	(7) conduct research and studies based on data from health records submitted to the 
18.10 	registry program and submit reports on intermediate or final research results to the legislature 
18.11 	and major scientific journals. The commissioner office may contract with a third party to 
18.12 	complete the requirements of this clause. Any reports submitted must comply with section 
18.13 	152.28, subdivision 2.
18.14 	(b) The commissioner office may add a delivery method under section 152.22, subdivision 
18.15 	6, or add, remove, or modify a qualifying medical condition under section 152.22, subdivision 
18.16 	14, upon a petition from a member of the public or the task force on medical cannabis 
18.17 	therapeutic research Cannabis Advisory Council under section 342.03, or as directed by 
18.18 	law. The commissioner office shall evaluate all petitions to add a qualifying medical condition 
18.19 	or to remove or modify an existing qualifying medical condition submitted by the task force 
18.20 	on medical cannabis therapeutic research Cannabis Advisory Council under section 342.03,
18.21 	or as directed by law and may make the addition, removal, or modification if the 
18.22 	commissioner office determines the addition, removal, or modification is warranted based 
18.23 	on the best available evidence and research. If the commissioner office wishes to add a 
18.24 	delivery method under section 152.22, subdivision 6, or add or remove modify a qualifying 
18.25 	medical condition under section 152.22, subdivision 14, the commissioner office must notify 
18.26 	the chairs and ranking minority members of the legislative policy committees having 
18.27 	jurisdiction over commerce, health, and public safety of the addition or removal modification
18.28 	and the reasons for its addition or removal modification, including any written comments 
18.29 	received by the commissioner office from the public and any guidance received from the 
18.30 	task force on medical cannabis research Cannabis Advisory Council under section 342.03, 
18.31 	by January 15 of the year in which the commissioner office wishes to make the change. The 
18.32 	change shall be effective on August 1 of that year, unless the legislature by law provides 
18.33 	otherwise.

18.34 	EFFECTIVE DATE. This section is effective July 1, 2024.

19.1 	Sec. 16. Minnesota Statutes 2022, section 152.27, subdivision 3, is amended to read:
19.2 		Subd. 3.Patient application. (a) The commissioner office shall develop a patient 
19.3 	application for enrollment into the registry program. The application shall be available to 
19.4 	the patient and given to health care practitioners in the state who are eligible to serve as 
19.5 	health care practitioners. The application must include:
19.6 	(1) the name, mailing address, and date of birth of the patient;
19.7 	(2) the name, mailing address, and telephone number of the patient's health care 
19.8 	practitioner;
19.9 	(3) the name, mailing address, and date of birth of the patient's designated caregiver, if 
19.10 	any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, or spouse 
19.11 	will be acting as a caregiver;
19.12 	(4) a copy of the certification from the patient's health care practitioner that is dated 
19.13 	within 90 days prior to submitting the application that certifies that the patient has been 
19.14 	diagnosed with a qualifying medical condition; and
19.15 	(5) all other signed affidavits and enrollment forms required by the commissioner office
19.16 	under sections 152.22 to 152.37, including, but not limited to, the disclosure form required 
19.17 	under paragraph (c) (b).
19.18 	(b) The commissioner shall require a patient to resubmit a copy of the certification from 
19.19 	the patient's health care practitioner on a yearly basis and shall require that the recertification 
19.20 	be dated within 90 days of submission.
19.21 	(c) (b) The commissioner office shall develop a disclosure form and require, as a condition 
19.22 	of enrollment, all patients to sign a copy of the disclosure. The disclosure must include:
19.23 	(1) a statement that, notwithstanding any law to the contrary, the commissioner office, 
19.24 	or an employee of any state agency, may not be held civilly or criminally liable for any 
19.25 	injury, loss of property, personal injury, or death caused by any act or omission while acting 
19.26 	within the scope of office or employment under sections 152.22 to 152.37; and
19.27 	(2) the patient's acknowledgment that enrollment in the patient registry program is 
19.28 	conditional on the patient's agreement to meet all of the requirements of sections 152.22 to 
19.29 	152.37.

19.30 	EFFECTIVE DATE. This section is effective July 1, 2024.

20.1 	Sec. 17. Minnesota Statutes 2022, section 152.27, is amended by adding a subdivision to 
20.2 	read:
20.3 		Subd. 3a.Application procedure for veterans. (a) The office shall establish an 
20.4 	alternative certification procedure for veterans to confirm that the veteran has been diagnosed 
20.5 	with a qualifying medical condition.
20.6 	(b) A patient who is also a veteran and is seeking to enroll in the registry program must 
20.7 	submit a copy of the patient's veteran health identification card issued by the United States 
20.8 	Department of Veterans Affairs and an application established by the office to certify that 
20.9 	the patient has been diagnosed with a qualifying medical condition.

20.10 	EFFECTIVE DATE. This section is effective July 1, 2024.

20.11 	Sec. 18. Minnesota Statutes 2022, section 152.27, subdivision 4, is amended to read:
20.12 		Subd. 4.Registered designated caregiver. (a) The commissioner office shall register 
20.13 	a designated caregiver for a patient if the patient requires assistance in administering medical 
20.14 	cannabis or obtaining medical cannabis from a distribution facility and the caregiver has 
20.15 	agreed, in writing, to be the patient's designated caregiver. As a condition of registration as 
20.16 	a designated caregiver, the commissioner shall require the person to:
20.17 	(1) be at least 18 years of age;
20.18 	(2) agree to only possess the patient's medical cannabis for purposes of assisting the 
20.19 	patient; and
20.20 	(3) agree that if the application is approved, the person will not be a registered designated 
20.21 	caregiver for more than six registered patients at one time. Patients who reside in the same 
20.22 	residence shall count as one patient.
20.23 	(b) The commissioner shall conduct a criminal background check on the designated 
20.24 	caregiver prior to registration to ensure that the person does not have a conviction for a 
20.25 	disqualifying felony offense. Any cost of the background check shall be paid by the person 
20.26 	seeking registration as a designated caregiver. A designated caregiver must have the criminal 
20.27 	background check renewed every two years.
20.28 	(c) (b) Nothing in sections 152.22 to 152.37 shall be construed to prevent a person 
20.29 	registered as a designated caregiver from also being enrolled in the registry program as a 
20.30 	patient and possessing and using medical cannabis as a patient.

20.31 	EFFECTIVE DATE. This section is effective July 1, 2024.

21.1 	Sec. 19. Minnesota Statutes 2022, section 152.27, subdivision 6, is amended to read:
21.2 		Subd. 6.Patient enrollment. (a) After receipt of a patient's application, application fees,
21.3 	and signed disclosure, the commissioner office shall enroll the patient in the registry program 
21.4 	and issue the patient and patient's registered designated caregiver or parent, legal guardian, 
21.5 	or spouse, if applicable, a registry verification. The commissioner office shall approve or 
21.6 	deny a patient's application for participation in the registry program within 30 days after 
21.7 	the commissioner office receives the patient's application and application fee. The 
21.8 	commissioner may approve applications up to 60 days after the receipt of a patient's 
21.9 	application and application fees until January 1, 2016. A patient's enrollment in the registry 
21.10 	program shall only be denied if the patient:
21.11 	(1) does not have certification from a health care practitioner that the patient has been 
21.12 	diagnosed with a qualifying medical condition or does not have the documentation required 
21.13 	under subdivision 3a if the patient is a veteran receiving care from the United States 
21.14 	Department of Veterans Affairs;
21.15 	(2) has not signed and returned the disclosure form required under subdivision 3, 
21.16 	paragraph (c), to the commissioner office;
21.17 	(3) does not provide the information required;
21.18 	(4) has previously been removed from the registry program for violations of section 
21.19 	152.30 or 152.33; or
21.20 	(5) provides false information.
21.21 	(b) The commissioner office shall give written notice to a patient of the reason for 
21.22 	denying enrollment in the registry program.
21.23 	(c) Denial of enrollment into the registry program is considered a final decision of the 
21.24 	commissioner office and is subject to judicial review under the Administrative Procedure 
21.25 	Act pursuant to chapter 14.
21.26 	(d) A patient's enrollment in the registry program may only be revoked upon the death 
21.27 	of the patient or if a patient violates a requirement under section 152.30 or 152.33.
21.28 	(e) The commissioner office shall develop a registry verification to provide to the patient, 
21.29 	the health care practitioner identified in the patient's application, and to the manufacturer. 
21.30 	The registry verification shall include:
21.31 	(1) the patient's name and date of birth;
21.32 	(2) the patient registry number assigned to the patient; and
22.1 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
22.2 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
22.3 	spouse will be acting as a caregiver.

22.4 	EFFECTIVE DATE. This section is effective July 1, 2024.

22.5 	Sec. 20. Minnesota Statutes 2023 Supplement, section 152.28, subdivision 1, is amended 
22.6 	to read:
22.7 		Subdivision 1.Health care practitioner duties. (a) Prior to a patient's enrollment in 
22.8 	the registry program, a health care practitioner shall:
22.9 	(1) determine, in the health care practitioner's medical judgment, whether a patient suffers 
22.10 	from a qualifying medical condition, and, if so determined, provide the patient with a 
22.11 	certification of that diagnosis;
22.12 	(2) advise patients, registered designated caregivers, and parents, legal guardians, or 
22.13 	spouses who are acting as caregivers of the existence of any nonprofit patient support groups 
22.14 	or organizations;
22.15 	(3) provide explanatory information from the commissioner to patients with qualifying 
22.16 	medical conditions, including disclosure to all patients about the experimental nature of 
22.17 	therapeutic use of medical cannabis; the possible risks, benefits, and side effects of the 
22.18 	proposed treatment; the application and other materials from the commissioner; and provide 
22.19 	patients with the Tennessen warning as required by section 13.04, subdivision 2; and
22.20 	(4) agree to continue treatment of the patient's qualifying medical condition and report 
22.21 	medical findings to the commissioner.
22.22 	(b) Upon notification from the commissioner of the patient's enrollment in the registry 
22.23 	program, the health care practitioner shall:
22.24 	(1) participate in the patient registry reporting system under the guidance and supervision 
22.25 	of the commissioner;
22.26 	(2) report health records of the patient throughout the ongoing treatment of the patient 
22.27 	to the commissioner in a manner determined by the commissioner and in accordance with 
22.28 	subdivision 2;
22.29 	(3) determine, on a yearly basis every three years, if the patient continues to suffer from 
22.30 	a qualifying medical condition and, if so, issue the patient a new certification of that 
22.31 	diagnosis; and
22.32 	(4) otherwise comply with all requirements developed by the commissioner.
23.1 	(c) A health care practitioner may utilize telehealth, as defined in section 62A.673, 
23.2 	subdivision 2, for certifications and recertifications.
23.3 	(d) Nothing in this section requires a health care practitioner to participate in the registry 
23.4 	program.

23.5 	EFFECTIVE DATE. This section is effective July 1, 2024.

23.6 	Sec. 21. Minnesota Statutes 2022, section 152.28, subdivision 2, is amended to read:
23.7 		Subd. 2.Data. Data collected on patients by a health care practitioner and reported to 
23.8 	the patient registry, including data on patients who are veterans who receive care from the 
23.9 	United States Department of Veterans Affairs, are health records under section 144.291, 
23.10 	and are private data on individuals under section 13.02, but may be used or reported in an 
23.11 	aggregated, nonidentifiable form as part of a scientific, peer-reviewed publication of research 
23.12 	conducted under section 152.25 or in the creation of summary data, as defined in section 
23.13 	13.02, subdivision 19.

23.14 	EFFECTIVE DATE. This section is effective July 1, 2024.

23.15 	Sec. 22. Minnesota Statutes 2022, section 152.29, subdivision 3, is amended to read:
23.16 		Subd. 3.Manufacturer; distribution. (a) A manufacturer shall require that employees 
23.17 	licensed as pharmacists pursuant to chapter 151 be the only employees to give final approval 
23.18 	for the distribution of medical cannabis to a patient. A manufacturer may transport medical 
23.19 	cannabis or medical cannabis products that have been cultivated, harvested, manufactured, 
23.20 	packaged, and processed by that manufacturer to another registered manufacturer for the 
23.21 	other manufacturer to distribute.
23.22 	(b) A manufacturer may distribute medical cannabis products, whether or not the products 
23.23 	have been manufactured by that manufacturer.
23.24 	(c) Prior to distribution of any medical cannabis, the manufacturer shall:
23.25 	(1) verify that the manufacturer has received the registry verification from the 
23.26 	commissioner office for that individual patient;
23.27 	(2) verify that the person requesting the distribution of medical cannabis is the patient, 
23.28 	the patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse 
23.29 	listed in the registry verification using the procedures described in section 152.11, subdivision 
23.30 	2d;
23.31 	(3) assign a tracking number to any medical cannabis distributed from the manufacturer;
24.1 	(4) ensure that any employee of the manufacturer licensed as a pharmacist pursuant to 
24.2 	chapter 151 has consulted with the patient to determine the proper dosage for the individual 
24.3 	patient after reviewing the ranges of chemical compositions of the medical cannabis and 
24.4 	the ranges of proper dosages reported by the commissioner office. For purposes of this 
24.5 	clause, a consultation may be conducted remotely by secure videoconference, telephone, 
24.6 	or other remote means, so long as the employee providing the consultation is able to confirm 
24.7 	the identity of the patient and the consultation adheres to patient privacy requirements that 
24.8 	apply to health care services delivered through telehealth. A pharmacist consultation under 
24.9 	this clause is not required when a manufacturer is distributing medical cannabis to a patient 
24.10 	according to a patient-specific dosage plan established with that manufacturer and is not 
24.11 	modifying the dosage or product being distributed under that plan and the medical cannabis 
24.12 	is distributed by a pharmacy technician only required:
24.13 	(i) if the patient is purchasing the product not previously purchased;
24.14 	(ii) if the patient purchases a product that the patient must administer using a different 
24.15 	method than the patient's previous method of administration;
24.16 	(iii) if the patient purchases a product with a cannabinoid concentration of at least double 
24.17 	the patient's prior dosage; and
24.18 	(iv) upon request of the patient; and
24.19 	(5) properly package medical cannabis in compliance with the United States Poison 
24.20 	Prevention Packing Act regarding child-resistant packaging and exemptions for packaging 
24.21 	for elderly patients, and label distributed medical cannabis with a list of all active ingredients 
24.22 	and individually identifying information, including:
24.23 	(i) the patient's name and date of birth;
24.24 	(ii) the name and date of birth of the patient's registered designated caregiver or, if listed 
24.25 	on the registry verification, the name of the patient's parent or legal guardian, if applicable;
24.26 	(iii) the patient's registry identification number;
24.27 	(iv) the chemical composition of the medical cannabis; and
24.28 	(v) the dosage; and.
24.29 	(6) ensure that the medical cannabis distributed contains a maximum of a 90-day supply 
24.30 	of the dosage determined for that patient.
24.31 	(d) A manufacturer shall require any employee of the manufacturer who is transporting 
24.32 	medical cannabis or medical cannabis products to a distribution facility or to another 
25.1 	registered manufacturer to carry identification showing that the person is an employee of 
25.2 	the manufacturer.
25.3 	(e) A manufacturer shall distribute medical cannabis in dried raw cannabis form only 
25.4 	to a patient age 21 or older, or to the registered designated caregiver, parent, legal guardian, 
25.5 	or spouse of a patient age 21 or older.

25.6 	EFFECTIVE DATE. This section is effective July 1, 2024.

25.7 	Sec. 23. Minnesota Statutes 2023 Supplement, section 152.30, is amended to read:
25.8 	152.30 PATIENT DUTIES.
25.9 	(a) A patient shall apply to the commissioner for enrollment in the registry program by 
25.10 	submitting an application as required in section 152.27and an annual registration fee as 
25.11 	determined under section 152.35.
25.12 	(b) As a condition of continued enrollment, patients shall agree to:
25.13 	(1) continue to receive regularly scheduled treatment for their qualifying medical 
25.14 	condition from their health care practitioner; and
25.15 	(2) report changes in their qualifying medical condition to their health care practitioner.
25.16 	(c) A patient shall only receive medical cannabis from a registered manufacturer or 
25.17 	Tribal medical cannabis program but is not required to receive medical cannabis products 
25.18 	from only a registered manufacturer or Tribal medical cannabis program.

25.19 	EFFECTIVE DATE. This section is effective July 1, 2024.

25.20 	Sec. 24. Minnesota Statutes 2023 Supplement, section 256B.0625, subdivision 13d, is 
25.21 	amended to read:
25.22 		Subd. 13d.Drug formulary. (a) The commissioner shall establish a drug formulary. Its 
25.23 	establishment and publication shall not be subject to the requirements of the Administrative 
25.24 	Procedure Act, but the Formulary Committee shall review and comment on the formulary 
25.25 	contents.
25.26 	(b) The formulary shall not include:
25.27 	(1) drugs, active pharmaceutical ingredients, or products for which there is no federal 
25.28 	funding;
25.29 	(2) over-the-counter drugs, except as provided in subdivision 13;
26.1 	(3) drugs or active pharmaceutical ingredients when used for the treatment of impotence 
26.2 	or erectile dysfunction;
26.3 	(4) drugs or active pharmaceutical ingredients for which medical value has not been 
26.4 	established;
26.5 	(5) drugs from manufacturers who have not signed a rebate agreement with the 
26.6 	Department of Health and Human Services pursuant to section 1927 of title XIX of the 
26.7 	Social Security Act; and
26.8 	(6) medical cannabis flower as defined in section 342.01, subdivision 5416, or medical
26.9 	cannabinoid products as defined in section 342.01, subdivision 5212, or cannabis products 
26.10 	as defined in section 342.01, subdivision 20.
26.11 	(c) If a single-source drug used by at least two percent of the fee-for-service medical 
26.12 	assistance recipients is removed from the formulary due to the failure of the manufacturer 
26.13 	to sign a rebate agreement with the Department of Health and Human Services, the 
26.14 	commissioner shall notify prescribing practitioners within 30 days of receiving notification 
26.15 	from the Centers for Medicare and Medicaid Services (CMS) that a rebate agreement was 
26.16 	not signed.

26.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

26.18 	Sec. 25. Minnesota Statutes 2023 Supplement, section 290.0132, subdivision 29, is amended 
26.19 	to read:
26.20 		Subd. 29.Disallowed section 280E expenses; cannabis licensees. The amount of 
26.21 	expenses of a medical cannabis business license holder, as defined under section 342.01, 
26.22 	subdivision 53 48, related to the business of medical cannabis under sections 342.47 to 
26.23 	342.59, or a license holder under chapter 342, related to the business of nonmedical cannabis 
26.24 	under that chapter,cannabis or hemp and not allowed for federal income tax purposes under 
26.25 	section 280E of the Internal Revenue Code is a subtraction.

26.26 	EFFECTIVE DATE. This section is effective the day following final enactment.

26.27 	Sec. 26. Minnesota Statutes 2023 Supplement, section 290.0134, subdivision 19, is amended 
26.28 	to read:
26.29 		Subd. 19.Disallowed section 280E expenses; cannabis licensees. The amount of 
26.30 	expenses of a medical cannabis business license holder, as defined under section 342.01, 
26.31 	subdivision 53 48, related to the business of medical cannabis under sections 342.47 to 
26.32 	342.59, or a license holder under chapter 342, related to the business of nonmedical cannabis 
27.1 	under that chapter,cannabis or hemp and not allowed for federal income tax purposes under 
27.2 	section 280E of the Internal Revenue Code is a subtraction.

27.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

27.4 	Sec. 27. Minnesota Statutes 2023 Supplement, section 295.81, subdivision 1, is amended 
27.5 	to read:
27.6 		Subdivision 1.Definitions. (a) For purposes of this section, the following terms have 
27.7 	the meanings given.
27.8 	(b) "Bundled transaction" means the retail sale of two or more products when the products 
27.9 	are otherwise distinct and identifiable and the products are sold for one nonitemized price.
27.10 	(c) "Cannabis flower" has the meaning given in section 342.01, subdivision 16.
27.11 	(d) "Cannabis product" has the meaning given in section 342.01, subdivision 20.
27.12 	(e) "Cannabis solution product" means any cartridge, bottle, or other package that contains 
27.13 	a taxable cannabis product in a solution that is consumed or meant to be consumed through 
27.14 	the use of a heating element, power source, electronic circuit, or other electronic, chemical, 
27.15 	or mechanical means that produces vapor or aerosol. A cannabis solution product includes 
27.16 	any electronic delivery system, electronic vaping device, electronic vape pen, electronic 
27.17 	oral device, electronic delivery device, or similar product or device, and any batteries, 
27.18 	heating elements, or other components, parts, or accessories sold with and meant to be used 
27.19 	in the consumption of a solution containing a taxable cannabis product.
27.20 	(f) "Cannabis mezzobusiness" means a cannabis business licensed under section 342.29.
27.21 	(g) "Cannabis microbusiness" means a cannabis business licensed under section 342.28.
27.22 	(h) "Cannabis retailer" means a cannabis business licensed under section 342.32.
27.23 	(i) "Commissioner" means the commissioner of revenue.
27.24 	(j) "Gross receipts" means the total amount received in money or by barter or exchange 
27.25 	for all taxable cannabis product sales at retail as measured by the sales price. Gross receipts 
27.26 	include but are not limited to delivery charges and packaging costs. Gross receipts do not 
27.27 	include:
27.28 	(1) any taxes imposed directly on the customer that are separately stated on the invoice, 
27.29 	bill of sale, or similar document given to the purchaser; and
27.30 	(2) discounts, including cash, terms, or coupons, that are not reimbursed by a third party 
27.31 	and that are allowed by the seller and taken by a purchaser on a sale.
28.1 	(k) "Hemp-derived consumer product" has the meaning given in section 342.01, 
28.2 	subdivision 37.
28.3 	(l) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision 
28.4 	50.
28.5 	(m) "Lower-potency hemp edible retailer" means a cannabis business licensed under 
28.6 	section 342.43, subdivision 1, clause (2).
28.7 	(n) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 54.
28.8 	(o) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision 
28.9 	52.
28.10 	(p) "Medical cannabis paraphernalia" has the meaning given in section 342.01, 
28.11 	subdivision 55.
28.12 	(q) (n) "Retail sale" has the meaning given in section 297A.61, subdivision 4.
28.13 	(r) (o) "Taxable cannabis product" means cannabis flower, cannabis product, cannabis 
28.14 	solution product, hemp-derived consumer product, lower-potency hemp edible, and any 
28.15 	substantially similar item, and does not include items exempt from tax under subdivision 
28.16 	4, paragraph (b).
28.17 	(s) (p) "Taxable cannabis product retailer" means a retailer that sells any taxable cannabis 
28.18 	product, and includes a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness, 
28.19 	medical cannabis combination business, and lower-potency hemp edible retailer. Taxable 
28.20 	cannabis product retailer includes but is not limited to a:
28.21 	(1) retailer maintaining a place of business in this state;
28.22 	(2) marketplace provider maintaining a place of business in this state, as defined in 
28.23 	section 297A.66, subdivision 1, paragraph (a);
28.24 	(3) retailer not maintaining a place of business in this state; and
28.25 	(4) marketplace provider not maintaining a place of business in this state, as defined in 
28.26 	section 297A.66, subdivision 1, paragraph (b).

28.27 	EFFECTIVE DATE. This section is effective the day following final enactment.

28.28 	Sec. 28. Minnesota Statutes 2023 Supplement, section 295.81, subdivision 4, is amended 
28.29 	to read:
28.30 		Subd. 4.Exemptions. (a) The use tax imposed under subdivision 3, paragraph (a), does 
28.31 	not apply to the possession, use, or storage of taxable cannabis products if (1) the taxable 
29.1 	cannabis products have an aggregate cost in any calendar month to the customer of $100 
29.2 	or less, and (2) the taxable cannabis products were carried into this state by the customer.
29.3 	(b) The tax imposed under this section does not apply to sales by a cannabis business 
29.4 	with a medical cannabis retail endorsement or by a medical cannabis combination business 
29.5 	of medical the following items purchased by or for a patient: cannabis flower, cannabinoid 
29.6 	products, or cannabis paraphernalia. Items sold under this paragraph must be sold to a person
29.7 	enrolled in the registry program, including medical cannabis flower, medical cannabinoid 
29.8 	products, or medical cannabis paraphernalia.
29.9 	(c) Unless otherwise specified in this section, the exemptions applicable to taxes imposed 
29.10 	under chapter 297A are not applicable to the taxes imposed under this section.
29.11 	(d) The tax imposed under this section does not apply to:
29.12 	(1) sales made in Indian country as defined in United States Code, title 18, section 1151, 
29.13 	by a cannabis business licensed by a Minnesota Tribal government, as defined in section 
29.14 	3.9228, subdivision 1, paragraph (f); or
29.15 	(2) use tax owed on taxable cannabis products purchased on Tribally regulated land as 
29.16 	defined in section 3.9228, subdivision 1, from a cannabis business licensed by a Minnesota 
29.17 	Tribal government as defined in section 3.9228, subdivision 1, paragraph (f).

29.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

29.19 	Sec. 29. Minnesota Statutes 2023 Supplement, section 297A.67, subdivision 2, is amended 
29.20 	to read:
29.21 		Subd. 2.Food and food ingredients. Except as otherwise provided in this subdivision, 
29.22 	food and food ingredients are exempt. For purposes of this subdivision, "food" and "food 
29.23 	ingredients" mean substances, whether in liquid, concentrated, solid, frozen, dried, or 
29.24 	dehydrated form, that are sold for ingestion or chewing by humans and are consumed for 
29.25 	their taste or nutritional value. Food and food ingredients exempt under this subdivision do 
29.26 	not include candy, soft drinks, dietary supplements, and prepared foods. Food and food 
29.27 	ingredients do not include alcoholic beverages, tobacco, taxable cannabis products, medical 
29.28 	cannabis flower, and medical cannabinoid products and any item exempt from tax under 
29.29 	section 295.81, subdivision 4, paragraph (b). For purposes of this subdivision, "alcoholic 
29.30 	beverages" means beverages that are suitable for human consumption and contain one-half 
29.31 	of one percent or more of alcohol by volume. For purposes of this subdivision, "tobacco" 
29.32 	means cigarettes, cigars, chewing or pipe tobacco, or any other item that contains tobacco. 
29.33 	For purposes of this subdivision, "taxable cannabis product" has the meaning given in section 
30.1 	295.81, subdivision 1, paragraph (r), "medical cannabis flower" has the meaning given in 
30.2 	section 342.01, subdivision 54, and "medical cannabinoid product" has the meaning given 
30.3 	in section 342.01, subdivision 52 (o). For purposes of this subdivision, "dietary supplements" 
30.4 	means any product, other than tobacco, intended to supplement the diet that:
30.5 	(1) contains one or more of the following dietary ingredients:
30.6 	(i) a vitamin;
30.7 	(ii) a mineral;
30.8 	(iii) an herb or other botanical;
30.9 	(iv) an amino acid;
30.10 	(v) a dietary substance for use by humans to supplement the diet by increasing the total 
30.11 	dietary intake; and
30.12 	(vi) a concentrate, metabolite, constituent, extract, or combination of any ingredient 
30.13 	described in items (i) to (v);
30.14 	(2) is intended for ingestion in tablet, capsule, powder, softgel, gelcap, or liquid form, 
30.15 	or if not intended for ingestion in such form, is not represented as conventional food and is 
30.16 	not represented for use as a sole item of a meal or of the diet; and
30.17 	(3) is required to be labeled as a dietary supplement, identifiable by the supplement facts 
30.18 	box found on the label and as required pursuant to Code of Federal Regulations, title 21, 
30.19 	section 101.36.

30.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

30.21 	Sec. 30. Minnesota Statutes 2023 Supplement, section 297A.70, subdivision 2, is amended 
30.22 	to read:
30.23 		Subd. 2.Sales to government. (a) All sales, except those listed in paragraph (b), to the 
30.24 	following governments and political subdivisions, or to the listed agencies or instrumentalities 
30.25 	of governments and political subdivisions, are exempt:
30.26 	(1) the United States and its agencies and instrumentalities;
30.27 	(2) school districts, local governments, the University of Minnesota, state universities, 
30.28 	community colleges, technical colleges, state academies, the Perpich Minnesota Center for 
30.29 	Arts Education, and an instrumentality of a political subdivision that is accredited as an 
30.30 	optional/special function school by the North Central Association of Colleges and Schools;
31.1 	(3) hospitals and nursing homes owned and operated by political subdivisions of the 
31.2 	state of tangible personal property and taxable services used at or by hospitals and nursing 
31.3 	homes;
31.4 	(4) other states or political subdivisions of other states, if the sale would be exempt from 
31.5 	taxation if it occurred in that state; and
31.6 	(5) public libraries, public library systems, multicounty, multitype library systems as 
31.7 	defined in section 134.001, county law libraries under chapter 134A, state agency libraries, 
31.8 	the state library under section 480.09, and the Legislative Reference Library.
31.9 	(b) This exemption does not apply to the sales of the following products and services:
31.10 	(1) building, construction, or reconstruction materials purchased by a contractor or a 
31.11 	subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed 
31.12 	maximum price covering both labor and materials for use in the construction, alteration, or 
31.13 	repair of a building or facility;
31.14 	(2) construction materials purchased by tax exempt entities or their contractors to be 
31.15 	used in constructing buildings or facilities which will not be used principally by the tax 
31.16 	exempt entities;
31.17 	(3) the leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except 
31.18 	for leases entered into by the United States or its agencies or instrumentalities;
31.19 	(4) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2), 
31.20 	prepared food, candy, soft drinks, alcoholic beverages as defined in section 297A.67, 
31.21 	subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision 
31.22 	1, paragraph (r), except for lodging, prepared food, candy, soft drinks, alcoholic beverages, 
31.23 	and taxable cannabis products purchased directly by the United States or its agencies or 
31.24 	instrumentalities; or
31.25 	(5) goods or services purchased by a local government as inputs to a liquor store, taxable 
31.26 	cannabis product retailer as defined under section 295.81, subdivision 1, paragraph (p), gas 
31.27 	or electric utility, solid waste hauling service, solid waste recycling service, landfill, golf 
31.28 	course, marina, campground, cafe, or laundromat.
31.29 	(c) As used in this subdivision, "school districts" means public school entities and districts 
31.30 	of every kind and nature organized under the laws of the state of Minnesota, and any 
31.31 	instrumentality of a school district, as defined in section 471.59.
31.32 	(d) For purposes of the exemption granted under this subdivision, "local governments" 
31.33 	has the following meaning:
32.1 	(1) for the period prior to January 1, 2017, local governments means statutory or home 
32.2 	rule charter cities, counties, and townships; and
32.3 	(2) beginning January 1, 2017, local governments means statutory or home rule charter 
32.4 	cities, counties, and townships; special districts as defined under section 6.465; any 
32.5 	instrumentality of a statutory or home rule charter city, county, or township as defined in 
32.6 	section 471.59; and any joint powers board or organization created under section 471.59.

32.7 	EFFECTIVE DATE. This section is effective the day following final enactment.

32.8 	Sec. 31. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 3, is amended 
32.9 	to read:
32.10 		Subd. 3.Adult-use cannabis flower. "Adult-use cannabis flower" means cannabis 
32.11 	flower that is approved for sale by the office or is substantially similar to a product approved 
32.12 	by the office. Adult-use cannabis flower does not include medical cannabis flower, hemp 
32.13 	plant parts, or hemp-derived consumer products.

32.14 	EFFECTIVE DATE. This section is effective the day following final enactment.

32.15 	Sec. 32. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 4, is amended 
32.16 	to read:
32.17 		Subd. 4.Adult-use cannabis product. "Adult-use cannabis product" means a cannabis 
32.18 	product that is approved for sale by the office or is substantially similar to a product approved 
32.19 	by the office. Adult-use cannabis product includes edible cannabis products but does not 
32.20 	include medical cannabinoid products or lower-potency hemp edibles.

32.21 	EFFECTIVE DATE. This section is effective the day following final enactment.

32.22 	Sec. 33. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 12, is amended 
32.23 	to read:
32.24 		Subd. 12.Cannabinoid product. "Cannabinoid product" means any of the following:
32.25 	(1) a cannabis product,;
32.26 	(2) a hemp-derived consumer product, or;
32.27 	(3) a lower-potency hemp edible; or
32.28 	(4) a product that consists of or contains cannabis concentrate or hemp concentrate or 
32.29 	is infused with cannabinoids, and is provided to:
32.30 	(i) a patient enrolled in the registry program;
33.1 	(ii) a registered designated caregiver; or
33.2 	(iii) a parent, legal guardian, or spouse of an enrolled patient, if provided by a cannabis 
33.3 	retailer or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical 
33.4 	condition.

33.5 	Sec. 34. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 14, is amended 
33.6 	to read:
33.7 		Subd. 14.Cannabis business. "Cannabis business" means any of the following licensed 
33.8 	under this chapter:
33.9 	(1) cannabis microbusiness;
33.10 	(2) cannabis mezzobusiness;
33.11 	(3) cannabis cultivator;
33.12 	(4) cannabis manufacturer;
33.13 	(5) cannabis retailer;
33.14 	(6) cannabis wholesaler;
33.15 	(7) cannabis transporter;
33.16 	(8) cannabis testing facility;
33.17 	(9) cannabis event organizer;
33.18 	(10) cannabis delivery service; and
33.19 	(11) medical cannabis cultivator;
33.20 	(12) medical cannabis processor;
33.21 	(13) medical cannabis retailer; and
33.22 	(14) (11) medical cannabis combination business.

33.23 	EFFECTIVE DATE. This section is effective the day following final enactment.

33.24 	Sec. 35. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 16, is amended 
33.25 	to read:
33.26 		Subd. 16.Cannabis flower. "Cannabis flower" means the harvested flower, bud, leaves, 
33.27 	and or stems of a cannabis plant. Cannabis flower includes adult-use cannabis flower and 
34.1 	medical cannabis flower. Cannabis flower does not include cannabis seed, hemp plant parts, 
34.2 	or hemp-derived consumer products.

34.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

34.4 	Sec. 36. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 17, is amended 
34.5 	to read:
34.6 		Subd. 17.Cannabis industry. "Cannabis industry" means every item, product, person, 
34.7 	process, action, business, or other thing related to cannabis plants, cannabis flower, and 
34.8 	cannabis products and subject to regulation under this chapter.

34.9 	EFFECTIVE DATE. This section is effective the day following final enactment.

34.10 	Sec. 37. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 19, is amended 
34.11 	to read:
34.12 		Subd. 19.Cannabis plant. "Cannabis plant" means all parts of the plant of the genus 
34.13 	Cannabis that is are growing or has have not been harvested and has a delta-9 
34.14 	tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis, including 
34.15 	but not limited to a mother plant; a mature, flowering plant; an immature plant; or a seedling. 
34.16 	Cannabis plant does not include industrial hemp as defined in section 18K.02, subdivision 
34.17 	3.

34.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

34.19 	Sec. 38. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 20, is amended 
34.20 	to read:
34.21 		Subd. 20.Cannabis product. (a) "Cannabis product" means any of the following:
34.22 	(1) cannabis concentrate;
34.23 	(2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol, 
34.24 	extracted or derived from cannabis plants or cannabis flower; or
34.25 	(3) any other product that contains cannabis concentrate.
34.26 	(b) Cannabis product includes adult-use cannabis products, including but not limited to 
34.27 	edible cannabis products and medical cannabinoid products. Cannabis product does not 
34.28 	include cannabis flower, artificially derived cannabinoid, lower-potency hemp edibles, 
34.29 	hemp-derived consumer products, or hemp-derived topical products.

34.30 	EFFECTIVE DATE. This section is effective the day following final enactment.

35.1 	Sec. 39. Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a 
35.2 	subdivision to read:
35.3 		Subd. 31a.Endorsement. "Endorsement" means an authorization from the Office of 
35.4 	Cannabis Management to conduct a specified operation activity.

35.5 	EFFECTIVE DATE. This section is effective the day following final enactment.

35.6 	Sec. 40. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 48, is amended 
35.7 	to read:
35.8 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
35.9 	that holds any of the following licenses:
35.10 	(1) cannabis microbusiness;
35.11 	(2) cannabis mezzobusiness;
35.12 	(3) cannabis cultivator;
35.13 	(4) cannabis manufacturer;
35.14 	(5) cannabis retailer;
35.15 	(6) cannabis wholesaler;
35.16 	(7) cannabis transporter;
35.17 	(8) cannabis testing facility;
35.18 	(9) cannabis event organizer;
35.19 	(10) cannabis delivery service;
35.20 	(11) lower-potency hemp edible manufacturer;
35.21 	(12) lower-potency hemp edible retailer; or
35.22 	(13) medical cannabis cultivator;
35.23 	(14) medical cannabis processor;
35.24 	(15) medical cannabis retailer; or
35.25 	(16) (13) medical cannabis combination business.

35.26 	EFFECTIVE DATE. This section is effective the day following final enactment.

36.1 	Sec. 41. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 57, is amended 
36.2 	to read:
36.3 		Subd. 57.Office. "Office" means the director of the Office of Cannabis Management.

36.4 	Sec. 42. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 64, is amended 
36.5 	to read:
36.6 		Subd. 64.Registered designated caregiver. "Registered designated caregiver" means 
36.7 	an individual who:
36.8 	(1) is at least 18 years old;
36.9 	(2) is not disqualified for a criminal offense according to rules adopted pursuant to 
36.10 	section 342.15, subdivision 2;
36.11 	(3) (2) has been approved by the Division of Medical Cannabis Office of Cannabis 
36.12 	Management to assist a patient with obtaining medical cannabis flower and medical
36.13 	cannabinoid products from a cannabis retailer or medical cannabis retailerbusiness with a 
36.14 	medical cannabis retail endorsement and with administering medical cannabis flower and 
36.15 	medical cannabinoid products; and
36.16 	(4) (3) is authorized by the Division of Medical Cannabis Office of Cannabis Management
36.17 	to assist a patient with the use of medical cannabis flower and medical cannabinoid products.

36.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

36.19 	Sec. 43. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 65, is amended 
36.20 	to read:
36.21 		Subd. 65.Registry or registry program. "Registry" or "registry program" means the 
36.22 	medical cannabis patient registry established under this chapter listing patients each person
36.23 	authorized to:
36.24 	(1) obtain medical cannabis flower, medical cannabinoid products, and medical cannabis 
36.25 	paraphernalia from a cannabis retailers and medical cannabis retailers business with a 
36.26 	medical cannabis retail endorsement; and
36.27 	(2) administer medical cannabis flower and medical cannabinoid products.

36.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

37.1 	Sec. 44. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 66, is amended 
37.2 	to read:
37.3 		Subd. 66.Registry verification. "Registry verification" means the verification provided 
37.4 	by the Division of Medical Cannabis Office of Cannabis Management that a patient is 
37.5 	enrolled in the registry program and that includes the patient's name, patient registry number, 
37.6 	and, if applicable, the name of the patient's registered designated caregiver or parent, legal 
37.7 	guardian, or spouse.

37.8 	EFFECTIVE DATE. This section is effective the day following final enactment.

37.9 	Sec. 45. Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a 
37.10 	subdivision to read:
37.11 		Subd. 69a.Tincture. "Tincture" means a solution of hemp extract, derived either directly 
37.12 	from a hemp plant or from a manufactured hemp extract, dissolved in glycerin, food-grade 
37.13 	oils, or other food-grade solvents and that is intended to be consumed through oral 
37.14 	administration or intended to be consumed in combination with food products, including 
37.15 	beverages.

37.16 	Sec. 46. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 2, is amended 
37.17 	to read:
37.18 		Subd. 2.Powers and duties. (a) The office has the following powers and duties:
37.19 	(1) to develop, maintain, and enforce an organized system of regulation for the cannabis 
37.20 	industry and hemp consumer industry;
37.21 	(2) to establish programming, services, and notification to protect, maintain, and improve 
37.22 	the health of citizens;
37.23 	(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency 
37.24 	hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;
37.25 	(4) to establish and regularly update standards for product manufacturing, testing, 
37.26 	packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by 
37.27 	date;
37.28 	(5) to promote economic growth with an emphasis on growth in areas that experienced 
37.29 	a disproportionate, negative impact from cannabis prohibition;
37.30 	(6) to issue and renew licenses;
38.1 	(7) to require fingerprints from individuals determined to be subject to fingerprinting, 
38.2 	including the submission of fingerprints to the Federal Bureau of Investigation where 
38.3 	required by law and to obtain criminal conviction data for individuals seeking a license 
38.4 	from the office on the individual's behalf or as a cooperative member or director, manager, 
38.5 	or general partner of a business entity;
38.6 	(8) to receive reports required by this chapter and inspect the premises, records, books, 
38.7 	and other documents of license holders to ensure compliance with all applicable laws and 
38.8 	rules;
38.9 	(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations 
38.10 	pursuant to the office's authority;
38.11 	(10) to impose and collect civil and administrative penalties as provided in this chapter;
38.12 	(11) to publish such information as may be deemed necessary for the welfare of cannabis 
38.13 	businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety 
38.14 	of citizens;
38.15 	(12) to make loans and grants in aid to the extent that appropriations are made available 
38.16 	for that purpose;
38.17 	(13) to authorize research and studies on cannabis flower, cannabis products, artificially 
38.18 	derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the 
38.19 	cannabis industry, and the hemp consumer industry;
38.20 	(14) to provide reports as required by law;
38.21 	(15) to develop a warning label regarding the effects of the use of cannabis flower and 
38.22 	cannabis products by persons 25 years of age or younger;
38.23 	(16) to determine, based on a review of medical and scientific literature, whether it is 
38.24 	appropriate to require additional health and safety warnings containing information that is 
38.25 	both supported by credible science and helpful to consumers in considering potential health 
38.26 	risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and 
38.27 	hemp-derived consumer products, including but not limited to warnings regarding any risks 
38.28 	associated with use by pregnant or breastfeeding individuals, or by individuals planning to 
38.29 	become pregnant, and the effects that use has on brain development for individuals under 
38.30 	the age of 25;
38.31 	(17) to establish limits on the potency of cannabis flower and cannabis products that can 
38.32 	be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and 
39.1 	licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis 
39.2 	products to customers;
39.3 	(18) to establish rules authorizing an increase in plant canopy limits and outdoor 
39.4 	cultivation limits to meet market demand and limiting cannabis manufacturing consistent 
39.5 	with the goals identified in subdivision 1; and
39.6 	(19) to order a person or business that manufactures or produces cannabis flower, cannabis 
39.7 	products, artificially derived cannabinoids, lower-potency hemp edibles, hemp-derived 
39.8 	consumer products, or hemp-derived topical products to recall a product if the office 
39.9 	determines that the product represents a risk of causing a serious adverse incident; and
39.10 	(19) (20) to exercise other powers and authority and perform other duties required by 
39.11 	law.
39.12 	(b) In addition to the powers and duties in paragraph (a), the office has the following 
39.13 	powers and duties until January 1, 2027:
39.14 	(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis 
39.15 	products that can be sold to customers by licensed cannabis retailers, licensed cannabis 
39.16 	microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell 
39.17 	adult-use cannabis flower and adult-use cannabis products to customers; and
39.18 	(2) to permit, upon application to the office in the form prescribed by the director of the 
39.19 	office, a licensee under this chapter to perform any activity if such permission is substantially 
39.20 	necessary for the licensee to perform any other activity permitted by the applicant's license 
39.21 	and is not otherwise prohibited by law.

39.22 	EFFECTIVE DATE. This section is effective the day following final enactment.

39.23 	Sec. 47. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 5, is amended 
39.24 	to read:
39.25 		Subd. 5.Rulemaking. (a) The office may adopt rules to implement any provisions in 
39.26 	this chapter.
39.27 	(b) Rules for which a notice of intent to adopt rules is published in the State Register 
39.28 	before July 1, 2025, may be adopted using the expedited rulemaking process in section 
39.29 	14.389. The 18-month time limit imposed by section 14.125 does not apply to rules adopted 
39.30 	under this paragraph.

39.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

40.1 	Sec. 48. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 6, is amended 
40.2 	to read:
40.3 		Subd. 6.Director. (a) The governor shall appoint a director of the officeOffice of 
40.4 	Cannabis Management with the advice and consent of the senate. The director must be in 
40.5 	the unclassified service and must serve at the pleasure of the governor.
40.6 	(b) The salary of the director must not exceed the salary limit established under section 
40.7 	15A.0815, subdivision 3.
40.8 	(b) The director may appoint and employ no more than two deputy directors.
40.9 	(c) The director has administrative control of the Office of Cannabis Management. The 
40.10 	director has the powers described in section 15.06, subdivision 6.
40.11 	(d) The director may apply for and accept on behalf of the state any grants, bequests, 
40.12 	gifts, or contributions for the purpose of carrying out the duties and responsibilities of the 
40.13 	director.
40.14 	(e) Pursuant to state law, the director may apply for and receive money made available 
40.15 	from federal sources for the purpose of carrying out the duties and responsibilities of the 
40.16 	director.
40.17 	(f) The director may make contracts with and grants to Tribal Nations, public and private 
40.18 	agencies, for-profit and nonprofit organizations, and individuals using appropriated money.

40.19 	EFFECTIVE DATE. This section is effective the day following final enactment.

40.20 	Sec. 49. Minnesota Statutes 2023 Supplement, section 342.07, subdivision 3, is amended 
40.21 	to read:
40.22 		Subd. 3.Edible cannabinoid product handler endorsement. (a) Any person seeking 
40.23 	to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency 
40.24 	hemp edible, other than an edible cannabis product or lower-potency hemp edible that has 
40.25 	been placed in its final packaging, must first obtain an edible cannabinoid product handler 
40.26 	endorsement.
40.27 	(b) In consultation with the commissioner of agriculture, the office shall establish an 
40.28 	edible cannabinoid product handler endorsement.
40.29 	(c) The office must regulate edible cannabinoid product handlers and assess penalties 
40.30 	in the same in a manner provided for consistent with Department of Agriculture regulation 
40.31 	of food handlers under chapters 28A, 31, and 34A and associated rules, with the following 
40.32 	exceptions:
41.1 	(1) the office must issue an edible cannabinoid product handler endorsement, rather than 
41.2 	a license;
41.3 	(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons 
41.4 	who possess a valid license issued by the office;
41.5 	(3) the office may not charge a fee for issuing or renewing the endorsement;
41.6 	(4) the office must align the term and renewal period for edible cannabinoid product 
41.7 	handler endorsements with the term and renewal period of the license issued by the office; 
41.8 	and
41.9 	(5) an edible cannabis product or lower-potency hemp edible must not be considered 
41.10 	adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis 
41.11 	concentrate, hemp concentrate, artificially derived cannabinoids, or any other material 
41.12 	extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant 
41.13 	parts.
41.14 	(d) The edible cannabinoid product handler endorsement must prohibit the manufacture 
41.15 	of edible cannabis products at the same premises where food is manufactured, except for 
41.16 	the limited production of edible products produced solely for product development, sampling, 
41.17 	or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.

41.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

41.19 	Sec. 50. Minnesota Statutes 2023 Supplement, section 342.09, subdivision 1, is amended 
41.20 	to read:
41.21 		Subdivision 1.Personal adult use, possession, and transportation of cannabis flower 
41.22 	and cannabinoid products. (a) An individual 21 years of age or older may:
41.23 	(1) use, possess, or transport cannabis paraphernalia;
41.24 	(2) possess or transport two ounces or less of adult-use cannabis flower in a public place;
41.25 	(3) possess two pounds or less of adult-use cannabis flower in the individual's private 
41.26 	residence;
41.27 	(4) possess or transport eight grams or less of adult-use cannabis concentrate;
41.28 	(5) possess or transport edible cannabis products or lower-potency hemp edibles infused 
41.29 	with a combined total of 800 milligrams or less of tetrahydrocannabinol;
41.30 	(6) give for no remuneration to an individual who is at least 21 years of age:
41.31 	(i) two ounces or less of adult-use cannabis flower;
42.1 	(ii) eight grams or less of adult-use cannabis concentrate; or
42.2 	(iii) an edible cannabis product or lower-potency hemp edible infused with 800 milligrams 
42.3 	or less of tetrahydrocannabinol; and
42.4 	(7) use adult-use cannabis flower and adult-use cannabis products in the following 
42.5 	locations:
42.6 	(i) a private residence, including the individual's curtilage or yard;
42.7 	(ii) on private property, not generally accessible by the public, unless the individual is 
42.8 	explicitly prohibited from consuming cannabis flower, cannabis products, lower-potency 
42.9 	hemp edibles, or hemp-derived consumer products on the property by the owner of the 
42.10 	property; or
42.11 	(iii) on the premises of an establishment or event licensed to permit on-site consumption.
42.12 	(b) Except as provided in paragraph (c), an individual may not:
42.13 	(1) use, possess, or transport cannabis flower, cannabis products, lower-potency hemp 
42.14 	edibles, or hemp-derived consumer products if the individual is under 21 years of age;
42.15 	(2) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
42.16 	consumer products in a motor vehicle as defined in section 169A.03, subdivision 15;
42.17 	(3) use cannabis flower, cannabis products, or hemp-derived consumer products in a 
42.18 	manner that involves the inhalation of smoke, aerosol, or vapor at any location where 
42.19 	smoking is prohibited under section 144.414;
42.20 	(4) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
42.21 	hemp-derived consumer products in a public school, as defined in section 120A.05, 
42.22 	subdivisions 9, 11, and 13, or in a charter school governed by chapter 124E, including all 
42.23 	facilities, whether owned, rented, or leased, and all vehicles that a school district owns, 
42.24 	leases, rents, contracts for, or controls;
42.25 	(5) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
42.26 	hemp-derived consumer products in a state correctional facility;
42.27 	(6) operate a motor vehicle while under the influence of cannabis flower, cannabis 
42.28 	products, lower-potency hemp edibles, or hemp-derived consumer products;
42.29 	(7) give for no remuneration cannabis flower, cannabis products, lower-potency hemp 
42.30 	edibles, or hemp-derived consumer products to an individual under 21 years of age;
43.1 	(8) give for no remuneration cannabis flower or cannabis products as a sample or 
43.2 	promotional gift if the giver is in the business of selling goods or services; or
43.3 	(9) vaporize or smoke cannabis flower, cannabis products, artificially derived 
43.4 	cannabinoids, or hemp-derived consumer products in any location where the smoke, aerosol, 
43.5 	or vapor would be inhaled by a minor.
43.6 	(c) The prohibitions under paragraph (b), clauses (1) to (4), do not apply to use other 
43.7 	than by smoking or by a vaporized delivery method, possession, or transportation of medical
43.8 	cannabis flower or medical cannabinoid products by a patient; a registered designated 
43.9 	caregiver; or a parent, legal guardian, or spouse of a patient.
43.10 	(d) The possession limits in paragraph (a), clauses (2) to (5), do not apply to a person 
43.11 	enrolled in the medical cannabis patient registry program under section 342.52 if the person 
43.12 	possesses cannabis flower or cannabinoid products that include patient-specific labeling 
43.13 	according to sections 342.51, subdivision 2, and 342.63, subdivision 4.
43.14 	(d) (e) A proprietor of a family or group family day care program must disclose to parents 
43.15 	or guardians of children cared for on the premises of the family or group family day care 
43.16 	program, if the proprietor permits the smoking or use of cannabis flower, cannabis products, 
43.17 	lower-potency hemp edibles, or hemp-derived consumer products on the premises outside 
43.18 	of its hours of operation. Disclosure must include posting on the premises a conspicuous 
43.19 	written notice and orally informing parents or guardians. Cannabis flower or cannabis 
43.20 	products must be inaccessible to children and stored away from food products.

43.21 	EFFECTIVE DATE. This section is effective the day following final enactment.

43.22 	Sec. 51. Minnesota Statutes 2023 Supplement, section 342.09, subdivision 3, is amended 
43.23 	to read:
43.24 		Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent 
43.25 	prohibited. No person may use a volatile solvent to separate or extract cannabis concentrate 
43.26 	or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis 
43.27 	manufacturer, medical cannabis processor, or lower-potency hemp edible manufacturer 
43.28 	license issued under this chapter.

43.29 	EFFECTIVE DATE. This section is effective the day following final enactment.

44.1 	Sec. 52. Minnesota Statutes 2023 Supplement, section 342.10, is amended to read:
44.2 	342.10 LICENSES; TYPES.
44.3 	The office shall issue the following types of license:
44.4 	(1) cannabis microbusiness;
44.5 	(2) cannabis mezzobusiness;
44.6 	(3) cannabis cultivator;
44.7 	(4) cannabis manufacturer;
44.8 	(5) cannabis retailer;
44.9 	(6) cannabis wholesaler;
44.10 	(7) cannabis transporter;
44.11 	(8) cannabis testing facility;
44.12 	(9) cannabis event organizer;
44.13 	(10) cannabis delivery service;
44.14 	(11) lower-potency hemp edible manufacturer;
44.15 	(12) lower-potency hemp edible retailer; or
44.16 	(13) medical cannabis cultivator;
44.17 	(14) medical cannabis processor;
44.18 	(15) medical cannabis retailer; or
44.19 	(16) (13) medical cannabis combination business.

44.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

44.21 	Sec. 53. Minnesota Statutes 2023 Supplement, section 342.11, is amended to read:
44.22 	342.11 LICENSES; FEES.
44.23 	(a) The office shall require the payment of application fees, initial licensing fees, and 
44.24 	renewal licensing fees as provided in this section. The initial license fee shall include the 
44.25 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
44.26 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
44.27 	Nothing in this section prohibits a local unit of government from charging the retailer 
45.1 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
45.2 	renewal licensing fees are nonrefundable.
45.3 	(b) Application and licensing fees shall be as follows:
45.4 	(1) for a cannabis microbusiness:
45.5 	(i) an application fee of $500;
45.6 	(ii) an initial license fee of $0; and
45.7 	(iii) a renewal license fee of $2,000;
45.8 	(2) for a cannabis mezzobusiness:
45.9 	(i) an application fee of $5,000;
45.10 	(ii) an initial license fee of $5,000; and
45.11 	(iii) a renewal license fee of $10,000;
45.12 	(3) for a cannabis cultivator:
45.13 	(i) an application fee of $10,000;
45.14 	(ii) an initial license fee of $20,000; and
45.15 	(iii) a renewal license fee of $30,000;
45.16 	(4) for a cannabis manufacturer:
45.17 	(i) an application fee of $10,000;
45.18 	(ii) an initial license fee of $10,000; and
45.19 	(iii) a renewal license fee of $20,000;
45.20 	(5) for a cannabis retailer:
45.21 	(i) an application fee of $2,500;
45.22 	(ii) an initial license fee of $2,500; and
45.23 	(iii) a renewal license fee of $5,000;
45.24 	(6) for a cannabis wholesaler:
45.25 	(i) an application fee of $5,000;
45.26 	(ii) an initial license fee of $5,000; and
45.27 	(iii) a renewal license fee of $10,000;
46.1 	(7) for a cannabis transporter:
46.2 	(i) an application fee of $250;
46.3 	(ii) an initial license fee of $500; and
46.4 	(iii) a renewal license fee of $1,000;
46.5 	(8) for a cannabis testing facility:
46.6 	(i) an application fee of $5,000;
46.7 	(ii) an initial license fee of $5,000; and
46.8 	(iii) a renewal license fee of $10,000;
46.9 	(9) for a cannabis delivery service:
46.10 	(i) an application fee of $250;
46.11 	(ii) an initial license fee of $500; and
46.12 	(iii) a renewal license fee of $1,000;
46.13 	(10) for a cannabis event organizer:
46.14 	(i) an application fee of $750; and
46.15 	(ii) an initial license fee of $750;
46.16 	(11) for a lower-potency hemp edible manufacturer:
46.17 	(i) an application fee of $250;
46.18 	(ii) an initial license fee of $1,000; and
46.19 	(iii) a renewal license fee of $1,000;
46.20 	(12) for a lower-potency hemp edible retailer:
46.21 	(i) an application fee of $250 per retail location;
46.22 	(ii) an initial license fee of $250 per retail location; and
46.23 	(iii) a renewal license fee of $250 per retail location; and
46.24 	(13) for a medical cannabis cultivator:
46.25 	(i) an application fee of $250;
46.26 	(ii) an initial license fee of $0; and
46.27 	(iii) a renewal license fee of $0;
47.1 	(14) for a medical cannabis processor:
47.2 	(i) an application fee of $250;
47.3 	(ii) an initial license fee of $0; and
47.4 	(iii) a renewal license fee of $0;
47.5 	(15) for a medical cannabis retailer:
47.6 	(i) an application fee of $250;
47.7 	(ii) an initial license fee of $0; and
47.8 	(iii) a renewal license fee of $0; and
47.9 	(16) (13) for a medical cannabis combination business:
47.10 	(i) an application fee of $10,000;
47.11 	(ii) an initial license fee of $20,000; and
47.12 	(iii) a renewal license fee of $70,000.

47.13 	EFFECTIVE DATE. This section is effective the day following final enactment.

47.14 	Sec. 54. Minnesota Statutes 2023 Supplement, section 342.12, is amended to read:
47.15 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
47.16 	(a) Licenses A person holding a license issued under this chapter may be freely transferred
47.17 	transfer that license to another entity subject to the prior written approval of the office, 
47.18 	which approval may be given or withheld in the office's sole discretion, provided that a 
47.19 	social equity applicant may only transfer the applicant's license to another social equity 
47.20 	applicant unless the license is temporary or is held by a social equity applicant. A new 
47.21 	license must be obtained when:
47.22 	(1) the form of the licensee's legal business structure converts or changes to a different 
47.23 	type of legal business structure; or
47.24 	(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency, 
47.25 	or receivership proceedings; merges with another legal organization; or assigns all or 
47.26 	substantially all of its assets for the benefit of creditors.
47.27 	(b) Transfers between Notwithstanding paragraph (a), during the first three years from 
47.28 	the date that a social equity applicant holds a license, the social equity applicants applicant 
47.29 	may only transfer the license to another social equity applicant. Three years after a license 
48.1 	was initially issued, a social equity applicant may transfer the license to any entity. A license 
48.2 	transfer by a social equity applicant must be reviewed by the Division of Social Equity.
48.3 	(c) Licenses must be renewed annually.
48.4 	(d) License holders may petition the office to adjust the tier of a license issued within a 
48.5 	license category provided that the license holder meets all applicable requirements.
48.6 	(e) The office by rule may permit the relocation of a licensed cannabis business,; permit 
48.7 	the relocation of an approved operational location, including a grow or retail location; adopt 
48.8 	requirements for the submission of a license relocation application,; establish standards for 
48.9 	the approval of a relocation application,; and charge a fee not to exceed $250 for reviewing 
48.10 	and processing applications. Relocation of a licensed premises pursuant to this paragraph 
48.11 	does not extend or otherwise modify the license term of the license subject to relocation.

48.12 	EFFECTIVE DATE. This section is effective the day following final enactment.

48.13 	Sec. 55. Minnesota Statutes 2023 Supplement, section 342.13, is amended to read:
48.14 	342.13 LOCAL CONTROL.
48.15 	(a) A local unit of government may not prohibit the possession, transportation, or use 
48.16 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
48.17 	consumer products authorized under this chapter.
48.18 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
48.19 	the establishment or operation of a cannabis business licensed under this chapter.
48.20 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
48.21 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
48.22 	the establishment or operation of cannabis businesses. A local unit of government may 
48.23 	prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a 
48.24 	day care, residential treatment facility, or an attraction within a public park that is regularly 
48.25 	used by minors, including a playground or athletic field.
48.26 	(d) The office shall work with local units of government to:
48.27 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
48.28 	of the operation of a cannabis business;
48.29 	(2) develop standardized forms and procedures for the issuance of a retail registration 
48.30 	pursuant to section 342.22; and
49.1 	(3) develop model policies and procedures for the performance of compliance checks 
49.2 	required under section 342.22.
49.3 	(e) If a local unit of government is conducting studies or has authorized a study to be 
49.4 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
49.5 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
49.6 	a cannabis business, the governing body of the local unit of government may adopt an 
49.7 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
49.8 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
49.9 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
49.10 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
49.11 	or a portion thereof until January 1, 2025.
49.12 	(f) Within 30 days of receiving a copy of an application from the office, a local unit of 
49.13 	government shall certify on a form provided by the office whether a proposed cannabis 
49.14 	business complies with local zoning ordinances and, if applicable, whether the proposed 
49.15 	business complies with the state fire code and building code. The office may not issue a 
49.16 	licensean endorsement to a cannabis business if a the cannabis business does not meet local 
49.17 	zoning and land use laws.
49.18 	(g) Upon receipt of an application for a license issued under this chapter, the office shall 
49.19 	contact the local unit of government in which the business would be located and provide 
49.20 	the local unit of government with 30 days in which to provide input on the application. The 
49.21 	local unit of government may provide the office with any additional information it believes 
49.22 	is relevant to the office's decision on whether to issue a license, including but not limited 
49.23 	to identifying concerns about the proposed location of a cannabis business or sharing public 
49.24 	information about an applicant.
49.25 	(h) (g) The office by rule shall establish an expedited complaint process to receive, 
49.26 	review, and respond to complaints made by a local unit of government about a cannabis 
49.27 	business. Complaints may include alleged violations of local ordinances or other alleged 
49.28 	violations. At a minimum, the expedited complaint process shall require the office to provide 
49.29 	an initial response to the complaint within seven days and perform any necessary inspections 
49.30 	within 30 days. Nothing in this paragraph prohibits a local unit of government from enforcing 
49.31 	a local ordinance. If a local unit of government notifies the office that a cannabis business 
49.32 	other than a cannabis retailer, cannabis microbusiness with a retail operations endorsement, 
49.33 	cannabis mezzobusiness, lower-potency hemp edible retailer, medical cannabis retailer, or 
49.34 	medical cannabis combination business poses an immediate threat to the health or safety 
50.1 	of the public, the office must respond within one business day and may take any action 
50.2 	described in section 342.19 or 342.21.
50.3 	(i) (h) A local government unit that issues cannabis retailer registration under section 
50.4 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
50.5 	mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with 
50.6 	a retail operations endorsement to no fewer than one registration for every 12,500 residents.
50.7 	(j) (i) If a county has one active registration for every 12,500 residents, a city or town 
50.8 	within the county is not obligated to register a cannabis business.
50.9 	(k) (j) Nothing in this section shall prohibit a local government unit from allowing 
50.10 	licensed cannabis retailers in excess of the minimums set in paragraph (i) (h).
50.11 	(l) (k) Notwithstanding the foregoing provisions, the state shall not issue a license to 
50.12 	any cannabis business to operate in Indian country, as defined in United States Code, title 
50.13 	18, section 1151, of a Minnesota Tribal government without the consent of the Tribal 
50.14 	government.

50.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

50.16 	Sec. 56. Minnesota Statutes 2023 Supplement, section 342.14, is amended to read:
50.17 	342.14 CANNABIS LICENSE APPLICATION AND RENEWAL.
50.18 		Subdivision 1.Application; contents. (a) The office by rule shall establish forms and
50.19 	procedures for the processing of cannabis licenses issued under this chapter. At a minimum, 
50.20 	any application to obtain or renew a cannabis license shall include the following information, 
50.21 	if applicable:
50.22 	(1) the name, address, and date of birth of the applicant;
50.23 	(2) the disclosure of ownership and control required under paragraph (b);
50.24 	(3) the disclosure of whether the applicant or, if the applicant is a business, any officer, 
50.25 	director, manager, and general partner of the business has ever filed for bankruptcy;
50.26 	(4) the address and legal property description of the business, if applicable, except an 
50.27 	applicant is not required to secure a physical premises for the business at the time of 
50.28 	application;
50.29 	(5) a general description of the location or locations that the applicant plans to operate, 
50.30 	including the planned square feet of planned space for cultivation, wholesaling, and retailing, 
50.31 	as applicable;
51.1 	(6) a copy of the security plan, including security monitoring, security equipment, and 
51.2 	facility maps;
51.3 	(7) proof of trade name registration;
51.4 	(8) a copy of the applicant's business plan showing the expected size of the business; 
51.5 	anticipated growth; the methods of record keeping; the knowledge and experience of the 
51.6 	applicant and any officer, director, manager, and general partner of the business; the 
51.7 	environmental plan; and other relevant financial and operational components;
51.8 	(9) standard operating procedures for:
51.9 	(i) quality assurance;
51.10 	(ii) inventory control, storage, and diversion prevention; and
51.11 	(iii) accounting and tax compliance;
51.12 	(9) (10) an attestation signed by a bona fide labor organization stating that the applicant 
51.13 	has entered into a labor peace agreement;
51.14 	(11) a description of the training and education that will be provided to any employee;
51.15 	(12) a disclosure of any government violations of a license agreement or federal, state, 
51.16 	or local laws or regulations, including but not limited to criminal, environmental, food 
51.17 	safety, workplace safety, wage and hour, worker's compensation, labor and employment, 
51.18 	whistleblower protection, human rights, discrimination, tax, or other laws and regulations 
51.19 	relevant to business operations and working conditions;
51.20 	(10) (13) certification that the applicant will comply with the requirements of this chapter 
51.21 	relating to the ownership and operation of a cannabis business;
51.22 	(11) (14) identification of one or more controlling persons or managerial employees as 
51.23 	agents who shall be responsible for dealing with the office on all matters; and
51.24 	(12) (15) a statement that the applicant agrees to respond to the office's supplemental 
51.25 	requests for information.; and
51.26 	(16) every applicant or, in the case of a business entity, every cooperative member or 
51.27 	director, manager, and general partner of the business entity for a cannabis business license 
51.28 	must provide a release for the office to perform the background checks in section 342.15.
51.29 	(b) An applicant must file and update as necessary a disclosure of ownership and control. 
51.30 	The office by rule shall establish the contents and form of the disclosure. Except as provided 
51.31 	in paragraph (f), the disclosure shall, at a minimum, include the following:
52.1 	(1) the management structure, ownership, and control of the applicant or license holder, 
52.2 	including the name of each cooperative member, officer, director, manager, general partner, 
52.3 	or business entity; the office or position held by each person; each person's percentage 
52.4 	ownership interest, if any; and, if the business has a parent company, the name of each 
52.5 	owner, board member, and officer of the parent company and the owner's, board member's, 
52.6 	or officer's percentage ownership interest in the parent company and the cannabis business;
52.7 	(2) a statement from the applicant and, if the applicant is a business, from every officer, 
52.8 	director, manager, and general partner of the business, indicating whether that person has 
52.9 	previously held, or currently holds, an ownership interest in a cannabis business in Minnesota, 
52.10 	any other state or territory of the United States, or any other country;
52.11 	(3) if the applicant is a corporation, copies of the applicant's articles of incorporation 
52.12 	and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
52.13 	(4) copies of any partnership agreement, operating agreement, or shareholder agreement;
52.14 	(5) copies of any promissory notes, security instruments, or other similar agreements;
52.15 	(6) an explanation detailing the funding sources used to finance the business;
52.16 	(7) a list of operating and investment accounts for the business, including any applicable 
52.17 	financial institution and account number; and
52.18 	(8) a list of each outstanding loan and financial obligation obtained for use in the business, 
52.19 	including the loan amount, loan terms, and name and address of the creditor.
52.20 	(c) An application may include:
52.21 	(1) proof that the applicant is a social equity applicant;
52.22 	(2) a description of the training and education that will be provided to any employee; 
52.23 	or
52.24 	(3) a copy of business policies governing operations to ensure compliance with this 
52.25 	chapter.
52.26 	(d) Commitments made by an applicant in its application, including but not limited to 
52.27 	the maintenance of a labor peace agreement, shall be an ongoing material condition of 
52.28 	maintaining and renewing the license.
52.29 	(e) An application on behalf of a corporation or association shall be signed by at least 
52.30 	two officers or managing agents of that entity.
53.1 	(f) The office may, by rule, establish exceptions to the disclosures required under 
53.2 	paragraph (b) for members of a cooperative who hold less than a five percent ownership 
53.3 	interest in the cooperative.
53.4 		Subd. 2.Application; process. (a) An applicant must submit all required information 
53.5 	to the office on the forms and in the manner prescribed by the office.
53.6 	(b) If the office receives an application that fails to provide the required information, 
53.7 	the office shall issue a deficiency notice to the applicant. The applicant shall have ten 
53.8 	business days from the date of the deficiency notice to submit the required information.
53.9 	(c) Failure by an applicant to submit all required information will result in the application 
53.10 	being rejected.
53.11 	(d) An applicant seeking an endorsement for a specified operation activity must submit 
53.12 	required information to the office in the manner prescribed by the office.
53.13 	(e) Once all required information contained in subdivision 1 is submitted, the office 
53.14 	must review the materials, and where applicable under section 342.18, enter the applicants 
53.15 	into a lottery. An applicant not selected in the lottery will result in the application being 
53.16 	rejected.
53.17 	(f) An application is deemed complete once the office receives all required information 
53.18 	in subdivision 1 and the applicant provides the office with the address and legal property 
53.19 	description of the business, and the name of the local unit of government where the applicant 
53.20 	intends to locate its business.
53.21 	(g) The office may deny an application that:
53.22 	(1) is incomplete;
53.23 	(2) contains materially false statements about the applicant or omits material information 
53.24 	about the applicant; or
53.25 	(3) is not submitted by the deadline established by the office.
53.26 	(d) (h) Upon receipt of a completed application and fee, the office shall forward a copy 
53.27 	of the application to the local unit of government in which the business operates or intends 
53.28 	to operate with a form for certification as to whether a proposed cannabis business complies 
53.29 	with local zoning ordinances and, if applicable, whether the proposed business complies 
53.30 	with the state fire code and building code. Within 30 days of receiving a copy of an 
53.31 	application and a certification form from the office, a local unit of government must return 
54.1 	the completed form to the office. In the event a local unit of government fails to return the 
54.2 	form within 30 days, the office may issue a license.
54.3 	(e) (i) Within 90 days of receiving a completed application and the results of any required 
54.4 	criminal historybackground check, the office shall issue the appropriate license and any 
54.5 	applicable endorsements or send the applicant a notice of rejection setting forth specific 
54.6 	reasons that the office did not approve the application.
54.7 		Subd. 2a.Reconsideration. An applicant not granted a license, or where applicable, not 
54.8 	entered into a lottery, may seek reconsideration from the office. A decision by the office 
54.9 	on the request is final.
54.10 		Subd. 2b.Retention. The Office of Cannabis Management must retain all application 
54.11 	materials for 12 months after it issues a decision on the application and must consider the 
54.12 	application in any subsequent round commenced by the office in the 12-month retention 
54.13 	period, unless the applicant requests to be removed from consideration. The office must not 
54.14 	require applicants considered under this section to pay an application fee. An applicant may 
54.15 	supplement the application during the subsequent round. This subdivision does not apply 
54.16 	to applicants seeking a license under section 342.39.
54.17 		Subd. 3.License revocation. The office may revoke a cannabis business license if the 
54.18 	licensee has not made good faith efforts to obtain an endorsement within 18 months of the 
54.19 	date that the license was issued. The office may give a licensee a onetime extension to obtain 
54.20 	an endorsement if the licensee demonstrates that the licensee made good faith efforts to 
54.21 	obtain an endorsement within 18 months of the date that the license was issued.

54.22 	EFFECTIVE DATE. This section is effective the day following final enactment.

54.23 	Sec. 57. Minnesota Statutes 2023 Supplement, section 342.15, subdivision 1, is amended 
54.24 	to read:
54.25 		Subdivision 1.Criminal history check. (a) Upon request by the office, every license 
54.26 	applicant, license holder, or, in the case of a business entity, every individual responsible 
54.27 	for conducting the affairs of the entity, including but not limited to every owner and every 
54.28 	cooperative member or director, manager, and general partner of the business entity, for a 
54.29 	cannabis business license, or in the case of a business entity, every cooperative member or 
54.30 	director, manager, and general partner of the business entity, and prospective cannabis 
54.31 	worker must submit a completed criminal history records check consent form, a full set of 
54.32 	classifiable fingerprints, and the required fees to the office. Upon receipt of this information, 
55.1 	the office must submit the completed criminal history records check consent form, full set 
55.2 	of classifiable fingerprints, and required fees to the Bureau of Criminal Apprehension.
55.3 	(b) After receiving this information, the bureau must conduct a Minnesota state criminal 
55.4 	history records check of the license applicant or prospective cannabis worker an individual 
55.5 	identified in paragraph (a). The bureau may exchange a license applicant's or prospective 
55.6 	cannabis worker's an individual's fingerprints with the Federal Bureau of Investigation to 
55.7 	obtain the license applicant's or prospective cannabis worker's national criminal history 
55.8 	record information of the individual. The bureau must return the results of the Minnesota
55.9 	state and federal criminal history records checks to the office to determine if the license 
55.10 	applicant or prospective cannabis worker individual is disqualified under rules adopted 
55.11 	pursuant to this section.
55.12 	(b)(c) The office may, by rule, establish exceptions to the requirement under paragraph
55.13 	paragraphs (a) and (b) for members of a cooperative who hold less than a five percent 
55.14 	ownership interest in the cooperative.

55.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

55.16 	Sec. 58. Minnesota Statutes 2023 Supplement, section 342.15, subdivision 2, is amended 
55.17 	to read:
55.18 		Subd. 2.Criminal offenses; disqualifications. The office may by rule determine whether 
55.19 	any felony convictions shall, including but not limited to convictions for noncannabis 
55.20 	controlled substance crimes in the first or second degree, human trafficking, labor trafficking, 
55.21 	fraud, or financial crimes, disqualify a person an individual from holding or receiving a 
55.22 	cannabis business license issued under this chapter or working for a cannabis business, and 
55.23 	the length of any such disqualification. In adopting rules pursuant to this subdivision, the 
55.24 	office shall not disqualify a person an individual for a violation of section 152.025.

55.25 	EFFECTIVE DATE. This section is effective the day following final enactment.

55.26 	Sec. 59. Minnesota Statutes 2023 Supplement, section 342.15, is amended by adding a 
55.27 	subdivision to read:
55.28 		Subd. 5.Civil and regulatory offenses; disqualifications. The office may determine 
55.29 	whether any civil or regulatory violations, as determined by another state agency, local unit 
55.30 	of government, or any other jurisdiction, disqualify an individual from holding or receiving 
55.31 	a cannabis business license issued under this chapter or disqualify an individual from working 
55.32 	for a cannabis business, and the length of the disqualification. Upon the office's request, a 
56.1 	state agency, as defined in section 13.02, subdivision 17, may release civil investigative 
56.2 	data, including data classified as protected nonpublic or confidential under section 13.39, 
56.3 	subdivision 2, if the request is related to a specific applicant and the data is necessary to 
56.4 	make a determination under this section.

56.5 	EFFECTIVE DATE. This section is effective the day following final enactment.

56.6 	Sec. 60. [342.151] EMPLOYEES OF LICENSE HOLDERS.
56.7 		Subdivision 1.Criminal history check. A license holder may employ or contract with 
56.8 	as many unlicensed individuals as may be necessary, provided that the license holder is at 
56.9 	all times accountable for the good conduct of every individual employed by or contracted 
56.10 	with the license holder. Before hiring an individual as a cannabis worker, the license holder 
56.11 	must submit to the Bureau of Criminal Apprehension the individual's full set of fingerprints 
56.12 	and written consent for the bureau to conduct a state and national criminal history check. 
56.13 	The bureau may exchange an individual's fingerprints with the Federal Bureau of 
56.14 	Investigation. The Bureau of Criminal Apprehension must determine whether the individual 
56.15 	is qualified to be employed as a cannabis worker and must notify the license holder of the 
56.16 	bureau's determination. The license holder must not employ an individual who is disqualified 
56.17 	from being employed as a cannabis worker.
56.18 		Subd. 2.Disqualification. (a) A license holder must not employ an individual as a 
56.19 	cannabis worker if the individual has been convicted of any of the following crimes that 
56.20 	would constitute a felony:
56.21 	(1) human trafficking;
56.22 	(2) noncannabis controlled substance crimes in the first or second degree;
56.23 	(3) labor trafficking;
56.24 	(4) fraud;
56.25 	(5) embezzlement;
56.26 	(6) extortion;
56.27 	(7) money laundering; or
56.28 	(8) insider trading;
56.29 	if committed in this state or any other jurisdiction for which a full pardon or similar relief 
56.30 	has not been granted.
57.1 	(b) A license holder must not employ an individual as a cannabis worker if the individual 
57.2 	made any false statement in an application for employment.

57.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

57.4 	Sec. 61. Minnesota Statutes 2023 Supplement, section 342.16, is amended to read:
57.5 	342.16 CANNABIS BUSINESSES; GENERAL OWNERSHIP 
57.6 	DISQUALIFICATIONS AND REQUIREMENTS.
57.7 	(a) A license holder or applicant must meet each of the following requirements, if 
57.8 	applicable, to hold or receive a cannabis license issued under this chapter:
57.9 	(1) be at least 21 years of age;
57.10 	(2) have completed an application for licensure or application for renewal;
57.11 	(3) have paid the applicable application fee and license fee;
57.12 	(4) if the applicant or license holder is a business entity, be incorporated in the state or 
57.13 	otherwise formed or organized under the laws of the state;
57.14 	(5) not be employed by the office or any state agency with regulatory authority under 
57.15 	this chapter or the rules adopted pursuant to this chapter;
57.16 	(6) not be a licensed peace officer, as defined in section 626.84, subdivision 1, paragraph 
57.17 	(c);
57.18 	(7) never have had a license previously issued under this chapter revoked, and never 
57.19 	have had a cannabis license, a registration, an agreement, or another authorization to operate 
57.20 	a cannabis business issued under the laws of another state revoked;
57.21 	(8) have filed any previously required tax returns for a cannabis business;
57.22 	(9) have paid and remitted any business taxes, gross receipts taxes, interest, or penalties 
57.23 	due relating to the operation of a cannabis business;
57.24 	(10) have fully and truthfully complied with all information requests of the office relating 
57.25 	to license application and renewal;
57.26 	(11) not be disqualified under section 342.15;
57.27 	(12) not employ an individual who is disqualified from working for a cannabis business 
57.28 	under this chapter; and
57.29 	(13) meet the ownership and operational requirements for the type of license and, if 
57.30 	applicable, endorsement sought or held; and
58.1 	(14) not have had any confirmed labor violation with the Department of Labor, National 
58.2 	Labor Relations Board, or the Occupational Safety and Health Administration within the 
58.3 	last five years.
58.4 	(b) A health care practitioner who certifies qualifying medical conditions for patients is 
58.5 	prohibited from:
58.6 	(1) holding a direct or indirect economic interest in a cannabis business;
58.7 	(2) serving as a cooperative member, director, manager, general partner, or employee 
58.8 	of a cannabis business; or
58.9 	(3) advertising with a cannabis business in any way.
58.10 	(c) If the license holder or applicant is a business entity, every officer, director, manager, 
58.11 	and general partner of the business entity must meet each of the requirements of this section.
58.12 	(d) The ownership disqualifications and requirements under this section do not apply to 
58.13 	a hemp business license holder or applicant.

58.14 	Sec. 62. Minnesota Statutes 2023 Supplement, section 342.17, is amended to read:
58.15 	342.17 SOCIAL EQUITY APPLICANTS.
58.16 	(a) An applicant qualifies as a social equity applicant if the applicant:
58.17 	(1) was convicted of an offense involving the possession or sale of cannabis or marijuana 
58.18 	prior to May 1, 2023;
58.19 	(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense 
58.20 	involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
58.21 	(3) was a dependent of an individual who was convicted of an offense involving the 
58.22 	possession or sale of cannabis or marijuana prior to May 1, 2023;
58.23 	(4) is a military veteran, including status as a service-disabled veteran, current or former 
58.24 	member of the national guard, or;
58.25 	(5) any military veteran or current or former member of the national guard who lost 
58.26 	honorable status due to an offense involving the possession or sale of cannabis or marijuana;
58.27 	(5) (6) has been a resident for the last five years of one or more subareas, such as census 
58.28 	tracts or neighborhoods, that experienced a disproportionately large amount of cannabis 
58.29 	enforcement as determined by the study conducted by the office pursuant to section 342.04, 
58.30 	paragraph (b), and reported in the preliminary report, final report, or both;
59.1 	(6) is an emerging farmer as defined in section 17.055, subdivision 1; or
59.2 	(7) has participated in the business operation of a farm for at least three years and 
59.3 	currently provides the majority of the day-to-day physical labor and management of a farm 
59.4 	that had gross farm sales of at least $5,000 but not more than $100,000 in the previous year; 
59.5 	or
59.6 	(7) (8) has been a resident for the last five years of one or more census tracts where, as 
59.7 	reported in the most recently completed decennial census published by the United States 
59.8 	Bureau of the Census, either:
59.9 	(i) the poverty rate was 20 percent or more; or
59.10 	(ii) the median family income did not exceed 80 percent of statewide median family 
59.11 	income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide 
59.12 	median family income or 80 percent of the median family income for that metropolitan 
59.13 	area.
59.14 	(b) The qualifications described in paragraph (a) apply to each individual applicant or, 
59.15 	in the case of a business entity, every cooperative member or director, manager, and general 
59.16 	partner apply to at least 65 percent of the controlling ownership of the business entity.

59.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

59.18 	Sec. 63. [342.175] SOCIAL EQUITY LICENSE CLASSIFICATION.
59.19 		Subdivision 1.Social equity license classification. (a) The office must make a social 
59.20 	equity classification available to a social equity applicant under section 342.17.
59.21 	(b) The office must classify any type of license under section 342.10 as a social equity 
59.22 	license if the license is held by a social equity applicant.
59.23 		Subd. 2.Social equity applicants; license preapprovals. After accepting and reviewing 
59.24 	an application for a license from a social equity applicant, the office may issue a license 
59.25 	preapproval according to section 342.125 to the social equity applicant.

59.26 	EFFECTIVE DATE. This section is effective the day following final enactment.

59.27 	Sec. 64. Minnesota Statutes 2023 Supplement, section 342.18, subdivision 2, is amended 
59.28 	to read:
59.29 		Subd. 2.Vertical integration prohibited; exceptions. (a) Except as otherwise provided 
59.30 	in this subdivision, the office shall not issue licenses to a single applicant that would result 
59.31 	in the applicant being vertically integrated in violation of the provisions of this chapter.
60.1 	(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses or,
60.2 	mezzobusiness licenses, or medical cannabis combination business licenses, or the issuance 
60.3 	of both lower-potency hemp edible manufacturer and lower-potency hemp edible retailer 
60.4 	licenses to the same person or entity.

60.5 	Sec. 65. Minnesota Statutes 2023 Supplement, section 342.18, subdivision 3, is amended 
60.6 	to read:
60.7 		Subd. 3.Application score; license priority review. (a) The office shall award points 
60.8 	to review each completed application for a license to operate a cannabis business in the 
60.9 	following categories:
60.10 	(1) status as a social equity applicant or as an applicant who is substantially similar to 
60.11 	a social equity applicant as described in paragraph (c);
60.12 	(2) status as a veteran or retired national guard applicant who does not meet the definition 
60.13 	of social equity applicant;
60.14 	(3) (1) security and record keeping;
60.15 	(4) (2) employee training plan;
60.16 	(5) (3) business plan and financial situation;
60.17 	(6) (4) labor and employment practices;
60.18 	(7) (5) knowledge and experience; and
60.19 	(8) (6) environmental plan.
60.20 	(b) The office may award additional points to an application if the license holder would 
60.21 	expand service to an underrepresented market, including but not limited to participation in 
60.22 	the medical cannabis program.
60.23 	(c) The office shall establish application materials permitting individual applicants to 
60.24 	demonstrate the impact that cannabis prohibition has had on that applicant, including but 
60.25 	not limited to the arrest or imprisonment of the applicant or a member of the applicant's 
60.26 	immediate family, and the office may award points to such applicants in the same manner 
60.27 	as points are awarded to social equity applicants.
60.28 	(d) (b) The office shall establish policies and guidelines, which the office must be made
60.29 	make available to the public, regarding the number of points available minimum 
60.30 	qualifications in each category and the basis for awarding those points. Status as a social 
60.31 	equity applicant must account for at least 20 percent of the total available points. In 
61.1 	determining the number of points to award to a cooperative or business applying as a social 
61.2 	equity applicant, the office shall consider the number or ownership percentage of cooperative 
61.3 	members, officers, directors, managers, and general partners who qualify as social equity 
61.4 	applicants criteria that the office uses to determine whether an applicant meets the minimum 
61.5 	qualifications in each category.
61.6 	(e) Consistent with the goals identified in subdivision 1, the office shall issue licenses 
61.7 	in each license category, giving priority to applicants who receive the highest score under 
61.8 	paragraphs (a) and (b). If there are insufficient licenses available for entities that receive 
61.9 	identical scores, the office shall utilize a lottery to randomly select license recipients from 
61.10 	among those entities.

61.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

61.12 	Sec. 66. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
61.13 	subdivision to read:
61.14 		Subd. 4.Maximum number of licenses. (a) Through as many licensing periods as the 
61.15 	office deems necessary, the office shall issue no more than the maximum number of licenses 
61.16 	in each license category listed in paragraphs (e) and (f) to applicants that meet the minimum 
61.17 	qualifications in subdivision 3. After 24 months from the beginning of the license application 
61.18 	process, the office may adjust the maximum number of licenses of any type listed in this 
61.19 	subdivision based on market demand, consistent with the objectives in section 342.02, 
61.20 	subdivision 1, and the annual report required under section 342.04, paragraph (f).
61.21 	(b) If there are insufficient licenses available for all applicants that meet the minimum 
61.22 	qualifications in subdivision 3, the office shall hold a lottery to randomly select license 
61.23 	recipients from among the applicants. The office may issue as many licenses as the office 
61.24 	deems necessary of a license type that is not listed in this subdivision. The office is not 
61.25 	required to issue a license for a license type that is not listed in this subdivision.
61.26 	(c) Cannabis microbusiness and cannabis mezzobusiness license holders with a retail 
61.27 	endorsement must obtain at least one other endorsement for authorized actions under the 
61.28 	license category within 18 months of license issuance or the office may revoke the license 
61.29 	holder's license or take appropriate enforcement action.
61.30 	(d) The office is not required to issue licenses to meet the maximum number of licenses 
61.31 	that may be issued under paragraphs (e) and (f).
61.32 	(e) For licenses that are available to social equity applicants, the maximum number of 
61.33 	licenses that the office may issue are:
62.1 	(1) cultivator licenses, 19;
62.2 	(2) product manufacturer licenses, 12;
62.3 	(3) retailer licenses, 100; and
62.4 	(4) cannabis mezzobusiness licenses, 30.
62.5 	(f) For licenses that are available to all applicants, the maximum number of licenses that 
62.6 	the office may issue are:
62.7 	(1) cultivator licenses, 19;
62.8 	(2) product manufacturer licenses, 12;
62.9 	(3) retailer licenses, 100; and
62.10 	(4) cannabis mezzobusiness licenses, 30.
62.11 	(g) Of the available license preapprovals listed in paragraph (f), the following number 
62.12 	of license preapprovals will be available for applicants that notify the office they will apply 
62.13 	for a medical retail endorsement and intend to serve the medical registry market for at least 
62.14 	three years:
62.15 	(1) cannabis mezzobusiness, six; and
62.16 	(2) cannabis retailer, 20.
62.17 	Failure to receive a medical retail endorsement or to serve the medical registry market for 
62.18 	at least three years will result in a revocation of license.

62.19 	EFFECTIVE DATE. This section is effective the day following final enactment.

62.20 	Sec. 67. [342.185] TRUE PARTY OF INTEREST.
62.21 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
62.22 	meanings given.
62.23 	(b) "Control" means the power to independently order or direct the management, 
62.24 	managers, or policies of a licensed business.
62.25 	(c) "Financial institution" means any bank, mutual savings bank, consumer loan company, 
62.26 	credit union, savings and loan association, trust company, or other lending institution under 
62.27 	the jurisdiction of the Department of Commerce.
62.28 	(d) "Financier" means any person or entity that:
62.29 	(1) is not a financial institution or government entity;
63.1 	(2) provides money as a gift, grant, or loan to an applicant for a cannabis business license, 
63.2 	a cannabis business, or both; and
63.3 	(3) expects to be paid back, with or without reasonable interest.
63.4 	(e) "Gross profit" means sales minus the cost of goods sold.
63.5 	(f) "Revenue" means the income generated from the sale of goods and services associated 
63.6 	with the main operations of a business before any costs or expenses are deducted.
63.7 	(g) "True party of interest" means:
63.8 	(1) for a sole proprietorship, the sole proprietor;
63.9 	(2) for a general partnership, all partners;
63.10 	(3) for a limited partnership, limited liability partnership, or limited liability limited 
63.11 	partnership, all general partners and limited partners;
63.12 	(4) for a limited liability company, all limited liability company members and managers;
63.13 	(5) for a privately held corporation, all corporate officers and directors or persons with 
63.14 	equivalent titles and all stockholders;
63.15 	(6) for multilevel ownership structures, all persons and entities that make up the 
63.16 	ownership structure;
63.17 	(7) for any entity or person with a right to receive revenue, gross profit or net profit or 
63.18 	exercise control over a licensed business; any entity or person with the right to receive some 
63.19 	or all of the revenue, gross profit, or net profit from a licensed business during any full or 
63.20 	partial calendar or fiscal year; and any entity or person who exercises control over a licensed 
63.21 	business; and
63.22 	(8) for a nonprofit corporation, all individuals and entities with membership rights in 
63.23 	accordance with the provisions of the articles of incorporation or bylaws.
63.24 	True party of interest does not include:
63.25 	(1) a person or entity receiving payment for rent on a fixed basis under a lease or rental 
63.26 	agreement. Notwithstanding, if there is a common ownership interest between the applicant 
63.27 	or licensee and the entity that owns the real property, the office may investigate all funds 
63.28 	associated with the landlord to determine if a financier relationship exists. The office may 
63.29 	also investigate a landlord in situations in which a rental payment has been waived or 
63.30 	deferred;
64.1 	(2) a person who receives a bonus or commission based on the person's sales, so long 
64.2 	as the commission does not exceed ten percent of the person's sales in any given bonus or 
64.3 	commission period. Commission-based compensation agreements must be in writing;
64.4 	(3) a person or entity contracting with a licensee to receive a commission for the sale of 
64.5 	a business or real property;
64.6 	(4) a consultant receiving a flat or hourly rate compensation under a written contractual 
64.7 	agreement;
64.8 	(5) a person with an option to purchase the applied for or licensed business, so long as 
64.9 	no money has been paid to the licensee under an option contract or agreement for the 
64.10 	purchase or sale of a licensed business or a business that is applying for a license;
64.11 	(6) any business or individual with a contract or agreement for services with a licensed 
64.12 	business, such as a branding or staffing company, as long as the licensee retains the right 
64.13 	to and controls the business; or
64.14 	(7) a financial institution.
64.15 		Subd. 2.Application number limitations. Notwithstanding other sections within this 
64.16 	chapter, an individual may not be a true party of interest for more than one application. The 
64.17 	limitation does not apply to a person who holds ten percent or less controlling ownership 
64.18 	of the business entity.
64.19 		Subd. 3.License number limitations. Notwithstanding other sections within this chapter, 
64.20 	an individual may not be a true party of interest for more than one license unless otherwise 
64.21 	allowed by this chapter. The limitation does not apply to a person who holds ten percent or 
64.22 	less controlling ownership of the business entity.
64.23 		Subd. 4.Limitation on married couples. A married couple may not be a true party of 
64.24 	interest in more than one cannabis microbusiness, one cannabis mezzobusiness, five cannabis 
64.25 	retailer businesses, three cannabis cultivator businesses, or three cannabis manufacturer 
64.26 	businesses. The limitations in section 342.18, subdivision 2, apply to a married couple as 
64.27 	if the licenses were held by a single entity.
64.28 		Subd. 5.Notification. Except as otherwise provided in this subdivision, a cannabis 
64.29 	business has a continuing duty to disclose the source of all money that will be invested in 
64.30 	the business, including but not limited to all money obtained from financiers, before investing 
64.31 	the money in the licensed business. The notice requirement under this section does not apply 
64.32 	to:
64.33 	(1) revenues of a licensed cannabis business that are reinvested in the business;
65.1 	(2) proceeds of a revolving loan if the loan has been approved by the office within the 
65.2 	three previous years, unless the source of the money has changed or the approved loan 
65.3 	amount has increased; and
65.4 	(3) if the source of the money is an identified true party of interest on the license, a 
65.5 	previously approved financier associated with the license, or a previously approved revolving 
65.6 	loan, the office must allow the money to be used upon receipt of an application to use the 
65.7 	money. The office must then investigate the source of the money. If the office cannot verify 
65.8 	the source of the money after reasonable inquiry, or the office determines that the money 
65.9 	was obtained in a manner in violation of the law, the office may take actions consistent with 
65.10 	the provisions of this chapter.
65.11 		Subd. 6.Disclosure agreements and intellectual property. A cannabis business must 
65.12 	not enter into an intellectual property agreement with another cannabis business if a single 
65.13 	entity could not hold licenses for both types of cannabis business.
65.14 		Subd. 7.Financiers. (a) A financier may not receive an ownership interest, control of 
65.15 	a business, a share of revenue, gross profits or net profits, a profit sharing interest, or a 
65.16 	percentage of the profits in exchange for a loan or gift of money, unless the financier, if 
65.17 	directly involved in the loaning of money, receives office approval and has qualified on the 
65.18 	license as a true party of interest.
65.19 	(b) The office must conduct a financial and criminal background investigation on all 
65.20 	financiers.

65.21 	Sec. 68. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
65.22 	subdivision to read:
65.23 		Subd. 5.Conversion to hemp business license. (a) After the office adopts initial rules 
65.24 	pertaining to cannabis, the office may permit a holder of a hemp-derived cannabinoid 
65.25 	business registration pursuant to section 151.72 to convert the holder's registration to a 
65.26 	comparable lower-potency hemp edible business license if:
65.27 	(1) the registration was active before the office adopted initial rules pertaining to cannabis;
65.28 	(2) the registrant submits documentation to the office sufficient to meet the minimum 
65.29 	requirements in section 342.44;
65.30 	(3) the registrant pays an application and licensing fee as required by section 342.11; 
65.31 	and
65.32 	(4) the registrant is in good standing with the state.
66.1 	(b) A registrant with an active hemp-derived cannabinoid business registration pursuant 
66.2 	to section 151.72 may continue operations under an active registration for no more than 30 
66.3 	days after the office begins accepting applications for a lower-potency hemp edible business 
66.4 	license.
66.5 	(c) Upon the submission of an application for a lower-potency hemp edible business 
66.6 	license to the office, a registrant's hemp-derived cannabinoid business registration shall 
66.7 	remain active until the office makes a determination regarding the registrant's application, 
66.8 	as long as the registrant remains in good standing with the state.

66.9 	Sec. 69. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 1, is amended 
66.10 	to read:
66.11 		Subdivision 1.Authority to inspect. (a) In order to carry out the purposes of this chapter, 
66.12 	the office, upon presenting appropriate credentials to the owner, operator, or agent in charge, 
66.13 	is authorized to:
66.14 	(1) enter any cannabis business or hemp business the place of business of any cannabis 
66.15 	business, hemp business, or business engaged in the cultivation, manufacture, or retail sale 
66.16 	of cannabis without a license under this chapter without delay and at reasonable times;
66.17 	(2) inspect and investigate during regular working hours and at other reasonable times, 
66.18 	within reasonable limits and in a reasonable manner, any cannabis business or hemp business
66.19 	the place of business of any cannabis business, hemp business, or business engaged in the 
66.20 	cultivation, manufacture, or retail sale of cannabis without a license under this chapter and 
66.21 	all relevant conditions, equipment, records, and materials therein; and
66.22 	(3) question privately any employer, owner, operator, agent, or employee of a cannabis 
66.23 	business or hemp business any cannabis business, hemp business, or business engaged in 
66.24 	the cultivation, manufacture, or retail sale of cannabis without a license under this chapter.
66.25 	(b) An employer, owner, operator, agent, or employee must not refuse the office entry 
66.26 	or otherwise deter or prohibit the office from taking action under paragraph (a).

66.27 	Sec. 70. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 3, is amended 
66.28 	to read:
66.29 		Subd. 3.Aiding of inspection. Subject to rules issued by the office, a representative of 
66.30 	a cannabis business or hemp business shall business participating in the cannabis industry 
66.31 	or hemp consumer industry must be given an opportunity to accompany the office during 
67.1 	the physical inspection of any cannabis business or hemp the business for the purpose of 
67.2 	aiding such inspection.

67.3 	Sec. 71. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 4, is amended 
67.4 	to read:
67.5 		Subd. 4.Complaints and reports; priority of inspection. (a) The office may conduct 
67.6 	inspections of any licensed cannabis business or hemp business cannabis business, hemp 
67.7 	business, or a business engaged in the cultivation, manufacture, or retail sale of cannabis 
67.8 	without a license under this chapter at any time to ensure compliance with the ownership 
67.9 	and operation requirements of this chapter.
67.10 	(b) Any person may report a suspected violation of a safety or health standard. If upon 
67.11 	receipt of such notification the office determines that there are reasonable grounds to believe 
67.12 	that such violation or danger exists, the office shall make a special inspection as soon as 
67.13 	practicable to determine if such danger or violation exists.
67.14 	(c) The office shall prioritize inspections of cannabis businesses and hemp businesses
67.15 	where there are reasonable grounds to believe that a violation by a person or business poses 
67.16 	imminent danger to the public or customers. Inspections must take place within one business 
67.17 	day of the receipt of a credible report.
67.18 	(d) The office shall promptly inspect cannabis businesses and hemp businesses the place 
67.19 	of business of any cannabis business, hemp business, or a business engaged in the cultivation, 
67.20 	manufacture, or retail sale of cannabis without a license under this chapter that are is the 
67.21 	subject of complaint by a local unit of government.

67.22 	Sec. 72. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 5, is amended 
67.23 	to read:
67.24 		Subd. 5.Violations; administrative orders and penalties. (a) The office may issue an 
67.25 	administrative order to any licensed cannabis business or hemp business cannabis business, 
67.26 	hemp business, or a business engaged in the cultivation, manufacture, or retail sale of 
67.27 	cannabis without a license under this chapter that the office determines has committed a 
67.28 	violation of this chapter or rules adopted pursuant to this chapter. The administrative order 
67.29 	may require the business to correct the violation or to cease and desist from committing the 
67.30 	violation. The order must state the deficiencies that constitute the violation and the time by 
67.31 	which the violation must be corrected. If the business believes that the information in the 
67.32 	administrative order is in error, the business may ask the office to consider the parts of the 
67.33 	order that are alleged to be in error. The request must be in writing, delivered to the office 
68.1 	by certified mail within seven days after receipt of the order, and provide documentation 
68.2 	to support the allegation of error. The office must respond to a request for reconsideration 
68.3 	within 15 days after receiving the request. A request for reconsideration does not stay the 
68.4 	correction order unless the office issues a supplemental order granting additional time. The 
68.5 	office's disposition of a request for reconsideration is final.
68.6 	(b) For each violation of this chapter or rules adopted pursuant to this chapter, the office 
68.7 	may issue to each cannabis business or hemp individual or business a monetary penalty of 
68.8 	up to $10,000, an amount that deprives the individual or business of any economic advantage 
68.9 	gained by the violation, or both.
68.10 	(c) An administrative penalty may be recovered in a civil action in the name of the state 
68.11 	brought in the district court of the county where the violation is alleged to have occurred 
68.12 	or the district court where the office is housed.
68.13 	(d) In addition to penalties listed in this subdivision, a person or business who violates 
68.14 	the provisions of this chapter is subject to any applicable criminal penalty.

68.15 	Sec. 73. Minnesota Statutes 2023 Supplement, section 342.22, is amended to read:
68.16 	342.22 RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT.
68.17 		Subdivision 1.Registration required. Before receiving a retail operations endorsement 
68.18 	and making retail sales to customers or patients, a cannabis microbusiness with a retail 
68.19 	operations endorsement, cannabis mezzobusiness with a retail operations endorsement, 
68.20 	cannabis retailer, medical cannabis retailer, medical cannabis combination business, or 
68.21 	lower-potency hemp edible retailer must register with the city, town, or county in which 
68.22 	the retail establishment is located. A county may issue a registration in cases where a city 
68.23 	or town has provided consent for the county to issue the registration for the jurisdiction.
68.24 		Subd. 2.Registration fee. (a) A local unit of government may impose an initial retail 
68.25 	registration fee of $500 or up to half the amount of the applicable initial license fee under 
68.26 	section 342.11, whichever is less. The local unit of government may also impose a renewal 
68.27 	retail registration fee of $1,000 or up to half the amount of the applicable renewal license 
68.28 	fee under section 342.11, whichever is less. The initial registration fee shall include the fee 
68.29 	for initial registration and the first annual renewal. Any renewal fee imposed by the local 
68.30 	unit of government shall be charged at the time of the second renewal and each subsequent 
68.31 	annual renewal thereafter.
68.32 	(b) The local unit of government may not charge an application fee.
69.1 	(c) A cannabis business with a cannabis retailer license and a medical cannabis retailer 
69.2 	license for the same location may only be charged a single registration fee.
69.3 	(d) (c) Registration fees are nonrefundable.
69.4 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
69.5 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
69.6 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
69.7 	retailer, or lower-potency hemp edible retailer that:
69.8 	(1) has a valid license issued an application that has been approved by the office;
69.9 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
69.10 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
69.11 	compliance check that the local unit of government performs; and
69.12 	(4) if applicable, is current on all property taxes and assessments at the location where 
69.13 	the retail establishment is located.
69.14 	(b) Before issuing a retail registration, the local unit of government may conduct a 
69.15 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
69.16 	compliance with the any applicable operation requirements and the limits on the types of 
69.17 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
69.18 	products that may be sold local ordinance established pursuant to section 342.13.
69.19 	(c) A local unit of government shall renew the retail registration of a cannabis business 
69.20 	or hemp business when the office renews the license of the cannabis business or hemp 
69.21 	business.
69.22 	(d) A retail registration issued under this section may not be transferred.
69.23 		Subd. 4.Compliance checks. (a) A local unit of government shall conduct compliance 
69.24 	checks of every cannabis business and hemp business with a retail registration issued by 
69.25 	the local unit of government. The checks During a compliance check, a local unit of 
69.26 	government shall assess a business's compliance with age verification requirements, the
69.27 	and compliance with any applicable operation requirements, and the applicable limits on 
69.28 	the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
69.29 	hemp-derived consumer products being sold local ordinance established pursuant to section 
69.30 	342.13.
69.31 	(b) The A local unit of government must conduct unannounced age verification 
69.32 	compliance checks of every cannabis business and hemp business at least once each calendar 
70.1 	year. Age verification compliance checks must involve persons at least 17 years of age but 
70.2 	under the age of 21 who, with the prior written consent of a parent or guardian if the person 
70.3 	is under the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis 
70.4 	products, lower-potency hemp edibles, or hemp-derived consumer products under the direct 
70.5 	supervision of a law enforcement officer or an employee of the local unit of government.
70.6 	(c) Checks to ensure compliance with the applicable operation requirements and the 
70.7 	limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
70.8 	hemp-derived consumer products that may be sold must be performed at least once each 
70.9 	calendar year and may be performed by a law enforcement officer or an employee of the 
70.10 	local unit of government.
70.11 		Subd. 5.Registration suspension and cancellation; notice to office; penalties. (a) If 
70.12 	a local unit of government determines that a cannabis business or hemp business with a 
70.13 	retail registration issued by the local unit of government is not operating in compliance with 
70.14 	the requirements of this chapter a local ordinance authorized under section 342.13 or that 
70.15 	the operation of the business poses an immediate threat to the health or safety of the public, 
70.16 	the local unit of government may suspend the retail registration of the cannabis business or 
70.17 	hemp business. The local unit of government must immediately notify the office of the 
70.18 	suspension and shall include a description of the grounds for the suspension.
70.19 	(b) The office shall review the retail registration suspension and may order reinstatement 
70.20 	of the retail registration or take any action described in section 342.19 or 342.21.
70.21 	(c) The retail registration suspension must be for up to 30 days unless the office suspends 
70.22 	the license and operating privilege of the cannabis business or hemp business for a longer 
70.23 	period or revokes the license.
70.24 	(d) The local unit of government may reinstate the retail registration if the local unit of 
70.25 	government determines that any violation has been cured. The local unit of government 
70.26 	must reinstate the retail registration if the office orders reinstatement.
70.27 	(e) No cannabis microbusiness with a retail operations endorsement, cannabis 
70.28 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
70.29 	retailer, medical cannabis combination business, or lower-potency hemp edible retailer may 
70.30 	make any sale to a customer or patient without a valid retail registration with a local unit 
70.31 	of government and a valid endorsement from the office. A local unit of government may 
70.32 	impose a civil penalty of up to $2,000 for each violation of this paragraph.

70.33 	EFFECTIVE DATE. This section is effective the day following final enactment.

71.1 	Sec. 74. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 1, is amended 
71.2 	to read:
71.3 		Subdivision 1.Individuals under 21 years of age. (a) A cannabis business may not 
71.4 	employ an individual under 21 years of age and may not contract with an individual under 
71.5 	21 years of age if the individual's scope of work involves the handling of cannabis plants, 
71.6 	cannabis flower, artificially derived cannabinoids, or cannabinoid products.
71.7 	(b) A cannabis business may not permit an individual under 21 years of age to enter the 
71.8 	business premises other than entry by a patient person enrolled in the registry program.
71.9 	(c) A cannabis business may not sell or give cannabis flower, cannabis products, 
71.10 	lower-potency hemp edibles, or hemp-derived consumer products to an individual under 
71.11 	21 years of age unless the individual is a patient; registered designated caregiver; or a parent, 
71.12 	legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical 
71.13 	cannabis flower or medical cannabinoid products enrolled in the patient registry program 
71.14 	and the cannabis business holds a medical cannabis retail endorsement.

71.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

71.16 	Sec. 75. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 2, is amended 
71.17 	to read:
71.18 		Subd. 2.Use of cannabis flower and products within a licensed cannabis business. (a) 
71.19 	A cannabis business may not permit an individual who is not an employee to consume 
71.20 	cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
71.21 	products within its licensed premises unless the business is licensed to permit on-site 
71.22 	consumption.
71.23 	(b) Except as otherwise provided in this subdivision, a cannabis business may not permit 
71.24 	an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles, 
71.25 	or hemp-derived consumer products within its licensed premises or while the employee is 
71.26 	otherwise engaged in activities within the course and scope of employment.
71.27 	(c) A cannabis business may permit an employee to use medical cannabis flower and 
71.28 	medical cannabinoid products if that individual is a patient enrolled in the registry program 
71.29 	and consuming cannabis as prescribed.
71.30 	(d) For quality control, employees of a licensed cannabis business may sample cannabis 
71.31 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products. 
71.32 	Employees may not interact directly with customers for at least three hours after sampling 
72.1 	a product. Employees may not consume more than three samples in a single 24-hour period. 
72.2 	All samples must be recorded in the statewide monitoring system.

72.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

72.4 	Sec. 76. Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a 
72.5 	subdivision to read:
72.6 		Subd. 1a.Cannabis research. A cannabis researcher employed by or affiliated with 
72.7 	institutions of higher education that are regionally or nationally accredited may apply for a 
72.8 	cannabis microbusiness license to conduct cannabis crop research. A cannabis researcher 
72.9 	with a cannabis microbusiness license may perform activities identified in subdivision 1, 
72.10 	clauses (1) to (9) and (13). Cannabis grown for research purposes must not be offered for 
72.11 	sale or otherwise enter the stream of commerce.

72.12 	EFFECTIVE DATE. This section is effective the day following final enactment.

72.13 	Sec. 77. Minnesota Statutes 2023 Supplement, section 342.28, subdivision 2, is amended 
72.14 	to read:
72.15 		Subd. 2.Size limitations. (a) A cannabis microbusiness that cultivates cannabis at an 
72.16 	indoor facility may cultivate up to 5,000 square feet of plant canopy. The office may adjust 
72.17 	plant canopy limits upward or downward but not below 5,000 square feet to meet market 
72.18 	demand consistent with the goals identified in section 342.02, subdivision 1.
72.19 	(b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate 
72.20 	up to one-half acre of mature, flowering plants unless the office increases that limit. The 
72.21 	office may increase the limit to no more than one acre if the office determines that expansion 
72.22 	is. The office may adjust size limits upward or downward but not below one-half acre to 
72.23 	meet market demand consistent with the goals identified in section 342.02, subdivision 1.
72.24 	(c) The office shall establish a limit on the manufacturing of cannabis products, 
72.25 	lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness 
72.26 	that manufactures such products may perform. The limit must be equivalent to the amount 
72.27 	of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square 
72.28 	feet in a year, but may be increased if the office expands the allowable area of cultivation 
72.29 	under paragraph (a).
72.30 	(d) A cannabis microbusiness with the appropriate endorsement may operate one retail 
72.31 	location.

72.32 	EFFECTIVE DATE. This section is effective the day following final enactment.

73.1 	Sec. 78. Minnesota Statutes 2023 Supplement, section 342.29, subdivision 1, is amended 
73.2 	to read:
73.3 		Subdivision 1.Authorized actions. A cannabis mezzobusiness license, consistent with 
73.4 	the specific license endorsement or endorsements, entitles the license holder to perform any 
73.5 	or all of the following within the limits established by this section:
73.6 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
73.7 	cannabis flower from a mature plant for use as adult-use cannabis flower or for use in 
73.8 	adult-use cannabis products;
73.9 	(2) grow cannabis plants from seed or immature plant to mature plant and harvest 
73.10 	cannabis flower from a mature plant for use as medical cannabis flower or for use in medical 
73.11 	cannabinoid products;
73.12 	(3) (2) make cannabis concentrate;
73.13 	(4) (3) make hemp concentrate, including hemp concentrate with a delta-9 
73.14 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
73.15 	(5) (4) manufacture artificially derived cannabinoids;
73.16 	(6) (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
73.17 	hemp-derived consumer products for public consumption;
73.18 	(7) (6) manufacture and process medical cannabinoid products;
73.19 	(8) (7) purchase immature cannabis plants and seedlings and cannabis flower from a 
73.20 	cannabis microbusiness, another cannabis mezzobusiness, a cannabis manufacturer, or a 
73.21 	cannabis wholesaler;
73.22 	(9) (8) purchase cannabis concentrate, hemp concentrate, and synthetically derived 
73.23 	cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis 
73.24 	manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products, 
73.25 	lower-potency hemp edibles, or hemp-derived consumer products;
73.26 	(10) (9) purchase hemp plant parts and propagules from a licensed hemp grower licensed 
73.27 	under chapter 18K;
73.28 	(11) (10) purchase hemp concentrate from an industrial hemp processor licensed under 
73.29 	chapter 18K;
73.30 	(12) (11) package and label adult-use cannabis flower, adult-use cannabis products, 
73.31 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
74.1 	(13) (12) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
74.2 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
74.3 	other products authorized by law to other cannabis businesses and to customers; and
74.4 	(14) (13) perform other actions approved by the office.

74.5 	EFFECTIVE DATE. This section is effective the day following final enactment.

74.6 	Sec. 79. Minnesota Statutes 2023 Supplement, section 342.29, subdivision 4, is amended 
74.7 	to read:
74.8 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
74.9 	cannabis mezzobusiness license may also hold a cannabis event organizer license and a 
74.10 	medical cannabis retailer license.
74.11 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
74.12 	cannabis mezzobusiness license may own or operate any other cannabis business or hemp 
74.13 	business or hold more than one cannabis mezzobusiness license.
74.14 	(c) For purposes of this subdivision, a restriction on the number or type of license that 
74.15 	a business may hold applies to every cooperative member or every director, manager, and 
74.16 	general partner of a cannabis business.

74.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

74.18 	Sec. 80. Minnesota Statutes 2023 Supplement, section 342.30, subdivision 4, is amended 
74.19 	to read:
74.20 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
74.21 	cannabis cultivator license may also hold a cannabis manufacturing license, medical cannabis 
74.22 	cultivator license, medical cannabis producer license, license to grow industrial hemp, and 
74.23 	cannabis event organizer license.
74.24 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
74.25 	cannabis cultivator license may own or operate any other cannabis business or hemp business. 
74.26 	This prohibition does not prevent the transportation of cannabis flower from a cannabis 
74.27 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
74.28 	and located on the same premises.
74.29 	(c) The office by rule may limit the number of cannabis cultivator licenses a person, 
74.30 	cooperative, or business may hold.
75.1 	(d) For purposes of this subdivision, a restriction on the number or type of license a 
75.2 	business may hold applies to every cooperative member or every director, manager, and 
75.3 	general partner of a cannabis business.

75.4 	EFFECTIVE DATE. This section is effective the day following final enactment.

75.5 	Sec. 81. Minnesota Statutes 2023 Supplement, section 342.31, subdivision 4, is amended 
75.6 	to read:
75.7 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
75.8 	cannabis manufacturer license may also hold a cannabis cultivator license, a medical cannabis 
75.9 	cultivator license, a medical cannabis processor license, and a cannabis event organizer 
75.10 	license.
75.11 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
75.12 	cannabis manufacturer license may own or operate any other cannabis business or hemp 
75.13 	business. This prohibition does not prevent transportation of cannabis flower from a cannabis 
75.14 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
75.15 	and located on the same premises.
75.16 	(c) The office by rule may limit the number of cannabis manufacturer licenses that a 
75.17 	person or business may hold.
75.18 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
75.19 	a business may hold applies to every cooperative member or every director, manager, and 
75.20 	general partner of a cannabis business.

75.21 	EFFECTIVE DATE. This section is effective the day following final enactment.

75.22 	Sec. 82. Minnesota Statutes 2023 Supplement, section 342.32, subdivision 4, is amended 
75.23 	to read:
75.24 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
75.25 	cannabis retailer license may also hold a cannabis delivery service license, a medical cannabis 
75.26 	retailer license, and a cannabis event organizer license.
75.27 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
75.28 	cannabis retailer license may own or operate any other cannabis business or hemp business.
75.29 	(c) No person, cooperative, or business may hold a license to own or operate more than 
75.30 	one cannabis retail business in one city and three retail businesses in one county.
76.1 	(d) The office by rule may limit the number of cannabis retailer licenses a person, 
76.2 	cooperative, or business may hold.
76.3 	(e) For purposes of this subdivision, a restriction on the number or type of license a 
76.4 	business may hold applies to every cooperative member or every director, manager, and 
76.5 	general partner of a cannabis business.

76.6 	EFFECTIVE DATE. This section is effective the day following final enactment.

76.7 	Sec. 83. Minnesota Statutes 2023 Supplement, section 342.35, subdivision 1, is amended 
76.8 	to read:
76.9 		Subdivision 1.Authorized actions. A cannabis transporter license entitles the license 
76.10 	holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis 
76.11 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
76.12 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
76.13 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
76.14 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis retailers, 
76.15 	medical cannabis processors, and industrial hemp growers to cannabis microbusinesses, 
76.16 	cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis 
76.17 	wholesalers, cannabis retailers, lower-potency hemp edible retailers, medical cannabis 
76.18 	processors, medical cannabis retailers, and medical cannabis combination businesses and 
76.19 	perform other actions approved by the office.

76.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

76.21 	Sec. 84. Minnesota Statutes 2023 Supplement, section 342.37, subdivision 1, is amended 
76.22 	to read:
76.23 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
76.24 	holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
76.25 	products, hemp plant parts, hemp concentrate, artificially derived cannabinoids, 
76.26 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
76.27 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
76.28 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis 
76.29 	cultivators, medical cannabis processors, medical cannabis combination businesses, and 
76.30 	industrial hemp growers.

76.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

77.1 	Sec. 85. Minnesota Statutes 2023 Supplement, section 342.40, subdivision 7, is amended 
77.2 	to read:
77.3 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
77.4 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, medical cannabis 
77.5 	combination businesses operating a retail location, and lower-potency hemp edible retailers, 
77.6 	including the cannabis event organizer, may be authorized to sell cannabis plants, adult-use 
77.7 	cannabis flower, adult-use cannabis products, lower-potency hemp edibles, and hemp-derived 
77.8 	consumer products to customers at a cannabis event.
77.9 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
77.10 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
77.11 	take place in a retail area as designated in the premises diagram.
77.12 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
77.13 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
77.14 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
77.15 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
77.16 	products to an individual under 21 years of age.
77.17 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
77.18 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
77.19 	consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis 
77.20 	products must be stored in a sample jar or display case and be accompanied by a label or 
77.21 	notice containing the information required to be affixed to the packaging or container 
77.22 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
77.23 	sample may not consist of more than eight grams of adult-use cannabis flower or adult-use 
77.24 	cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams 
77.25 	of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use 
77.26 	cannabis flower or adult-use cannabis product before purchase.
77.27 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
77.28 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
77.29 	and hemp-derived consumer products for sale at a cannabis event.
77.30 	(g) Authorized retailers may not:
77.31 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
77.32 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
78.1 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
78.2 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
78.3 	is legally permitted to possess;
78.4 	(3) sell medical cannabis flower or medical cannabinoid products;
78.5 	(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp 
78.6 	edibles, or hemp-derived consumer products; or
78.7 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
78.8 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
78.9 	(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis 
78.10 	product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis 
78.11 	plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, 
78.12 	and hemp-derived consumer products for sale at a cannabis event must be stored in a secure, 
78.13 	locked container that is not accessible to the public. Such items being stored at a cannabis 
78.14 	event shall not be left unattended.
78.15 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
78.16 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
78.17 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
78.18 	the testing, packaging, and labeling of those items.
78.19 	(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold, 
78.20 	damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring 
78.21 	system.

78.22 	EFFECTIVE DATE. This section is effective the day following final enactment.

78.23 	Sec. 86. Minnesota Statutes 2023 Supplement, section 342.41, subdivision 1, is amended 
78.24 	to read:
78.25 		Subdivision 1.Authorized actions. A cannabis delivery service license entitles the 
78.26 	license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles, 
78.27 	and hemp-derived consumer products from licensed cannabis microbusinesses with a retail 
78.28 	endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers, 
78.29 	medical cannabis retailers, and medical cannabis combination businesses; transport and 
78.30 	deliver cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived 
78.31 	consumable products to customers; and perform other actions approved by the office.

78.32 	EFFECTIVE DATE. This section is effective the day following final enactment.

79.1 	Sec. 87. Minnesota Statutes 2023 Supplement, section 342.41, subdivision 3, is amended 
79.2 	to read:
79.3 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
79.4 	cannabis delivery service license may also hold a cannabis retailer license, a cannabis 
79.5 	wholesaler license, a cannabis transporter license, and a cannabis event organizer license, 
79.6 	and a medical cannabis retailer license subject to the ownership limitations that apply to 
79.7 	those licenses.
79.8 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
79.9 	cannabis delivery service license may own or operate any other cannabis business or hemp 
79.10 	business.
79.11 	(c) The office by rule may limit the number of cannabis delivery service licenses that a 
79.12 	person or business may hold.
79.13 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
79.14 	a business may hold applies to every cooperative member or every director, manager, and 
79.15 	general partner of a cannabis business.

79.16 	EFFECTIVE DATE. This section is effective the day following final enactment.

79.17 	Sec. 88. Minnesota Statutes 2023 Supplement, section 342.44, subdivision 1, is amended 
79.18 	to read:
79.19 		Subdivision 1.Application; contents. (a) Except as otherwise provided in this 
79.20 	subdivision, the provisions of this chapter relating to license applications, license selection 
79.21 	criteria, general ownership disqualifications and requirements, and general operational 
79.22 	requirements do not apply to hemp businesses.
79.23 	(b) The office, by rule, shall establish forms and procedures for the processing of hemp 
79.24 	licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp 
79.25 	license shall include the following information, if applicable:
79.26 	(1) the name, address, and date of birth of the applicant;
79.27 	(2) the address and legal property description of the business;
79.28 	(3) proof of trade name registration;
79.29 	(4) certification that the applicant will comply with the requirements of this chapter 
79.30 	relating to the ownership and operation of a hemp business;
80.1 	(5) identification of one or more controlling persons or managerial employees as agents 
80.2 	who shall be responsible for dealing with the office on all matters; and
80.3 	(6) a statement that the applicant agrees to respond to the office's supplemental requests 
80.4 	for information.
80.5 	(c) An applicant for a lower-potency hemp edible manufacturer license must submit an 
80.6 	attestation signed by a bona fide labor organization stating that the applicant has entered 
80.7 	into a labor peace agreement.
80.8 	(d) (c) An application on behalf of a corporation or association shall be signed by at 
80.9 	least two officers or managing agents of that entity.

80.10 	Sec. 89. Minnesota Statutes 2023 Supplement, section 342.46, subdivision 6, is amended 
80.11 	to read:
80.12 		Subd. 6.Compliant products. (a) A lower-potency hemp edible retailer shall ensure 
80.13 	that all lower-potency hemp edibles offered for sale comply with the limits on the amount 
80.14 	and types of cannabinoids that a lower-potency hemp edible can contain, including but not 
80.15 	limited to the requirement that lower-potency hemp edibles:
80.16 	(1) consist of servings that contain no more than five milligrams of delta-9 
80.17 	tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams 
80.18 	of cannabigerol, or any combination of those cannabinoids that does not exceed the identified 
80.19 	amounts;
80.20 	(2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids 
80.21 	per serving; and
80.22 	(3) do not contain an artificially derived cannabinoid other than delta-9 
80.23 	tetrahydrocannabinol.
80.24 	(b) If a lower-potency hemp edible is packaged in a manner that includes more than a 
80.25 	single serving, the lower-potency hemp edible must indicate each serving by scoring, 
80.26 	wrapping, or other indicators that appear on the lower-potency hemp edible designating the 
80.27 	individual serving size. If it is not possible to indicate a single serving by scoring or use of 
80.28 	another indicator that appears on the product, the lower-potency hemp edible may not be 
80.29 	packaged in a manner that includes more than a single serving in each container, except 
80.30 	that a calibrated dropper, measuring spoon, or similar device for measuring a single serving 
80.31 	may be used for any tincture, or other edible cannabinoid products that are intended to be 
80.32 	combined with food products, including beverages, prior to consumption. If the lower-potency 
81.1 	hemp edible is meant to be consumed as a beverage, the beverage container may not contain 
81.2 	more than two servings per container.
81.3 	(c) A single package containing multiple servings of a lower-potency hemp edible must 
81.4 	contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of 
81.5 	cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that 
81.6 	does not exceed the identified amounts.

81.7 	Sec. 90. [342.465] LOWER-POTENCY HEMP EDIBLES; PROHIBITED CONDUCT.
81.8 	No person may sell, give, furnish, or in any way procure for another person lower-potency 
81.9 	hemp edibles for the use of an obviously impaired person.

81.10 	EFFECTIVE DATE. This section is effective the day following final enactment.

81.11 	Sec. 91. Minnesota Statutes 2023 Supplement, section 342.51, is amended to read:
81.12 	342.51 MEDICAL CANNABIS RETAILERS RETAIL ENDORSEMENT.
81.13 		Subdivision 1.Authorized actions. (a) The office must issue a medical cannabis retail 
81.14 	endorsement to a cannabis business, if the business:
81.15 	(1) submits a medical cannabis retail endorsement application to the office;
81.16 	(2) has at least one employee who earned a medical cannabis consultant certificate issued 
81.17 	by the office and has completed the required training or has at least one employee who is 
81.18 	a licensed pharmacist under chapter 151; and
81.19 	(3) otherwise meets all applicable requirements established by the office.
81.20 	(b) A medical cannabis retailer license retail endorsement entitles the license holder to 
81.21 	purchase medical cannabis flower and medical cannabinoid products from medical cannabis 
81.22 	cultivators and medical cannabis processors and sell or distribute medical cannabis flower 
81.23 	and medical cannabinoid products to any person authorized to receive medical cannabis 
81.24 	flower or medical cannabinoid products. sell or distribute the following products to any 
81.25 	person enrolled in the medical cannabis patient registry under section 342.52:
81.26 	(1) cannabis plants, cannabis flower, cannabis products, artificially derived cannabinoids, 
81.27 	lower-potency hemp edibles, and hemp-derived consumer products that are a product 
81.28 	category approved by the office and that comply with this chapter and rules adopted pursuant 
81.29 	to this chapter regarding the testing, packaging, and labeling of cannabis plants, cannabis 
81.30 	flower, cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, 
81.31 	and hemp-derived consumer products; and
82.1 	(2) associated paraphernalia.
82.2 	(b) (c) A medical cannabis retailer license retail endorsement holder must verify that all 
82.3 	medical cannabis flower and medical cannabinoid products under paragraph (b), clause (1), 
82.4 	have passed safety, potency, and consistency testing at a cannabis testing facility approved 
82.5 	by the office for the testing of medical cannabis flower and medical cannabinoid products 
82.6 	under paragraph (b), clause (1), before the medical cannabis retailer business may distribute 
82.7 	the medical cannabis flower or medical cannabinoid product products to any person 
82.8 	authorized to receive medical cannabis flower or medical cannabinoid products enrolled in 
82.9 	the medical cannabis patient registry program under section 342.52.
82.10 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
82.11 	or medical cannabinoid products, a medical cannabis retailer licensee products listed in 
82.12 	subdivision 1, paragraph (b), to a person enrolled in the patient registry program, an employee 
82.13 	with a valid medical cannabis consultant certificate issued by the office or a licensed 
82.14 	pharmacist under chapter 151 must:
82.15 	(1) review and confirm the patient's enrollment in the registry verification program;
82.16 	(2) verify that the person requesting the distribution of medical cannabis flower or 
82.17 	medical cannabinoid products listed under subdivision 1, paragraph (b), is the patient, the 
82.18 	patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse 
82.19 	using the procedures specified in section 152.11, subdivision 2d established by the office;
82.20 	(3) ensure that a pharmacist employee of the medical cannabis retailer has consulted 
82.21 	with the patient if required according to subdivision 3; and
82.22 	(3) provide consultation to the patient to determine the proper type of product, dosage, 
82.23 	and paraphernalia for the patient if required under subdivision 3;
82.24 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
82.25 	product that includes recommended dosage requirements and other information as required 
82.26 	by rules adopted by the office.; and
82.27 	(5) provide the patient with any other information required by the office.
82.28 	(b) A medical cannabis retailer retail endorsement holder may not deliver medical 
82.29 	cannabis flower or medical cannabinoid products listed in subdivision 1, paragraph (b), to 
82.30 	a person enrolled in the patient registry program unless the medical cannabis retailer retail 
82.31 	endorsement holder also holds a cannabis delivery service license. The delivery of medical 
82.32 	cannabis flower and medical cannabinoid products are a product listed in subdivision 1, 
82.33 	paragraph (b), is subject to the provisions of section 342.42.
83.1 		Subd. 3.Final approval for distribution of medical cannabis flower and medical 
83.2 	cannabinoid products. (a) A cannabis worker who is employed by a medical cannabis 
83.3 	retailer and retail endorsement holder who is licensed as a pharmacist pursuant to chapter 
83.4 	151shall be or certified as a medical cannabis consultant by the office is the only person 
83.5 	who may give final approval for the distribution of medical cannabis flower and medical 
83.6 	cannabinoid products listed in subdivision 1, paragraph (b). Prior to the distribution of 
83.7 	medical cannabis flower or medical cannabinoid products listed in subdivision 1, paragraph 
83.8 	(b), a pharmacist or certified medical cannabis consultant employed by the a business with 
83.9 	a medical cannabis retailer retail endorsement must consult with the patient to determine 
83.10 	the proper type of medical cannabis flower, medical cannabinoid product, or medical cannabis
83.11 	proper type of paraphernalia, and proper dosage for the patient after reviewing the range of 
83.12 	chemical compositions of medical cannabis flower or medical cannabinoid the product.
83.13 	intended for distribution:
83.14 	(1) if the patient is purchasing the product for the first time;
83.15 	(2) if the patient purchases a product that the patient must administer using a different 
83.16 	method than the patient's previous method of administration;
83.17 	(3) if the patient purchases a product with a cannabinoid concentration of at least double 
83.18 	the patient's prior dosage; or
83.19 	(4) upon the request of the patient.
83.20 	(b) For purposes of this subdivision, a consultation may be conducted remotely by secure 
83.21 	videoconference, telephone, or other remote means, as long as:
83.22 	(1) the pharmacist or consultant engaging in the consultation is able to confirm the 
83.23 	identity of the patient; and
83.24 	(2) the consultation adheres to patient privacy requirements that apply to health care 
83.25 	services delivered through telemedicine.
83.26 	(b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the 
83.27 	distribution of medical cannabis flower or medical cannabinoid products when a medical 
83.28 	cannabis retailer is distributing medical cannabis flower or medical cannabinoid products 
83.29 	to a patient according to a patient-specific dosage plan established with that medical cannabis 
83.30 	retailer and is not modifying the dosage or product being distributed under that plan. Medical 
83.31 	cannabis flower or medical cannabinoid products distributed under this paragraph must be 
83.32 	distributed by a pharmacy technician employed by the medical cannabis retailer.
84.1 		Subd. 4.90-day supply. A medical cannabis retailer shall not distribute more than a 
84.2 	90-day supply of medical cannabis flower or medical cannabinoid products to a patient, 
84.3 	registered designated caregiver, or parent, legal guardian, or spouse of a patient according 
84.4 	to the dosages established for the individual patient.
84.5 		Subd. 5.Distribution to recipient in a motor vehicle. A medical cannabis retailer retail 
84.6 	endorsement holder may distribute medical cannabis flower and medical cannabinoid 
84.7 	products a product listed in subdivision 1, paragraph (b), to a patient, registered designated 
84.8 	caregiver, or parent, legal guardian, or spouse of a patient person enrolled in the patient 
84.9 	registry program who is at a dispensary location but remains in a motor vehicle, provided 
84.10 	that:
84.11 	(1) staff receive payment and distribute medical cannabis flower and medical cannabinoid 
84.12 	products a product listed in subdivision 1, paragraph (b), in a designated zone that is as 
84.13 	close as feasible to the front door of the facility;
84.14 	(2) the medical cannabis retailer retail endorsement holder ensures that the receipt of 
84.15 	payment and distribution of medical cannabis flower and medical cannabinoid products a 
84.16 	product listed in subdivision 1, paragraph (b), are visually recorded by a closed-circuit 
84.17 	television surveillance camera and provides any other necessary security safeguards;
84.18 	(3) the medical cannabis retailer retail endorsement holder does not store medical cannabis 
84.19 	flower or medical cannabinoid products a product listed in subdivision 1, paragraph (b),
84.20 	outside a restricted access area and staff transport medical cannabis flower and medical 
84.21 	cannabinoid products the product from a restricted access area to the designated zone for 
84.22 	distribution only after confirming that the patient, designated caregiver, or parent, guardian, 
84.23 	or spouse person enrolled in the patient registry program has arrived in the designated zone;
84.24 	(4) the payment for and distribution of medical cannabis flower and medical cannabinoid 
84.25 	products a product listed in subdivision 1, paragraph (b), take place only after a pharmacist 
84.26 	consultation takes place, if required under subdivision 3 meeting the requirements in 
84.27 	subdivision 2;
84.28 	(5) immediately following the distribution of medical cannabis flower or medical 
84.29 	cannabinoid products a product listed in subdivision 1, paragraph (b), staff enter record the 
84.30 	transaction in the statewide monitoring system; and
84.31 	(6) immediately following the distribution of medical cannabis flower and medical 
84.32 	cannabinoid products a product listed in subdivision 1, paragraph (b), staff take the payment 
84.33 	received into the facility.

85.1 	EFFECTIVE DATE. This section is effective the day following final enactment.

85.2 	Sec. 92. Minnesota Statutes 2023 Supplement, section 342.515, is amended to read:
85.3 	342.515 MEDICAL CANNABIS COMBINATION BUSINESSES.
85.4 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
85.5 	medical cannabis combination business license is prohibited from owning or operating any 
85.6 	other cannabis business or hemp business or holding an active registration agreement under 
85.7 	section 152.25, subdivision 1.
85.8 	(b) A person or business may hold only one medical cannabis combination business 
85.9 	license.
85.10 	(c) A medical cannabis combination business license entitles the license holder to perform 
85.11 	any or all of the following within the limits established by this section:
85.12 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
85.13 	adult-use cannabis flower and medical cannabis flower from a mature plant;
85.14 	(2) make cannabis concentrate;
85.15 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
85.16 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
85.17 	(4) manufacture artificially derived cannabinoids;
85.18 	(5) manufacture medical cannabinoid products;
85.19 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
85.20 	hemp-derived consumer products for public consumption;
85.21 	(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis 
85.22 	microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler, 
85.23 	a medical cannabis cultivator, or another medical cannabis combination business;
85.24 	(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
85.25 	under chapter 18K;
85.26 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
85.27 	from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a 
85.28 	cannabis wholesaler, a medical cannabis processor, or another medical cannabis combination 
85.29 	business;
85.30 	(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
85.31 	18K;
86.1 	(11) package and label medical cannabis flower and medical cannabinoid products for 
86.2 	sale to medical cannabis processors, medical cannabis retailers, other medical cannabis 
86.3 	combination businesses, and patients enrolled in the registry program, registered designated 
86.4 	caregivers, and parents, legal guardians, and spouses of an enrolled patient;
86.5 	(12) package and label adult-use cannabis flower, adult-use cannabis products, 
86.6 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
86.7 	(13) sell medical cannabis flower and medical cannabinoid products to patients enrolled 
86.8 	in the registry program, registered designated caregivers, and parents, legal guardians, and 
86.9 	spouses of an enrolled patient;
86.10 	(14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
86.11 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
86.12 	other products authorized by law to other cannabis businesses and to customers; and
86.13 	(15) perform other actions approved by the office.
86.14 		Subd. 2.Cultivation; size limitations. (a) A medical cannabis combination business 
86.15 	may cultivate cannabis to be sold as medical cannabis flower or used in medical cannabinoid 
86.16 	products in an area of up to 60,000 square feet of plant canopy subject to the limits on 
86.17 	adult-use cannabis cultivation in paragraph (c).
86.18 	(b) A medical cannabis combination business may cultivate cannabis to be sold as 
86.19 	adult-use cannabis flower or used in adult-use cannabis products in an area authorized by 
86.20 	the office as described in paragraph (c).
86.21 	(c) The office shall authorize a medical cannabis combination business to cultivate 
86.22 	cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half 
86.23 	of the area the business used to cultivate cannabis sold in the medical market in the preceding 
86.24 	year. The office shall establish an annual verification and authorization procedure. The 
86.25 	office may increase the area of plant canopy in which a medical cannabis combination 
86.26 	business is authorized to cultivate cannabis for sale in the adult-use market between 
86.27 	authorization periods if the business demonstrates a significant increase in the sale of medical 
86.28 	cannabis and medical cannabis products.
86.29 		Subd. 3.Manufacturing; size limitations. The office may establish limits on cannabis 
86.30 	manufacturing that are consistent with the area of plant canopy a business is authorized to 
86.31 	cultivate.
86.32 		Subd. 4.Retail locations. A medical cannabis combination business may operate up to 
86.33 	one retail location in each congressional district. A medical cannabis combination business 
87.1 	must offer medical cannabis flower, medical cannabinoid products, or both at every retail 
87.2 	location. Each retail location of a medical cannabis combination business must continuously 
87.3 	make cannabis flower or cannabinoid products available to patients enrolled in the registry 
87.4 	program, registered designated caregivers, and parents, legal guardians, and spouses of an 
87.5 	enrolled patient.
87.6 		Subd. 5.Failure to participate; suspension or revocation of license. The office may 
87.7 	suspend or revoke a medical cannabis combination business license if the office determines 
87.8 	that the business is no longer actively participating in the medical cannabis market. The 
87.9 	office may, by rule, establish minimum requirements related to cannabis cultivation, 
87.10 	manufacturing of medical cannabinoid products, retail sales of medical cannabis flower and 
87.11 	medical cannabinoid products, and other relevant criteria to demonstrate active participation 
87.12 	in the medical cannabis market.
87.13 		Subd. 6.Operations. A medical cannabis combination business must comply with the 
87.14 	relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.

87.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

87.16 	Sec. 93. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 1, is amended 
87.17 	to read:
87.18 		Subdivision 1.Administration. The Division of Medical Cannabis office must administer 
87.19 	the medical cannabis patient registry program.

87.20 	EFFECTIVE DATE. This section is effective the day following final enactment.

87.21 	Sec. 94. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 2, is amended 
87.22 	to read:
87.23 		Subd. 2.Application procedure for patients. (a) A patient seeking to enroll in the 
87.24 	registry program must submit to the Division of Medical Cannabis office an application 
87.25 	established by the Division of Medical Cannabis office and a copy of the certification 
87.26 	specified in paragraph (b) or, if the patient is a veteran who receives care from the United 
87.27 	States Department of Veterans Affairs, the information required pursuant to subdivision 3. 
87.28 	The patient must provide at least the following information in the application:
87.29 	(1) the patient's name, mailing address, and date of birth;
87.30 	(2) the name, mailing address, and telephone number of the patient's health care 
87.31 	practitioner;
88.1 	(3) the name, mailing address, and date of birth of the patient's registered designated 
88.2 	caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, 
88.3 	or spouse will be acting as the patient's caregiver;
88.4 	(4) a disclosure signed by the patient that includes:
88.5 	(i) a statement that, notwithstanding any law to the contrary, the office of Cannabis 
88.6 	Management, the Division of Medical Cannabis, or an employee of the office of Cannabis 
88.7 	Management or Division of Medical Cannabis may not be held civilly or criminally liable 
88.8 	for any injury, loss of property, personal injury, or death caused by an act or omission while 
88.9 	acting within the employee's scope of office or employment under this section; and
88.10 	(ii) the patient's acknowledgment that enrollment in the registry program is conditional 
88.11 	on the patient's agreement to meet all other requirements of this section; and
88.12 	(5) all other information required by the Division of Medical Cannabis office.
88.13 	(b) As part of the application under this subdivision, a patient must submit a copy of a 
88.14 	certification from the patient's health care practitioner that is dated within 90 days prior to 
88.15 	the submission of the application and that certifies that the patient has been diagnosed with 
88.16 	a qualifying medical condition.
88.17 	(c) A patient's health care practitioner may submit a statement to the Division of Medical 
88.18 	Cannabis office declaring that the patient is no longer diagnosed with a qualifying medical 
88.19 	condition. Within 30 days after receipt of a statement from a patient's health care practitioner, 
88.20 	the Division of Medical Cannabis office must provide written notice to a patient stating that 
88.21 	the patient's enrollment in the registry program will be revoked in 30 days unless the patient 
88.22 	submits a certification from a health care practitioner that the patient is currently diagnosed 
88.23 	with a qualifying medical condition or, if the patient is a veteran, the patient submits 
88.24 	confirmation that the patient is currently diagnosed with a qualifying medical condition in 
88.25 	a form and manner consistent with the information required for an application made pursuant 
88.26 	to subdivision 3. If the Division of Medical Cannabis office revokes a patient's enrollment 
88.27 	in the registry program pursuant to this paragraph, the division must provide notice to the 
88.28 	patient and to the patient's health care practitioner.

88.29 	EFFECTIVE DATE. This section is effective the day following final enactment.

88.30 	Sec. 95. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 3, is amended 
88.31 	to read:
88.32 		Subd. 3.Application procedure for veterans. (a) The Division of Medical Cannabis
88.33 	office shall establish an alternative certification procedure for veterans who receive care 
89.1 	from the United States Department of Veterans Affairs to confirm that the veteran has been 
89.2 	diagnosed with a qualifying medical condition.
89.3 	(b) A patient who is also a veteran and is seeking to enroll in the registry program must 
89.4 	submit to the Division of Medical Cannabis office a copy of the patient's veteran health 
89.5 	identification card issued by the United States Department of Veterans Affairs and an 
89.6 	application established by the Division of Medical Cannabis that includes the information 
89.7 	identified in subdivision 2, paragraph (a), and the additional information required by the 
89.8 	Division of Medical Cannabis office to certify that the patient has been diagnosed with a 
89.9 	qualifying medical condition.

89.10 	EFFECTIVE DATE. This section is effective July 1, 2024.

89.11 	Sec. 96. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 4, is amended 
89.12 	to read:
89.13 		Subd. 4.Enrollment; denial of enrollment; revocation. (a) Within 30 days after the 
89.14 	receipt of an application and certification or other documentation of a diagnosis with a 
89.15 	qualifying medical condition, the Division of Medical Cannabis office must approve or 
89.16 	deny a patient's enrollment in the registry program. If the Division of Medical Cannabis
89.17 	office approves a patient's enrollment in the registry program, the office must provide notice 
89.18 	to the patient and to the patient's health care practitioner.
89.19 	(b) The office may deny a patient's enrollment in the registry program must only be 
89.20 	denied only if the patient:
89.21 	(1) does not submit a certification from a health care practitioner or, if the patient is a 
89.22 	veteran, the documentation required under subdivision 3 that the patient has been diagnosed 
89.23 	with a qualifying medical condition;
89.24 	(2) has not signed the disclosure required in subdivision 2;
89.25 	(3) does not provide the information required by the Division of Medical Cannabis
89.26 	office;
89.27 	(4) provided false information on the application; or
89.28 	(5) at the time of application, is also enrolled in a federally approved clinical trial for 
89.29 	the treatment of a qualifying medical condition with medical cannabis.
89.30 	(c) If the Division of Medical Cannabis office denies a patient's enrollment in the registry 
89.31 	program, the Division of Medical Cannabis office must provide written notice to a patient 
90.1 	of all reasons for denying enrollment. Denial of enrollment in the registry program is 
90.2 	considered a final decision of the office and is subject to judicial review under chapter 14.
90.3 	(d) The office may revoke a patient's enrollment in the registry program may be revoked
90.4 	only:
90.5 	(1) pursuant to subdivision 2, paragraph (c);
90.6 	(2) upon the death of the patient;
90.7 	(3) if the patient's certifying health care practitioner has filed a declaration under 
90.8 	subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the 
90.9 	patient does not submit another certification within 30 days;
90.10 	(4) if the patient does not comply with subdivision 6; or
90.11 	(5) if the patient intentionally sells or diverts medical cannabis flower or medical
90.12 	cannabinoid products in violation of this chapter.
90.13 	(e) If the office has revoked a patient's enrollment in the registry program has been 
90.14 	revoked due to a violation of subdivision 6, the patient may apply for enrollment 12 months 
90.15 	after the date on which the patient's enrollment was revoked. The office must process such 
90.16 	an application in accordance with this subdivision.

90.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

90.18 	Sec. 97. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 5, is amended 
90.19 	to read:
90.20 		Subd. 5.Registry verification. When a patient is enrolled in the registry program, the 
90.21 	Division of Medical Cannabis office must assign the patient a patient registry number and 
90.22 	must issue the patient and the patient's registered designated caregiver, parent, legal guardian, 
90.23 	or spouse, if applicable, a registry verification. The Division of Medical Cannabis office
90.24 	must also make the registry verification available to medical cannabis retailers businesses 
90.25 	with a medical cannabis retail endorsement. The registry verification must include:
90.26 	(1) the patient's name and date of birth;
90.27 	(2) the patient registry number assigned to the patient; and
90.28 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
90.29 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
90.30 	spouse will act as a caregiver.

90.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

91.1 	Sec. 98. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 9, is amended 
91.2 	to read:
91.3 		Subd. 9.Registered designated caregiver. (a) The Division of Medical Cannabis office
91.4 	must register a designated caregiver for a patient if the patient requires assistance in 
91.5 	administering medical cannabis flower or medical cannabinoid products or in obtaining 
91.6 	medical cannabis flower, medical cannabinoid products, or medical cannabis paraphernalia 
91.7 	from a medical cannabis retailer business with a medical cannabis retail endorsement under 
91.8 	section 342.51.
91.9 	(b) In order to serve as a designated caregiver, a person must:
91.10 	(1) be at least 18 years of age;
91.11 	(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid
91.12 	products purchased under section 342.51 for purposes of assisting the patient; and
91.13 	(3) agree that if the application is approved, the person will not serve as a registered 
91.14 	designated caregiver for more than six registered patients at one time. Patients who reside 
91.15 	in the same residence count as one patient.
91.16 	(c) The office shall conduct a criminal background check on the designated caregiver 
91.17 	prior to registration to ensure that the person does not have a conviction for a disqualifying 
91.18 	felony offense. Any cost of the background check shall be paid by the person seeking 
91.19 	registration as a designated caregiver. A designated caregiver must have the criminal 
91.20 	background check renewed every two years.
91.21 	(d) (c) Nothing in this section shall be construed to prevent a registered designated 
91.22 	caregiver from being enrolled in the registry program as a patient and possessing and 
91.23 	administering medical cannabis flower or medical cannabinoid products as a patient.

91.24 	EFFECTIVE DATE. This section is effective the day following final enactment.

91.25 	Sec. 99. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 11, is amended 
91.26 	to read:
91.27 		Subd. 11.Notice of change of name or address. Patients and registered designated 
91.28 	caregivers must notify the Division of Medical Cannabis office of any address or name 
91.29 	change within 30 days of the change having occurred. A patient or registered designated 
91.30 	caregiver is subject to a $100 fine for failure to notify the office of the change.

91.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

92.1 	Sec. 100. Minnesota Statutes 2023 Supplement, section 342.53, is amended to read:
92.2 	342.53 DUTIES OF OFFICE OF CANNABIS MANAGEMENT; REGISTRY 
92.3 	PROGRAM ADDING OR MODIFYING QUALIFYING MEDICAL CONDITIONS.
92.4 	The office may add an allowable form of medical cannabinoid product, and may add or 
92.5 	modify a qualifying medical condition upon its the office's own initiative, upon a petition 
92.6 	from a member of the public or from the Cannabis Advisory Council, or as directed by law. 
92.7 	The office must evaluate all petitions and must make the addition or modification if the 
92.8 	office determines that the addition or modification is warranted by the best available evidence 
92.9 	and research. If the office wishes to add an allowable form or add or modify a qualifying 
92.10 	medical condition, the office must notify the chairs and ranking minority members of the 
92.11 	legislative committees and divisions with jurisdiction over health finance and policy by 
92.12 	January 15 of the year in which the change becomes effective. In this notification, the office 
92.13 	must specify the proposed addition or modification, the reasons for the addition or 
92.14 	modification, any written comments received by the office from the public about the addition 
92.15 	or modification, and any guidance received from the Cannabis Advisory Council. An addition 
92.16 	or modification by the office under this subdivision becomes effective on August 1 of that 
92.17 	year unless the legislature by law provides otherwise.

92.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

92.19 	Sec. 101. Minnesota Statutes 2023 Supplement, section 342.54, is amended to read:
92.20 	342.54 DUTIES OF DIVISION OF MEDICAL CANNABIS OFFICE OF 
92.21 	CANNABIS MANAGEMENT; MEDICAL CANNABIS PATIENT REGISTRY 
92.22 	PROGRAM.
92.23 		Subdivision 1.Duties related to health care practitioners. The Division of Medical 
92.24 	Cannabis office must:
92.25 	(1) provide notice of the registry program to health care practitioners in the state;
92.26 	(2) allow health care practitioners to participate in the registry program if they request 
92.27 	to participate and meet the program's requirements;
92.28 	(3) provide explanatory information and assistance to health care practitioners to 
92.29 	understand the nature of the therapeutic use of medical cannabis flower and medical
92.30 	cannabinoid products within program requirements;
92.31 	(4) make available to participating health care practitioners a certification form in which 
92.32 	a health care practitioner certifies that a patient has a qualifying medical condition; and
93.1 	(5) supervise the participation of health care practitioners in the registry reporting system 
93.2 	in which health care practitioners report patient treatment and health records information 
93.3 	to the office in a manner that ensures stringent security and record keeping requirements 
93.4 	and that prevents the unauthorized release of private data on individuals as defined in section 
93.5 	13.02.
93.6 		Subd. 2.Duties related to the medical registry program. The Division of Medical 
93.7 	Cannabis office must:
93.8 	(1) administer the registry program according to section 342.52;
93.9 	(2) provide information to patients enrolled in the registry program on the existence of 
93.10 	federally approved clinical trials for the treatment of the patient's qualifying medical condition 
93.11 	with medical cannabis flower or medical cannabinoid products as an alternative to enrollment 
93.12 	in the registry program;
93.13 	(3) maintain safety criteria with which patients must comply as a condition of participation 
93.14 	in the registry program to prevent patients from undertaking any task under the influence 
93.15 	of medical cannabis flower or medical cannabinoid products that would constitute negligence 
93.16 	or professional malpractice;
93.17 	(4) review and publicly report on existing medical and scientific literature regarding the 
93.18 	range of recommended dosages for each qualifying medical condition, the range of chemical 
93.19 	compositions of medical cannabis flower and medical cannabinoid products that will likely 
93.20 	be medically beneficial for each qualifying medical condition, and any risks of noncannabis 
93.21 	drug interactions. This information must be updated by December 1 of each yearevery three 
93.22 	years. The office may consult with an independent laboratory under contract with the office 
93.23 	or other experts in reporting and updating this information; and
93.24 	(5) annually consult with cannabis businesses about medical cannabis that the businesses 
93.25 	cultivate, manufacture, and offer for sale and post on the Division of Medical Cannabis
93.26 	office website a list of the medical cannabis flower and medical cannabinoid products offered 
93.27 	for sale by each medical cannabis retailer.
93.28 		Subd. 3.Research. (a) The Division of Medical Cannabis office must conduct or contract 
93.29 	with a third party to conduct research and studies using data from health records submitted 
93.30 	to the registry program under section 342.55, subdivision 2, and data submitted to the registry 
93.31 	program under section 342.52, subdivisions 2 and 3. If the division office contracts with a 
93.32 	third party for research and studies, the third party must provide the division office with 
93.33 	access to all research and study results. The division office must submit reports on 
93.34 	intermediate or final research results to the legislature and major scientific journals. All 
94.1 	data used by the division office or a third party under this subdivision must be used or 
94.2 	reported in an aggregated nonidentifiable form as part of a scientific peer-reviewed 
94.3 	publication of research or in the creation of summary data, as defined in section 13.02, 
94.4 	subdivision 19.
94.5 	(b) The Division of Medical Cannabis office may submit medical research based on the 
94.6 	data collected under sections 342.55, subdivision 2, and data collected through the statewide 
94.7 	monitoring system to any federal agency with regulatory or enforcement authority over 
94.8 	medical cannabis flower and medical cannabinoid products to demonstrate the effectiveness 
94.9 	of medical cannabis flower or medical cannabinoid products for treating or alleviating the 
94.10 	symptoms of a qualifying medical condition.

94.11 	EFFECTIVE DATE. This section is effective July 1, 2024.

94.12 	Sec. 102. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 1, is amended 
94.13 	to read:
94.14 		Subdivision 1.Health care practitioner duties before patient enrollment. Before a 
94.15 	patient's enrollment in the registry program, a health care practitioner must:
94.16 	(1) determine, in the health care practitioner's medical judgment, whether a patient has 
94.17 	a qualifying medical condition and, if so determined, provide the patient with a certification 
94.18 	of that diagnosis;
94.19 	(2) advise patients, registered designated caregivers, and parents, legal guardians, and 
94.20 	spouses acting as caregivers of any nonprofit patient support groups or organizations;
94.21 	(3) provide to patients explanatory information from the Division of Medical Cannabis
94.22 	office, including information about the experimental nature of the therapeutic use of medical
94.23 	cannabis flower and medical cannabinoid products; the possible risks, benefits, and side 
94.24 	effects of the proposed treatment; and the application and other materials from the office;
94.25 	(4) provide to patients a Tennessen warning as required under section 13.04, subdivision 
94.26 	2; and
94.27 	(5) agree to continue treatment of the patient's qualifying medical condition and to report 
94.28 	findings to the Division of Medical Cannabis office.

94.29 	EFFECTIVE DATE. This section is effective the day following final enactment.

95.1 	Sec. 103. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 2, is amended 
95.2 	to read:
95.3 		Subd. 2.Duties upon patient's enrollment in registry program. Upon receiving 
95.4 	notification from the Division of Medical Cannabis office of the patient's enrollment in the 
95.5 	registry program, a health care practitioner must:
95.6 	(1) participate in the patient registry reporting system under the guidance and supervision 
95.7 	of the Division of Medical Cannabis office;
95.8 	(2) report to the Division of Medical Cannabis office patient health records throughout 
95.9 	the patient's ongoing treatment in a manner determined by the office and in accordance with 
95.10 	subdivision 4;
95.11 	(3) determine on a yearly basisevery three years if the patient continues to have a 
95.12 	qualifying medical condition and, if so, issue the patient a new certification of that diagnosis. 
95.13 	The patient assessment conducted under this clause may be conducted via telehealth, as 
95.14 	defined in section 62A.673, subdivision 2; and
95.15 	(4) otherwise comply with requirements established by the office of Cannabis 
95.16 	Management and the Division of Medical Cannabis.

95.17 	EFFECTIVE DATE. This section is effective July 1, 2024.

95.18 	Sec. 104. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 1, is amended 
95.19 	to read:
95.20 		Subdivision 1.Limitations on consumption; locations of consumption. (a) Nothing 
95.21 	in sections 342.47 342.51 to 342.60 permits any person to engage in, and does not prevent 
95.22 	the imposition of any civil, criminal, or other penalties for:
95.23 	(1) undertaking a task under the influence of medical cannabis flower or medical
95.24 	cannabinoid products that would constitute negligence or professional malpractice;
95.25 	(2) possessing or consuming medical cannabis flower or medical cannabinoid products:
95.26 	(i) on a school bus or van;
95.27 	(ii) in a correctional facility;
95.28 	(iii) in a state-operated treatment program, including the Minnesota sex offender program; 
95.29 	or
95.30 	(iv) on the grounds of a child care facility or family or group family day care program;
95.31 	(3) vaporizing or smoking medical cannabis:
96.1 	(i) on any form of public transportation;
96.2 	(ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would 
96.3 	be inhaled by a minor; or
96.4 	(iii) in any public place, including any indoor or outdoor area used by or open to the 
96.5 	general public or a place of employment, as defined in section 144.413, subdivision 1b; and
96.6 	(4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft, 
96.7 	train, or motorboat or working on transportation property, equipment, or facilities while 
96.8 	under the influence of medical cannabis flower or a medical cannabinoid product.
96.9 	(b) Except for the use of medical cannabis flower or medical cannabinoid products by 
96.10 	a patient enrolled in the patient registry program under section 342.52, the vaporizing or 
96.11 	smoking of cannabis flower, cannabis products, artificially derived cannabinoids, or 
96.12 	hemp-derived consumer products is prohibited in a multifamily housing building, including 
96.13 	balconies and patios appurtenant thereto. A violation of this paragraph is punishable through 
96.14 	a civil administrative fine in an amount of $250.

96.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

96.16 	Sec. 105. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 2, is amended 
96.17 	to read:
96.18 		Subd. 2.Health care facilities. (a) Health care facilities licensed under chapter 144A; 
96.19 	hospice providers licensed under chapter 144A; boarding care homes or supervised living 
96.20 	facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities 
96.21 	owned, controlled, managed, or under common control with hospitals licensed under chapter 
96.22 	144; and other health care facilities licensed by the commissioner of health or the 
96.23 	commissioner of human services may adopt reasonable restrictions on the use of medical
96.24 	cannabis flower or medical cannabinoid products by a patient enrolled in the registry program 
96.25 	who resides at or is actively receiving treatment or care at the facility. The restrictions may 
96.26 	include a provision that the facility must not store or maintain a patient's supply of medical
96.27 	cannabis flower or medical cannabinoid products on behalf of the patient; that a patient 
96.28 	store the patient's supply of medical cannabis flower or medicinal cannabinoid products in 
96.29 	a locked container accessible only to the patient, the patient's designated caregiver, or the 
96.30 	patient's parent, legal guardian, or spouse; that the facility is not responsible for providing 
96.31 	medical cannabis for patients; and that medical cannabis flower or medical cannabinoid 
96.32 	products are used only in a location specified by the facility or provider. Nothing in this 
97.1 	subdivision requires facilities and providers listed in this subdivision to adopt such 
97.2 	restrictions.
97.3 	(b) No facility or provider listed in this subdivision may unreasonably limit a patient's 
97.4 	access to or use of medical cannabis flower or medical cannabinoid products to the extent 
97.5 	that such use is authorized under sections 342.47 342.51 to 342.59. No facility or provider 
97.6 	listed in this subdivision may prohibit a patient access to or use of medical cannabis flower 
97.7 	or medical cannabinoid products due solely to the fact that cannabis is a Schedule I drug 
97.8 	pursuant to the federal Uniform Controlled Substances Act. If a federal regulatory agency, 
97.9 	the United States Department of Justice, or the federal Centers for Medicare and Medicaid 
97.10 	Services takes one of the following actions, a facility or provider may suspend compliance 
97.11 	with this paragraph until the regulatory agency, the United States Department of Justice, or 
97.12 	the federal Centers for Medicare and Medicaid Services notifies the facility or provider that 
97.13 	it may resume permitting the use of medical cannabis flower or medical cannabinoid products 
97.14 	within the facility or in the provider's service setting:
97.15 	(1) a federal regulatory agency or the United States Department of Justice initiates 
97.16 	enforcement action against a facility or provider related to the facility's compliance with 
97.17 	the medical cannabis program; or
97.18 	(2) a federal regulatory agency, the United States Department of Justice, or the federal 
97.19 	Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification 
97.20 	to the facility or provider that expressly prohibits the use of medical cannabis in health care 
97.21 	facilities or otherwise prohibits compliance with the medical cannabis program.
97.22 	(c) An employee or agent of a facility or provider listed in this subdivision or a person 
97.23 	licensed under chapter 144E is not violating this chapter or chapter 152 for the possession 
97.24 	of medical cannabis flower or medical cannabinoid products while carrying out employment 
97.25 	duties, including providing or supervising care to a patient enrolled in the registry program, 
97.26 	or distribution of medical cannabis flower or medical cannabinoid products to a patient 
97.27 	enrolled in the registry program who resides at or is actively receiving treatment or care at 
97.28 	the facility or from the provider with which the employee or agent is affiliated.

97.29 	EFFECTIVE DATE. This section is effective the day following final enactment.

97.30 	Sec. 106. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 1, is amended 
97.31 	to read:
97.32 		Subdivision 1.Presumption. There is a presumption that a patient or other person 
97.33 	enrolled in the registry program is engaged in the authorized use or possession of medical
98.1 	cannabis flower and medical cannabinoid products. This presumption may be rebutted by 
98.2 	evidence that the patient's use of medical cannabis flower or medical cannabinoid products
98.3 	use or possession of cannabis flower or cannabinoid products by a patient or other person 
98.4 	enrolled in the registry program was not for the purpose of assisting with, treating, or 
98.5 	alleviating the patient's or other person's qualifying medical condition or symptoms associated 
98.6 	with the patient's or other person's qualifying medical condition.

98.7 	EFFECTIVE DATE. This section is effective the day following final enactment.

98.8 	Sec. 107. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 2, is amended 
98.9 	to read:
98.10 		Subd. 2.Criminal and civil protections. (a) Subject to section 342.56, the use or 
98.11 	possession of cannabis flower, cannabinoid products, or cannabis paraphernalia by the 
98.12 	following are persons is not violations a violation of this chapter or chapter 152:
98.13 	(1) use or possession of medical cannabis flower, medical cannabinoid products, or 
98.14 	medical cannabis paraphernalia by a patient or person enrolled in the registry program or 
98.15 	by a visiting patient to whom medical cannabis flower or medical cannabinoid products are 
98.16 	distributed under section 342.51, subdivision 5;
98.17 	(2) possession of medical cannabis flower, medical cannabinoid products, or medical 
98.18 	cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or 
98.19 	spouse of a patient or person enrolled in the registry program; or
98.20 	(3) possession of medical cannabis flower, medical cannabinoid products, or medical 
98.21 	cannabis paraphernalia by any person while that person is carrying out duties required under 
98.22 	sections 342.47 342.51 to 342.60.
98.23 	(b) The office of Cannabis Management, members of the Cannabis Advisory Council, 
98.24 	office of Cannabis Management employees, agents or contractors of the office of Cannabis 
98.25 	Management, and health care practitioners participating in the registry program are not 
98.26 	subject to any civil penalties or disciplinary action by the Board of Medical Practice, the 
98.27 	Board of Nursing, or any business, occupational, or professional licensing board or entity 
98.28 	solely for participating in the registry program either in a professional capacity or as a 
98.29 	patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or 
98.30 	disciplinary action by the Board of Pharmacy when acting in accordance with sections 
98.31 	342.47342.51 to 342.60 either in a professional capacity or as a patient. Nothing in this 
98.32 	section prohibits a professional licensing board from taking action in response to a violation 
98.33 	of law.
99.1 	(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the 
99.2 	governor, or an employee of a state agency must not be held civilly or criminally liable for 
99.3 	any injury, loss of property, personal injury, or death caused by any act or omission while 
99.4 	acting within the scope of office or employment under sections 342.47 342.51 to 342.60.
99.5 	(d) Federal, state, and local law enforcement authorities are prohibited from accessing 
99.6 	the registry except when acting pursuant to a valid search warrant. Notwithstanding section 
99.7 	13.09, a violation of this paragraph is a gross misdemeanor.
99.8 	(e) Notwithstanding any law to the contrary, the office and employees of the office must 
99.9 	not release data or information about an individual contained in any report or document or 
99.10 	in the registry and must not release data or information obtained about a patient enrolled in 
99.11 	the registry program, except as provided in sections 342.47 342.51 to 342.60. 
99.12 	Notwithstanding section 13.09, a violation of this paragraph is a gross misdemeanor.
99.13 	(f) No information contained in a report or document, contained in the registry, or 
99.14 	obtained from a patient under sections 342.47 342.51 to 342.60 may be admitted as evidence 
99.15 	in a criminal proceeding, unless:
99.16 	(1) the information is independently obtained; or
99.17 	(2) admission of the information is sought in a criminal proceeding involving a criminal 
99.18 	violation of sections 342.47 342.51 to 342.60.
99.19 	(g) Possession of a registry verification or an application for enrollment in the registry 
99.20 	program:
99.21 	(1) does not constitute probable cause or reasonable suspicion;
99.22 	(2) must not be used to support a search of the person or property of the person with a 
99.23 	registry verification or application to enroll in the registry program; and
99.24 	(3) must not subject the person or the property of the person to inspection by any 
99.25 	government agency.

99.26 	EFFECTIVE DATE. This section is effective the day following final enactment.

99.27 	Sec. 108. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 3, is amended 
99.28 	to read:
99.29 		Subd. 3.School enrollment; rental property. (a) No school may refuse to enroll or 
99.30 	otherwise penalize a patient or person enrolled in the registry program as a pupil or otherwise 
99.31 	penalize a patient solely because the patient or person is enrolled in the registry program, 
100.1 	unless failing to do so would violate federal law or regulations or cause the school to lose 
100.2 	a monetary or licensing-related benefit under federal law or regulations.
100.3 	(b) No landlord may refuse to lease to a patient or person enrolled in the registry program 
100.4 	or otherwise penalize a patient or person enrolled in the registry program solely because 
100.5 	the patient or person is enrolled in the registry program, unless failing to do so would violate 
100.6 	federal law or regulations or cause the landlord to lose a monetary or licensing-related 
100.7 	benefit under federal law or regulations.

100.8 	EFFECTIVE DATE. This section is effective the day following final enactment.

100.9 	Sec. 109. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 4, is amended 
100.10 	to read:
100.11 		Subd. 4.Medical care. For purposes of medical care, including organ transplants, a 
100.12 	patient's use of medical cannabis flower or medical cannabinoid products according to 
100.13 	sections 342.47 342.51 to 342.60 is considered the equivalent of the authorized use of a 
100.14 	medication used at the discretion of a health care practitioner and does not disqualify a 
100.15 	patient from needed medical care.

100.16 	EFFECTIVE DATE. This section is effective the day following final enactment.

100.17 	Sec. 110. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 5, is amended 
100.18 	to read:
100.19 		Subd. 5.Employment. (a) Unless a failure to do so would violate federal or state law 
100.20 	or regulations or cause an employer to lose a monetary or licensing-related benefit under 
100.21 	federal law or regulations, an employer may not discriminate against a person in hiring, 
100.22 	termination, or any term or condition of employment, or otherwise penalize a person, if the 
100.23 	discrimination is based on:
100.24 	(1) the person's status as a patient or person enrolled in the registry program; or
100.25 	(2) a patient's positive drug test for cannabis components or metabolites, unless the 
100.26 	patient used, possessed, sold, transported, or was impaired by medical cannabis flower or 
100.27 	a medical cannabinoid product on work premises, during working hours, or while operating 
100.28 	an employer's machinery, vehicle, or equipment.
100.29 	(b) An employee who is a patient and whose employer requires the employee to undergo 
100.30 	drug testing according to section 181.953 may present the employee's registry verification 
100.31 	as part of the employee's explanation under section 181.953, subdivision 6.

101.1 	EFFECTIVE DATE. This section is effective the day following final enactment.

101.2 	Sec. 111. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 6, is amended 
101.3 	to read:
101.4 		Subd. 6.Custody; visitation; parenting time. A person must not be denied custody of 
101.5 	a minor child or visitation rights or parenting time with a minor child based solely on the 
101.6 	person's status as a patient or person enrolled in the registry program. There must be no 
101.7 	presumption of neglect or child endangerment for conduct allowed under sections 342.47
101.8 	342.51 to 342.60, unless the person's behavior creates an unreasonable danger to the safety 
101.9 	of the minor as established by clear and convincing evidence.

101.10 	EFFECTIVE DATE. This section is effective the day following final enactment.

101.11 	Sec. 112. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 7, is amended 
101.12 	to read:
101.13 		Subd. 7.Action for damages. In addition to any other remedy provided by law, a patient 
101.14 	or person enrolled in the registry program may bring an action for damages against any 
101.15 	person who violates subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is 
101.16 	liable to a patient or person enrolled in the registry program injured by the violation for the 
101.17 	greater of the person's actual damages or a civil penalty of $100 and reasonable attorney 
101.18 	fees.

101.19 	EFFECTIVE DATE. This section is effective the day following final enactment.

101.20 	Sec. 113. Minnesota Statutes 2023 Supplement, section 342.58, is amended to read:
101.21 	342.58 VIOLATION BY HEALTH CARE PRACTITIONER; CRIMINAL 
101.22 	PENALTY.
101.23 	A health care practitioner who knowingly refers patients to a medical cannabis business 
101.24 	or to a designated caregiver, who advertises as a retailer or producer of medical cannabis 
101.25 	flower or medical cannabinoid products, or who issues certifications while holding a financial 
101.26 	interest in a cannabis retailer or medical cannabis business is guilty of a misdemeanor and 
101.27 	may be sentenced to imprisonment for not more than 90 days or to payment of not more 
101.28 	than $1,000, or both.

101.29 	EFFECTIVE DATE. This section is effective the day following final enactment.

102.1 	Sec. 114. Minnesota Statutes 2023 Supplement, section 342.60, is amended to read:
102.2 	342.60 APPLIED RESEARCH.
102.3 	The Division of Medical Cannabis office may conduct, or award grants to health care 
102.4 	providers or research organizations to conduct, applied research on the safety and efficacy 
102.5 	of using medical cannabis flower or medical cannabinoid products to treat a specific health 
102.6 	condition. A health care provider or research organization receiving a grant under this section 
102.7 	must provide the office with access to all data collected in applied research funded under 
102.8 	this section. The office may use data from applied research conducted or funded under this 
102.9 	section as evidence to approve additional qualifying medical conditions or additional 
102.10 	allowable forms of medical cannabis.

102.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

102.12 	Sec. 115. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 4, is amended 
102.13 	to read:
102.14 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
102.15 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
102.16 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
102.17 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
102.18 	medical cannabis combination business shall make each batch of cannabis flower, cannabis 
102.19 	products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived 
102.20 	consumer products grown, manufactured, or imported by the cannabis business or hemp 
102.21 	business available to a cannabis testing facility.
102.22 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
102.23 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
102.24 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
102.25 	medical cannabis combination business must disclose all known information regarding 
102.26 	pesticides, fertilizers, solvents, or other foreign materials, including but not limited to 
102.27 	catalysts used in creating artificially derived cannabinoids, applied or added to the batch of 
102.28 	cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp 
102.29 	edibles, or hemp-derived consumer products subject to testing. Disclosure must be made 
102.30 	to the cannabis testing facility and must include information about all applications by any 
102.31 	person, whether intentional or accidental.
102.32 	(c) The cannabis testing facility shall select one or more representative samples from 
102.33 	each batch, test the samples for the presence of contaminants, and test the samples for 
103.1 	potency and homogeneity and to allow the cannabis flower, cannabis product, artificially 
103.2 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be 
103.3 	accurately labeled with its cannabinoid profile. Testing for contaminants must include testing 
103.4 	for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide 
103.5 	residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include 
103.6 	testing for other contaminants. A cannabis testing facility must destroy or return to the 
103.7 	cannabis business or hemp business any part of the sample that remains after testing.

103.8 	EFFECTIVE DATE. This section is effective the day following final enactment.

103.9 	Sec. 116. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 5, is amended 
103.10 	to read:
103.11 		Subd. 5.Test results. (a) If a sample meets the applicable testing standards, a cannabis 
103.12 	testing facility shall issue a certification to a cannabis microbusiness, cannabis 
103.13 	mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an 
103.14 	endorsement to import products, lower-potency hemp edible manufacturer, medical cannabis 
103.15 	cultivator, medical cannabis processor, or medical cannabis combination business and the 
103.16 	cannabis business or hemp business may then sell or transfer the batch of cannabis flower, 
103.17 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
103.18 	hemp-derived consumer products from which the sample was taken to another cannabis 
103.19 	business or hemp business, or offer the cannabis flower, cannabis products, lower-potency 
103.20 	hemp edibles, or hemp-derived consumer products for sale to customers or patients. If a 
103.21 	sample does not meet the applicable testing standards or if the testing facility is unable to 
103.22 	test for a substance identified pursuant to subdivision 4, paragraph (b), the batch from which 
103.23 	the sample was taken shall be subject to procedures established by the office for such batches, 
103.24 	including destruction, remediation, or retesting.
103.25 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
103.26 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
103.27 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
103.28 	medical cannabis combination business must maintain the test results for cannabis flower, 
103.29 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
103.30 	hemp-derived consumer products grown, manufactured, or imported by that cannabis 
103.31 	business or hemp business for at least five years after the date of testing.
103.32 	(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
103.33 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
103.34 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
104.1 	medical cannabis combination business shall make test results maintained by that cannabis 
104.2 	business or hemp business available for review by any member of the public, upon request. 
104.3 	Test results made available to the public must be in plain language.

104.4 	EFFECTIVE DATE. This section is effective the day following final enactment.

104.5 	Sec. 117. Minnesota Statutes 2023 Supplement, section 342.62, is amended by adding a 
104.6 	subdivision to read:
104.7 		Subd. 4.Prohibition of the sale of certain empty packaging. No person shall sell, 
104.8 	offer for sale, or facilitate the sale of empty packaging that, if used, would be a violation of 
104.9 	any provision of this section. Enforcement of this subdivision is subject to section 8.31.

104.10 	Sec. 118. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 2, is amended 
104.11 	to read:
104.12 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
104.13 	products that consist of hemp plant parts sold to customers or patients must have affixed 
104.14 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
104.15 	label that contains at least the following information:
104.16 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
104.17 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower where the 
104.18 	cannabis flower or hemp plant part was cultivated;
104.19 	(2) the net weight or volume of cannabis flower or hemp plant parts in the package or 
104.20 	container;
104.21 	(3) the batch number;
104.22 	(4) the cannabinoid profile;
104.23 	(5) a universal symbol established by the office indicating that the package or container 
104.24 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
104.25 	hemp-derived consumer product;
104.26 	(6) verification that the cannabis flower or hemp plant part was tested according to 
104.27 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
104.28 	standards;
104.29 	(7) the maximum dose, quantity, or consumption that may be considered medically safe 
104.30 	within a 24-hour period;
104.31 	(7) information on the usage of the cannabis flower or hemp-derived consumer product;
105.1 	(8) the following statement: "Keep this product out of reach of children."; and
105.2 	(9) any other statements or information required by the office.

105.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

105.4 	Sec. 119. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 3, is amended 
105.5 	to read:
105.6 		Subd. 3.Content of label; cannabinoid products. (a) All cannabis products, 
105.7 	lower-potency hemp edibles, hemp-derived consumer products other than products subject 
105.8 	to the requirements under subdivision 2, medical cannabinoid products, and hemp-derived 
105.9 	topical products sold to customers or patients must have affixed to the packaging or container 
105.10 	of the cannabis product a label that contains at least the following information:
105.11 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
105.12 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower that cultivated 
105.13 	the cannabis flower or hemp plant parts used in the cannabis product, lower-potency hemp 
105.14 	edible, hemp-derived consumer product, or medical cannabinoid product;
105.15 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
105.16 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis 
105.17 	processor, or industrial hemp grower that manufactured the cannabis concentrate, hemp 
105.18 	concentrate, or artificially derived cannabinoid and, if different, the name and license number 
105.19 	of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, or 
105.20 	lower-potency hemp edible manufacturer, or medical cannabis processor that manufactured 
105.21 	the product;
105.22 	(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or 
105.23 	hemp-derived consumer product in the package or container;
105.24 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
105.25 	product;
105.26 	(5) the batch number;
105.27 	(6) the serving size;
105.28 	(7) the cannabinoid profile per serving and in total;
105.29 	(8) a list of ingredients;
106.1 	(9) a universal symbol established by the office indicating that the package or container 
106.2 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
106.3 	hemp-derived consumer product;
106.4 	(10) a warning symbol developed by the office in consultation with the commissioner 
106.5 	of health and the Minnesota Poison Control System that:
106.6 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
106.7 	(ii) is in a highly visible color;
106.8 	(iii) includes a visual element that is commonly understood to mean a person should 
106.9 	stop;
106.10 	(iv) indicates that the product is not for children; and
106.11 	(v) includes the phone number of the Minnesota Poison Control System;
106.12 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
106.13 	consumer product, or medical cannabinoid product was tested according to section 342.61 
106.14 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
106.15 	or medical cannabinoid product complies with the applicable standards;
106.16 	(12) the maximum dose, quantity, or consumption that may be considered medically 
106.17 	safe within a 24-hour period;
106.18 	(12) information on the usage of the product;
106.19 	(13) the following statement: "Keep this product out of reach of children."; and
106.20 	(14) any other statements or information required by the office.
106.21 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
106.22 	hemp edibles that are imported into the state provided that those requirements provide 
106.23 	consumers with information that is substantially similar to the information described in 
106.24 	paragraph (a).

106.25 	EFFECTIVE DATE. This section is effective the day following final enactment.

106.26 	Sec. 120. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 4, is amended 
106.27 	to read:
106.28 		Subd. 4.Additional content of label; medical cannabis flower and medical
106.29 	cannabinoid products. In addition to the applicable requirements for labeling under 
106.30 	subdivision 2 or 3, all medical cannabis flower sold to patients and medical cannabinoid 
107.1 	products sold to patients must include at least the following information on the label affixed 
107.2 	to the packaging or container of the medical cannabis flower or medical cannabinoid product:
107.3 	(1) the patient's name and date of birth;
107.4 	(2) the name and date of birth of the patient's registered designated caregiver or, if listed 
107.5 	on the registry verification, the name of the patient's parent, legal guardian, or spouse, if 
107.6 	applicable; and
107.7 	(3) the patient's registry identification number.

107.8 	EFFECTIVE DATE. This section is effective the day following final enactment.

107.9 	Sec. 121. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended 
107.10 	to read:
107.11 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
107.12 	cannabis retailer, medical cannabis retailer, or medical cannabis combination business must 
107.13 	provide customers and patients with the following information:
107.14 	(1) factual information about impairment effects and the expected timing of impairment 
107.15 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
107.16 	lower-potency hemp edibles, and hemp-derived consumer products;
107.17 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
107.18 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
107.19 	hemp edibles, and hemp-derived consumer products;
107.20 	(3) resources customers and patients may consult to answer questions about cannabis 
107.21 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
107.22 	products, and any side effects and adverse effects;
107.23 	(4) contact information for the poison control center and a safety hotline or website for 
107.24 	customers to report and obtain advice about side effects and adverse effects of cannabis 
107.25 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
107.26 	products;
107.27 	(5) substance use disorder treatment options; and
107.28 	(6) any other information specified by the office.
107.29 	(b) A cannabis microbusiness, cannabis mezzobusiness, or cannabis retailer, or medical 
107.30 	cannabis retailer may include the information described in paragraph (a) on the label affixed 
108.1 	to the packaging or container of cannabis flower, cannabis products, lower-potency hemp 
108.2 	edibles, and hemp-derived consumer products by:
108.3 	(1) posting the information in the premises of the cannabis microbusiness, cannabis 
108.4 	mezzobusiness, cannabis retailer, medical cannabis retailer, or medical cannabis combination 
108.5 	business; or
108.6 	(2) providing the information on a separate document or pamphlet provided to customers 
108.7 	or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency 
108.8 	hemp edible, or a hemp-derived consumer product.

108.9 	EFFECTIVE DATE. This section is effective the day following final enactment.

108.10 	Sec. 122. Laws 2023, chapter 63, article 1, section 2, the effective date, is amended to 
108.11 	read:

108.12 	EFFECTIVE DATE. This section is effective July 1, 2023, except for subdivision 3, 
108.13 	which is effective March 1, 2025.

108.14 	Sec. 123. Laws 2023, chapter 63, article 1, section 51, the effective date, is amended to 
108.15 	read:

108.16 	EFFECTIVE DATE. This section is effective March 1, 2025 the day following final 
108.17 	enactment.

108.18 	Sec. 124. Laws 2023, chapter 63, article 1, section 52, the effective date, is amended to 
108.19 	read:

108.20 	EFFECTIVE DATE. This section is effective March 1, 2025 the day following final 
108.21 	enactment.

108.22 	Sec. 125. Laws 2023, chapter 63, article 1, section 53, the effective date, is amended to 
108.23 	read:

108.24 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

108.25 	Sec. 126. Laws 2023, chapter 63, article 1, section 54, the effective date, is amended to 
108.26 	read:

108.27 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

109.1 	Sec. 127. Laws 2023, chapter 63, article 1, section 55, the effective date, is amended to 
109.2 	read:

109.3 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

109.4 	Sec. 128. Laws 2023, chapter 63, article 1, section 56, the effective date, is amended to 
109.5 	read:

109.6 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

109.7 	Sec. 129. Laws 2023, chapter 63, article 1, section 57, the effective date, is amended to 
109.8 	read:

109.9 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

109.10 	Sec. 130. Laws 2023, chapter 63, article 1, section 58, the effective date, is amended to 
109.11 	read:

109.12 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

109.13 	Sec. 131. Laws 2023, chapter 63, article 1, section 59, the effective date, is amended to 
109.14 	read:

109.15 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

109.16 	Sec. 132. Laws 2023, chapter 63, article 1, section 61, the effective date, is amended to 
109.17 	read:

109.18 	EFFECTIVE DATE. This section is effective March 1, 2025 July 1, 2024.

109.19 	Sec. 133. Laws 2023, chapter 63, article 6, section 10, the effective date, is amended to 
109.20 	read:

109.21 	EFFECTIVE DATE. This section is effective March July 1, 2025 2024.

109.22 	Sec. 134. Laws 2023, chapter 63, article 6, section 73, the effective date, is amended to 
109.23 	read:

109.24 	EFFECTIVE DATE. Paragraph (a) is effective March 1, 2025. Paragraph (b) is effective 
109.25 	August 1, 2023. Paragraph (c) is effective July 1, 2023. This section is effective July 1, 
109.26 	2024.

110.1 	Sec. 135. EMPLOYEE TRANSFER.
 110.2 	(a) The powers, duties, rights, obligations, and other authority imposed by law on the 
110.3 	Department of Health with respect to the sale of certain cannabinoid products under 
110.4 	Minnesota Statutes, section 151.72, are transferred to the Office of Cannabis Management 
110.5 	under Minnesota Statutes, section 15.039.
110.6 	(b) The following protections shall apply to employees who are transferred from the 
110.7 	Department of Health to the Office of Cannabis Management:
110.8 	(1) the employment status and job classification of a transferred employee shall not be 
110.9 	altered as a result of the transfer;
110.10 	(2) transferred employees who were represented by an exclusive representative prior to 
110.11 	the transfer shall continue to be represented by the same exclusive representative after the 
110.12 	transfer;
110.13 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
110.14 	continue in full force and effect for such transferred employees after the transfer;
110.15 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
110.16 	employees about any proposed changes affecting or relating to the transferred employees' 
110.17 	terms and conditions of employment to the extent such changes are not addressed in the 
110.18 	applicable collective bargaining agreement; and
110.19 	(5) for an employee in a temporary unclassified position transferred to the Office of 
110.20 	Cannabis Management, the total length of time that the employee has served in the 
110.21 	appointment shall include all time served in the appointment at the transferring agency and 
110.22 	the time served in the appointment at the Office of Cannabis Management. An employee 
110.23 	in a temporary unclassified position who was hired by a transferring agency through an 
110.24 	open competitive selection process in accordance with a policy enacted by Minnesota 
110.25 	Management and Budget shall be considered to have been hired through such process after 
110.26 	the transfer.

110.27 	EFFECTIVE DATE. This section is effective July 1, 2024.

110.28 	Sec. 136. LICENSE PREAPPROVAL.
 110.29 		Subdivision 1.Establishment. Prior to the adoption of initial rules pursuant to Minnesota 
110.30 	Statutes, section 342.02, subdivision 5, the Office of Cannabis Management  may issue 
110.31 	license preapprovals to social equity applicants and local units of government as described 
111.1 	in this section. For purposes of this section, "office" means the Office of Cannabis 
111.2 	Management.
111.3 		Subd. 2.Notice. The office must announce the commencement of a license preapproval 
111.4 	application period at least 14 days before the date that the office begins accepting 
111.5 	applications. The announcement must include:
111.6 	(1) the types of license preapprovals that are available;
111.7 	(2) the number of license preapprovals available by license type;
111.8 	(3) the date on which the application period will begin; and
111.9 	(4) the date on which the application period will end.
111.10 		Subd. 3.Application requirements. Only a social equity applicant as described in 
111.11 	Minnesota Statutes, section 342.17, or a local unit of government is eligible for a license 
111.12 	preapproval. The office shall not require an applicant to have legal control of a premises to 
111.13 	operate a cannabis business at the time of the initial application. An applicant for license 
111.14 	preapproval must complete an initial application according to Minnesota Statutes, section 
111.15 	342.14, subdivision 1, on a form approved by the office and pay the application fee required 
111.16 	by Minnesota Statutes, section 342.11, paragraph (b), to the office.
111.17 		Subd. 4.Application review. (a) The office must accept applications for license 
111.18 	preapproval for 30 calendar days during the application period. As part of the application 
111.19 	process, the office must verify the applicant's status as a social equity applicant.
111.20 	(b) The office may deny an application that:
111.21 	(1) is incomplete;
111.22 	(2) contains a materially false statement about the applicant;
111.23 	(3) omits material information about the applicant;
111.24 	(4) fails to meet the minimum qualifications in Minnesota Statutes, section 342.18, 
111.25 	subdivision 3, for a license; or
111.26 	(5) is not submitted by the application deadline.
111.27 	(c) The office may request additional information from an applicant if the office 
111.28 	determines that the information is necessary to review or process the application. If the 
111.29 	applicant does not provide the additional requested information within 14 calendar days, 
111.30 	the office may deny the application.
112.1 	(d) The office may not issue a license preapproval in violation of Minnesota Statutes, 
112.2 	section 342.18, subdivision 2.
112.3 		Subd. 5.Lottery. (a) If the number of available license preapprovals is less than the 
112.4 	number of qualified social equity applicants, the office must conduct a lottery. The lottery 
112.5 	must be impartial, random, and in a format determined by the office. The office shall issue 
112.6 	no more than the following number of license preapprovals per application period:
112.7 	(1) cannabis microbusiness licenses, 100;
112.8 	(2) cannabis mezzobusiness licenses, 15;
112.9 	(3) cannabis cultivator licenses, 11;
112.10 	(4) cannabis manufacturer licenses, six;
112.11 	(5) cannabis retailer licenses, 50;
112.12 	(6) cannabis wholesaler licenses, 20;
112.13 	(7) cannabis transporter licenses, 20;
112.14 	(8) cannabis testing facility licenses, 25;
112.15 	(9) cannabis event organizer licenses, ten; and
112.16 	(10) cannabis delivery service licenses, ten.
112.17 	(b) Of the available license preapprovals listed in paragraph (a), the following number 
112.18 	of license preapprovals will be available for applicants that notify the office they will apply 
112.19 	for a medical retail endorsement and serve the medical registry market for at least three 
112.20 	years:
112.21 	(1) cannabis microbusiness, 20;
112.22 	(2) cannabis mezzobusiness, three; and
112.23 	(3) cannabis retailer, ten.
112.24 	Failure to receive a medical retail endorsement or to serve the medical registry market for 
112.25 	at least three years will result in a revocation of license.
112.26 	(c) The office shall only issue a license preapproval to a local unit of government if, 
112.27 	after issuing license preapprovals to social equity applicants, there are remaining license 
112.28 	preapprovals available. A license preapproval held by a local unit of government must not 
112.29 	count towards the limited number of licenses issued by a local government unit under 
112.30 	Minnesota Statutes, section 342.13.
113.1 	(d) The office must retain applications not selected for a license preapproval and include 
113.2 	them in subsequent lotteries for one year unless the applicant requests to be removed from 
113.3 	consideration or, if the applicant is a business entity, any cooperative member or director, 
113.4 	manager, or general partner of the business entity that has violated this chapter.
113.5 		Subd. 6.Preapproval authority and restrictions. (a) Once the office issues a license 
113.6 	preapproval to an applicant, the license preapproval is effective for 18 months after the date 
113.7 	of issuance or until it is converted to a full license, whichever is shorter. The holder of a 
113.8 	license preapproval may take the necessary steps to prepare for business operations, 
113.9 	including:
113.10 	(1) establishing legal control of the site of the cannabis business;
113.11 	(2) gaining zoning or planning approval for the site of the cannabis business from a local 
113.12 	unit of government; and
113.13 	(3) raising capital for the license holder's business operations.
113.14 	(b) The holder of a license preapproval shall not:
113.15 	(1) engage in purchasing, possessing, cultivating, manufacturing, or selling cannabis or 
113.16 	cannabis products;
113.17 	(2) grow, process, distribute, dispense, or otherwise handle cannabis;
113.18 	(3) make any change or transfer of ownership or control that would require a new business 
113.19 	registration with the secretary of state; or
113.20 	(4) make any transfer of ownership interest that causes the holder of the license 
113.21 	preapproval to no longer qualify as a social equity applicant as defined in Minnesota Statutes, 
113.22 	section 342.17.
113.23 		Subd. 7.Conversion to a full license. The office must convert a license preapproval 
113.24 	into a full license  at no cost to the applicant after the office adopts initial rules pursuant to 
113.25 	Minnesota Statutes, section 342.02, subdivision 5, unless the cannabis business does not 
113.26 	meet local zoning and land use laws. A license that is converted from a license preapproval 
113.27 	according to this subdivision expires 18 months after the date of the conversion to a full 
113.28 	license.
113.29 		Subd. 8.Enforcement and revocation. (a) The office may rescind a social equity 
113.30 	applicant's status as a selected lottery applicant if:
113.31 	(1) there are grounds for revocation under Minnesota Statutes, section 342.21;
113.32 	(2) the applicant is disqualified under Minnesota Statutes section 342.15; or
114.1 	(3) the applicant is determined to be in arrears on property, business, or personal taxes.
114.2 	(b) The office may revoke a license preapproval if the holder of the license preapproval 
114.3 	or, if the license holder is a business entity, any cooperative member or director, manager, 
114.4 	or general partner of the business entity:
114.5 	(1) fraudulently or deceptively obtained the license preapproval;
114.6 	(2) fails to reveal any material fact pertaining to the licensee's qualification for a license;
114.7 	(3) violates this chapter;
114.8 	(4) is not registered or in good standing with the Office of the Secretary of State; or
114.9 	(5) is in arrears on property, business, or personal taxes.
114.10 		Subd. 9.Applicants; right to a reconsideration. (a) If the office denies an application 
114.11 	for a license preapproval or removes an application from a lottery, the applicant may request 
114.12 	a records review of the submitted application materials within seven calendar days of 
114.13 	receiving notification that the office denied the application.
114.14 	(b) Upon an applicant's request, the office must allow the applicant to examine the 
114.15 	applicant's records received by the office.
114.16 	(c) A person whose license preapproval is later revoked by the office may request 
114.17 	reconsideration by the director.
114.18 	(d) A person whose application is denied, removed from a lottery, or not selected in a 
114.19 	lottery may not appeal or request a hearing.
114.20 		Subd. 10.Retention of applications. The office must retain an application that was not 
114.21 	selected in a lottery for one year. The retained application may be entered into subsequent 
114.22 	lotteries during that time.
114.23 		Subd. 11.Expiration. This section expires when the office adopts initial rules pursuant 
114.24 	to Minnesota Statutes, section 342.02, subdivision 5.

114.25 	EFFECTIVE DATE. This section is effective the day following final enactment and 
114.26 	expires when the office adopts initial rules pursuant to Minnesota Statutes, section 342.02, 
114.27 	subdivision 5.

114.28 	Sec. 137. EARLY CULTIVATION.
 114.29 	(a) The Office of Cannabis Management may authorize a social equity applicant with a 
114.30 	license preapproval for a cannabis microbusiness license, cannabis mezzobusiness license, 
114.31 	or cannabis cultivator license, who has provided a certificate from the applicable local unit 
115.1 	of government that states the social equity applicant is in compliance with local zoning 
115.2 	ordinances and state fire and building codes, to grow cannabis plants within the approved 
115.3 	amount of space from seed or immature plant.
115.4 	(b) The office shall require a person cultivating cannabis plants under this section to 
115.5 	comply with any relevant portions of Minnesota Rules, parts 4770.0100 to 4770.4030.
115.6 	(c) The office shall establish temporary guidelines through agency policy. Temporary 
115.7 	guidelines expire when the office adopts initial rules pursuant to Minnesota Statutes, section 
115.8 	342.02, subdivision 5.

115.9 	Sec. 138. TRANSFER OF ACTIVE AND INACTIVE COMPLAINTS.
 115.10 	The Department of Health shall transfer all data, including not public data as defined in 
115.11 	Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive 
115.12 	complaints involving alleged violations of Minnesota Statutes 2022, section 151.72, as well 
115.13 	as registration data collected under Minnesota Statutes 2022, section 151.72, subdivision 
115.14 	5b, to the Office of Cannabis Management. The Department of Health and the Office of 
115.15 	Cannabis Management shall ensure that the transfer takes place in a manner and on a schedule 
115.16 	that prioritizes public health.

115.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

115.18 	Sec. 139. TRANSFER OF MEDICAL PROGRAM.
 115.19 	(a) Notwithstanding the data's classification under Minnesota Statutes, chapter 13, the 
115.20 	Office of Cannabis Management may access data maintained by the commissioner of health 
115.21 	related to the responsibilities transferred under Minnesota Statutes, section 342.02, 
115.22 	subdivision 3. Data sharing authorized by this subdivision includes nonpublic data as defined 
115.23 	in Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive 
115.24 	complaints involving any alleged violation of Minnesota Statutes, sections 152.22 to 152.37, 
115.25 	by a medical cannabis manufacturer. Data sharing under this paragraph further includes 
115.26 	data in patient files maintained by the commissioner and the health care practitioner and 
115.27 	data submitted to or by a medical cannabis manufacturer classified as private data on 
115.28 	individuals, as defined in Minnesota Statutes, section 13.02, subdivision 12, or nonpublic 
115.29 	data, as defined in Minnesota Statutes, section 13.02, subdivision 9. Any data shared under 
115.30 	this section retain the data's classification from the agency holding the data.
115.31 	(b) All rules adopted by the commissioner of health pursuant to Minnesota Statutes, 
115.32 	sections 152.22 to 152.37, including but not limited to Minnesota Rules, chapter 4770, 
116.1 	remain effective and shall be enforced until amended or repealed consistent with Minnesota 
116.2 	Statutes, section 15.039, subdivision 3.
116.3 	(c) The director of the Office of Cannabis Management may use the good cause exempt 
116.4 	rulemaking process under Minnesota Statutes, section 14.388, subdivision 1, clauses (3) 
116.5 	and (4), to copy and adopt any portions of Minnesota Rules, parts 4770.0100 to 4770.4030, 
116.6 	that are necessary to effectuate the transfer of authority granted under Minnesota Statutes, 
116.7 	section 342.02, subdivision 3. The commissioner may make technical changes and any 
116.8 	changes necessary to conform with the transfer of authority. Any change to the rules that 
116.9 	is not authorized under this paragraph must be adopted according to Minnesota Statutes, 
116.10 	sections 14.001 to 14.366.
116.11 	(d) Unless otherwise specified in this section or Minnesota Statutes, section 342.02, 
116.12 	subdivision 3, transfer of the powers, duties, rights, obligations, and other authority imposed 
116.13 	by law on the Department of Health with respect to the medical cannabis program under 
116.14 	Minnesota Statutes 2022, sections 152.22 to 152.37, to the Office of Cannabis Management 
116.15 	is subject to Minnesota Statutes, section 15.039.

116.16 	EFFECTIVE DATE. This section is effective the day following final enactment.

116.17 	Sec. 140. REPEALER.
 116.18 	(a) Minnesota Statutes 2023 Supplement, sections 342.01, subdivisions 28, 52, 53, 54, 
116.19 	and 55; 342.27, subdivision 13; and 342.29, subdivision 9, are repealed.
116.20 	(b) Minnesota Statutes 2023 Supplement, sections 342.47; 342.48; 342.49; 342.50; and 
116.21 	342.52, subdivision 8, are repealed.
116.22 	(c) Laws 2023, chapter 63, article 7, sections 4; and 6, are repealed.
116.23 	(d) Minnesota Statutes 2022, sections 152.22, subdivision 3; and 152.36, are repealed.

116.24 	EFFECTIVE DATE. Paragraphs (a) and (b) are effective the day following final 
116.25 	enactment. Paragraphs (c) and (d) are effective July 1, 2024.

APPENDIX 

Repealed Minnesota Statutes: UEH4757-1 

152.22 DEFINITIONS.Subd. 3.Disqualifying felony offense. 
"Disqualifying felony offense" means a violation of a state or federal controlled substance law that is a felony under Minnesota law, or would be a felony if committed in Minnesota, regardless of the sentence imposed, unless the commissioner determines that the person's conviction was for the medical use of cannabis or assisting with the medical use of cannabis. 

152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC RESEARCH.Subdivision 1.Task force on medical cannabis therapeutic research. 
(a) A 23-member task force on medical cannabis therapeutic research is created to conduct an impact assessment of medical cannabis therapeutic research. The task force shall consist of the following members: 

(1) two members of the house of representatives, one selected by the speaker of the house, the other selected by the minority leader; 

(2) two members of the senate, one selected by the majority leader, the other selected by the minority leader; 

(3) four members representing consumers or patients enrolled in the registry program, including at least two parents of patients under age 18; 

(4) four members representing health care providers, including one licensed pharmacist; 

(5) four members representing law enforcement, one from the Minnesota Chiefs of Police Association, one from the Minnesota Sheriff's Association, one from the Minnesota Police and Peace Officers Association, and one from the Minnesota County Attorneys Association; 

(6) four members representing substance use disorder treatment providers; and 

(7) the commissioners of health, human services, and public safety. 

(b) Task force members listed under paragraph (a), clauses (3), (4), (5), and (6), shall be appointed by the governor under the appointment process in section 15.0597. Members shall serve on the task force at the pleasure of the appointing authority. All members must be appointed by July 15, 2014, and the commissioner of health shall convene the first meeting of the task force by August 1, 2014. 

(c) There shall be two cochairs of the task force chosen from the members listed under paragraph (a). One cochair shall be selected by the speaker of the house and the other cochair shall be selected by the majority leader of the senate. The authority to convene meetings shall alternate between the cochairs. 

(d) Members of the task force other than those in paragraph (a), clauses (1), (2), and (7), shall receive expenses as provided in section 15.059, subdivision 6. 

Subd. 1a.Administration. 
The commissioner of health shall provide administrative and technical support to the task force. 

Subd. 2.Impact assessment. 
The task force shall hold hearings to evaluate the impact of the use of medical cannabis and hemp and Minnesota's activities involving medical cannabis and hemp, including, but not limited to: 

(1) program design and implementation; 

(2) the impact on the health care provider community; 

(3) patient experiences; 

(4) the impact on the incidence of substance abuse; 

(5) access to and quality of medical cannabis, hemp, and medical cannabis products; 

(6) the impact on law enforcement and prosecutions; 

(7) public awareness and perception; and 

(8) any unintended consequences. 

Subd. 3.Cost assessment. 
By January 15 of each year, beginning January 15, 2015, and ending January 15, 2019, the commissioners of state departments impacted by the medical cannabis therapeutic research study shall report to the cochairs of the task force on the costs incurred by each department on implementing sections 152.22 to 152.37. The reports must compare actual costs to the estimated costs of implementing these sections and must be submitted to the task force on medical cannabis therapeutic research. 

Subd. 4.Reports to the legislature. 
(a) The cochairs of the task force shall submit the following reports to the chairs and ranking minority members of the legislative committees and divisions with jurisdiction over health and human services, public safety, judiciary, and civil law: 

(1) by February 1, 2015, a report on the design and implementation of the registry program; and every two years thereafter, a complete impact assessment report; and 

(2) upon receipt of a cost assessment from a commissioner of a state agency, the completed cost assessment. 

(b) The task force may make recommendations to the legislature on whether to add or remove conditions from the list of qualifying medical conditions. 

Subd. 5.No expiration. 
The task force on medical cannabis therapeutic research does not expire. 

342.01 DEFINITIONS.Subd. 28.Division of Medical Cannabis. 
"Division of Medical Cannabis" means a division housed in the Office of Cannabis Management that operates the medical cannabis program. 

Subd. 52.Medical cannabinoid product. 
(a) "Medical cannabinoid product" means a product that: 

(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with cannabinoids, including but not limited to artificially derived cannabinoids; and 

(2) is provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a cannabis retailer or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical condition. 

(b) A medical cannabinoid product must be in the form of: 

(1) liquid, including but not limited to oil; 

(2) pill; 

(3) liquid or oil for use with a vaporized delivery method; 

(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles; 

(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and sublingual tablets; 

(6) edible products in the form of gummies and chews; 

(7) topical formulation; or 

(8) any allowable form or delivery method approved by the office. 

(c) Medical cannabinoid product does not include adult-use cannabis products or hemp-derived consumer products. 

Subd. 53.Medical cannabis business. 
"Medical cannabis business" means an entity licensed under this chapter to engage in one or more of the following: 

(1) the cultivation of cannabis plants for medical cannabis flower; 

(2) the manufacture of medical cannabinoid products; and 

(3) the retail sale of medical cannabis flower and medical cannabinoid products. 

Subd. 54.Medical cannabis flower. 
"Medical cannabis flower" means cannabis flower provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a cannabis retailer or medical cannabis business to treat or alleviate the symptoms of a qualifying medical condition. Medical cannabis flower does not include adult-use cannabis flower. 

Subd. 55.Medical cannabis paraphernalia. 
"Medical cannabis paraphernalia" means a delivery device, related supply, or educational material used by a patient enrolled in the registry program to administer medical cannabis and medical cannabinoid products. 

342.27 RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS; GENERAL REQUIREMENTS.Subd. 13.Adult-use and medical cannabis; colocation. 
(a) A cannabis business with a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis flower and medical cannabinoid products on a portion of the business's premises. 

(b) The premises must provide an appropriate space for a pharmacist employee of the medical cannabis retailer to consult with a patient to determine the proper type of medical cannabis flower and medical cannabinoid products and proper dosage for the patient. 

342.29 CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.Subd. 9.Medical cannabis endorsement. 
A cannabis mezzobusiness that cultivates cannabis plants for use as medical cannabis flower or for use in medical cannabinoid products, processes medical cannabinoid products, or both, must comply with sections 342.49, paragraph (d); 342.50, paragraph (c), and any additional requirements established by the office. 

342.47 MEDICAL CANNABIS BUSINESS LICENSES.Subdivision 1.License types. 
(a) The office shall issue the following types of medical cannabis business licenses: 

(1) medical cannabis cultivator; 

(2) medical cannabis processor; 

(3) medical cannabis retailer; and 

(4) medical cannabis combination business license. 

(b) The Division of Medical Cannabis may oversee the licensing and regulation of medical cannabis businesses. 

Subd. 2.Multiple licenses; limits. 
(a) Except as provided in subdivision 3, a person, cooperative, or business holding: 

(1) a medical cannabis cultivator license may also hold a medical cannabis processor license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; 

(2) a medical cannabis processor license may also hold a medical cannabis cultivator license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; or 

(3) a medical cannabis retailer license may also hold a cannabis mezzobusiness license, a cannabis retailer license, a cannabis delivery service license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses. 

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a medical cannabis license may own or operate any other cannabis business or hemp business. 

(c) The office by rule may limit the number of medical cannabis business licenses that a person or business may hold. 

(d) For purposes of this subdivision, a restriction on the number of licenses or type of license that a business may hold applies to every cooperative member or every director, manager, and general partner of a medical cannabis business. 

Subd. 3.Medical cannabis combination business license. 
(a) A person, cooperative, or business holding a medical cannabis combination license is prohibited from owning or operating any other cannabis business or hemp business. 

(b) A person or business may only hold one medical cannabis combination license. 

342.48 MEDICAL CANNABIS BUSINESS APPLICATIONS.
In addition to the information required to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business seeking a medical cannabis business license must submit the following information in a form approved by the office: 

(1) for medical cannabis cultivator license applicants: 

(i) an operating plan demonstrating the proposed size and layout of the cultivation facility; plans for wastewater and waste disposal for the cultivation facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the cultivation facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) a cultivation plan demonstrating the proposed size and layout of the cultivation facility that will be used exclusively for cultivation for medical cannabis, including the total amount of plant canopy; and 

(iii) evidence that the business will comply with the applicable operation requirements for the license being sought; 

(2) for medical cannabis processor license applicants: 

(i) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems; plans for wastewater and waste disposal for the manufacturing facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the manufacturing facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) all methods of extraction and concentration that the applicant intends to use and the volatile chemicals, if any, that are involved in extraction or concentration; 

(iii) if the applicant is seeking an endorsement to manufacture products infused with cannabinoids for consumption by patients enrolled in the registry program, proof of an edible cannabinoid product handler endorsement from the office; and 

(iv) evidence that the applicant will comply with the applicable operation requirements for the license being sought; 

(3) for medical cannabis retailer license applicants: 

(i) a list of every retail license held by the applicant and, if the applicant is a business, every retail license held, either as an individual or as part of another business, by each officer, director, manager, and general partner of the cannabis business; 

(ii) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems, policies to avoid sales to individuals who are not authorized to receive the distribution of medical cannabis flower or medical cannabinoid products, identification of a restricted area for storage, and plans to prevent the visibility of cannabis flower and cannabinoid products; and 

(iii) evidence that the applicant will comply with the applicable operation requirements for the license being sought; or 

(4) for medical cannabis combination license applicants: 

(i) the information required under clauses (1) to (3); and 

(ii) any additional information required under sections 342.30, subdivision 3; 342.31, subdivision 3; and 342.32, subdivision 3. 

342.49 MEDICAL CANNABIS CULTIVATORS.
(a) A medical cannabis cultivator license entitles the license holder to grow cannabis plants within the approved amount of space up to 60,000 square feet of plant canopy from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to medical cannabis processors and medical cannabis retailers, transport medical cannabis flower to a medical cannabis processor located on the same premises, and perform other actions approved by the office. 

(b) A medical cannabis cultivator license holder must comply with all requirements of section 342.25. 

(c) A medical cannabis cultivator license holder must verify that every batch of medical cannabis flower has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower before the medical cannabis cultivator may package, label, or sell the medical cannabis flower to any other entity. 

(d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April 1, 2023. 

342.50 MEDICAL CANNABIS PROCESSORS.
(a) A medical cannabis processor license, consistent with the specific license endorsement or endorsements, entitles the license holder to: 

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from medical cannabis cultivators and other medical cannabis processors; 

(2) purchase hemp plant parts from industrial hemp growers; 

(3) make cannabis concentrate from medical cannabis flower; 

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight; 

(5) manufacture medical cannabinoid products; 

(6) package and label medical cannabinoid products for sale to other medical cannabis processors and to medical cannabis retailers; and 

(7) perform other actions approved by the office. 

(b) A medical cannabis processor license holder must comply with all requirements of section 342.26, including requirements to obtain specific license endorsements. 

(c) A medical cannabis processor license holder must verify that every batch of medical cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabinoid products before the medical cannabis processor may package, label, or sell the medical cannabinoid product to any other entity. 

342.52 PATIENT REGISTRY PROGRAM.Subd. 8.Allowable delivery methods. 
A patient in the registry program may receive medical cannabis flower and medical cannabinoid products. The office may approve additional delivery methods to expand the types of products that qualify as medical cannabinoid products. 

Repealed Minnesota Session Laws: UEH4757-1 

Laws 2023, chapter 63, article 7, section 4
Sec. 4. EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT. 
(a) The Department of Health shall enforce the provisions of Minnesota Statutes, section 151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements, and registrations related to that section adopted or issued by the Office of Medical Cannabis or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993 contained in Minnesota Statutes, sections 144.989 to 144.993, and the authority to embargo products described in paragraph (b). The commissioner of health may assign enforcement responsibilities to the Office of Medical Cannabis. 

(b) Whenever a duly authorized agent of the Department of Health finds or has probable cause to believe that any product is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the agent shall affix thereto an appropriate marking, giving notice that the article is, or is suspected of being in violation of Minnesota Statutes, section 151.72, has been embargoed, and warning that it is unlawful for any person to remove or dispose of the embargoed article by sale or otherwise without permission from the agent or the court. When an agent of the Department of Health has embargoed an article, the Department of Health shall, within 30 days, petition the district court in whose jurisdiction the article is embargoed for an order of condemnation. When an embargoed article is not so found by the agent, the agent shall remove the marking. If the court finds that an embargoed article is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the article shall be destroyed at the expense of the claimant thereof, who shall also pay all court costs and fees, storage, and other proper expenses. If the violation can be corrected by proper labeling or processing of the article, or by filing the proper documents with the court, the court, after the costs, fees, and expenses have been paid and a sufficient bond has been executed, may order that the article be delivered to the claimant for labeling, processing, or filing under supervision of an agent of the board. The expense of the supervision shall be paid by the claimant. The bond shall be returned to the claimant on the representation to the court by the board that the article is no longer in violation of this chapter and that the expenses of supervision have been paid. 

(c) The enforcement authority under paragraphs (a) and (b) shall transfer to the Office of Cannabis Management at any such time that the powers and duties of the Department of Health with respect to the medical cannabis program under Minnesota Statutes, sections 152.22 to 152.37, are transferred to the Office of Cannabis Management. The director of the Office of Cannabis Management may assign enforcement responsibilities to the Division of Medical Cannabis. 

(d) This section shall expire on March 1, 2025. 

EFFECTIVE DATE. 
This section is effective the day following final enactment. 

Laws 2023, chapter 63, article 7, section 6
Sec. 6. REPEALER. Minnesota Statutes 2022, section 151.72, is repealed.
EFFECTIVE DATE. 
This section is effective March 1, 2025.